European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Open accessAbstract
atrial tachycardias. . . . . .
AI snapshot
Written from the paper’s full text.
TL;DR
This EHRA consensus document summarizes diagnosis and management of supraventricular arrhythmias other than atrial fibrillation, integrating evidence and expert opinion. It emphasizes ECG/EP diagnosis, acute and chronic drug therapy, and catheter ablation, which is often recommended as first-line therapy in symptomatic SVT.
Key findings
- In a 3.5% sample of Marshfield Epidemiologic Study Area records, paroxysmal SVT prevalence was 2.25/1000 persons and incidence was 35/100,000 person-years, translating to an estimated 89,000 new cases/year and 570,000 patients with paroxysmal SVT in the USA. Atrial flutter incidence was 88/100,000 person-years, with 200,000 new US cases annually; 58% of AFL patients also had AF.
- Among 1754 patients undergoing catheter ablation, AVNRT was the most common mechanism (56%), followed by AVRT (27%) and atrial tachycardia (17%). In the first Latin American Catheter Ablation Registry of 15,099 procedures, AVRT was most frequently ablated (31%), followed by AVNRT (29%), typical AFL (14%), and AF (11%).
- Catheter ablation outcomes: slow pathway ablation for AVNRT had a 95% success rate, 0.5–1% risk of AV block, and 4% recurrence; typical AFL ablation with complete bidirectional cavotricuspid isthmus block had <10% recurrence; focal atrial tachycardia ablation success was 75–100%.
- In an 8-year prospective registry of 550 initially asymptomatic subjects with ventricular pre-excitation, ventricular fibrillation developed in 2.4% and malignant arrhythmias in 8.7%; risk stratification by electrophysiologic testing and ablation were considered for high-risk features such as accessory pathway anterograde refractory period <240 ms, inducible AVRT triggering pre-excited AF, and multiple accessory pathways.
Methods
- Design: EHRA consensus document endorsed by HRS, APHRS, and SOLAECE; it is not a primary study and explicitly does not cover atrial fibrillation.
- Data: narrative synthesis of published evidence and expert opinion from several countries, including cited registries and trials such as MESA, the Latin American Catheter Ablation Registry (15,099 procedures), and prospective WPW registries (550 and 2169 patients).
- Analysis: consensus recommendations graded with heart symbols; the document states that EHRA grading of consensus statements does not have separate definitions of Level of Evidence and is not directly similar to official society guideline classification/level systems.
Limitations
- Stated: the document includes evidence and expert opinions from several countries; pharmacologic and non-pharmacologic approaches may include drugs without governmental regulatory approval in all countries; grading is not directly comparable to official society guideline recommendations and lacks separate Level of Evidence definitions.
- Stated/evident: many recommendations are supported by strong observational evidence and authors’ consensus but no specific RCT; randomized data are limited or absent for several areas, including antiarrhythmic drugs in adult congenital heart disease, pregnancy, anticoagulation in atrial flutter, and asymptomatic WPW (two randomized trials based on small numbers).
- Evident: the text notes sparse and old epidemiologic data, poor distinction between AF, AFL, and other supraventricular arrhythmias, and many studies that are small, non-randomized, or have short follow-up.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 467 cited sources checked · 0 supported · 0 flagged
- Findingnone given
In supraventricular tachycardia, most economic analysis interest has focused on ablation techniques.
“In the case of SVT most of the interest in economic analysis has been focused on ablation techniques.”
Quote in the paperNot a substantial claim - Findingcitation
Cheng et al. compared radiofrequency ablation with pharmacological treatment in a Markov model in highly symptomatic adults with monthly supraventricular tachycardia recurrences, excluding patients with Wolff-Parkinson-White syndrome.
“Cheng et al. compared, in a Markov model, RF ablation vs. pharmacological treatment (continuous or only at the time of arrhythmia recurrence) in highly symptomatic adult patients with monthly recurrences of SVTs, excluding patients with WPW syndrome.247”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Cheng, 2000, Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia, Ann Intern Med source
Not checked in the free run.
- Findingcitation
In a 5-year study of patients with mild-to-moderate symptomatic supraventricular tachycardia, Goldberg et al. found that radiofrequency ablation compared with pharmacological treatment was associated with sustained improvement in quality of life and reduction in disease-specific symptoms, particularly in women and patients aged under 50 years.
“In a 5-year study performed in patients with mild-to-moderate symptomatic SVT, Goldberg et al. found that RF ablation when compared to pharmacological treatment was associated with a sustained improvement in QoL and a reduction in disease-specific symptoms, particularly in women and patients aged ,50 years.254”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [254] Goldberg, 2002, Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy), Am J Cardiol source
Not checked in the free run.
- Findingcitation
The foetus has been shown to have a high fibrillation threshold.
“the foetus has been shown to have a high fibrillation threshold.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [402] Tromp, 2011, Electrical cardioversion during pregnancy: safe or not?, Neth Heart J source
Not checked in the free run.
- Findingcitation
Long-term use of atenolol has been associated with intrauterine growth retardation, especially when given in early pregnancy.
“Long-term use of atenolol has been associated with intrauterine growth retardation, especially when given in early pregnancy, 409”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [409] Lydakis, 1999, Atenolol and fetal growth in pregnancies complicated by hypertension, Am J Hypertens source
Not checked in the free run.
- Findingcitation
Foetal bradycardia has been reported with verapamil.
“Bradycardia in the foetus has however been reported and caution is advised.406”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [406] Joglar, 2001, Antiarrhythmic drugs in pregnancy, Curr Opin Cardiol source
Not checked in the free run.
- Findingcitation
Radiofrequency ablation was highly cost-effective (dominant) compared with medical treatment of supraventricular tachycardia in adults in Latin America (Guatemala).
“RF ablation was also found highly cost-effective ('dominant') in a comparative study vs. medical treatment of SVT of adult patients in Latin America (Guatemala) (Table 21).416”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [416] Rodriguez, 2015, Cost-Effectiveness of radiofrequency ablation for supraventricular tachycardia in Guatemala: patient outcomes and economic analysis from a low-middle-income country, Value Health Reg Issues source
Not checked in the free run.
- Findingcitation
Adenosine has been used safely for termination of supraventricular tachycardia in pregnant women.
“Adenosine has been used safely for termination of SVT in pregnant women, 400”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [400] Elkayam, 1995, Adenosine therapy for supraventricular tachycardia during pregnancy, Am J Cardiol source
Not checked in the free run.
- Findingcitation
Symptoms during arrhythmia episodes are more pronounced in pregnant women than in the non-pregnant state.
“as well as more pronounced symptoms during arrhythmia episodes than in the non-pregnant state.398”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [398] Lee, 1995, Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia, Am J Cardiol source
Not checked in the free run.
- Findingcitation
Flecainide and sotalol appear well tolerated and reasonably safe, based on limited data.
“Although based on limited data flecainide and sotalol appear to be well tolerated and reasonably safe.406”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [406] Joglar, 2001, Antiarrhythmic drugs in pregnancy, Curr Opin Cardiol source
Not checked in the free run.
- Findingcitation
An increased incidence of supraventricular tachycardia during pregnancy has been described.
“Although often well tolerated, an increased incidence of SVT during pregnancy has been described, 396,397”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingcitation
Transient foetal arrhythmias have been reported after direct current cardioversion.
“since transient foetal arrhythmias have been reported, foetal rhythm monitoring is recommended.402,410”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [402] Tromp, 2011, Electrical cardioversion during pregnancy: safe or not?, Neth Heart J source
Not checked in the free run.
- cites [410] Barnes, 2002, Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section, BJOG source
Not checked in the free run.
- Findingcitation
Verapamil is associated with a higher degree of maternal hypotension and subsequent foetal hypoperfusion.
“Verapamil is associated with a higher degree of maternal hypotension and subsequent foetal hypoperfusion”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [403] Ghosh, 2011, The acute treatment of maternal supraventricular tachycardias during pregnancy: a review of the literature, J Obstet Gynaecol Can source
Not checked in the free run.
- Findingcitation
Disopyramide has been associated with contractions of the uterus.
“the latter has been associated with contractions of the uterus.406”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [406] Joglar, 2001, Antiarrhythmic drugs in pregnancy, Curr Opin Cardiol source
Not checked in the free run.
- Findingcitation
The main concern with beta-blockers in pregnancy is intrauterine growth retardation.
“The main concern is related to intrauterine growth retardation.404”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [404] Ersbøll, 2014, Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction, BJOG source
Not checked in the free run.
- Findingcitation
One day of hospitalization costs ranges from $476-835 in European countries to $4287 on average in the USA.
“It is worth emphasizing that one day of hospitalization has important costs, ranging from $476 -835 in European countries to $4287 (on average) in the USA.415”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [415] 2012
Not checked in the free run.
- Findingcitation
The current reaching the foetus during direct current cardioversion is insignificant.
“The current reaching the foetus is insignificant”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [402] Tromp, 2011, Electrical cardioversion during pregnancy: safe or not?, Neth Heart J source
Not checked in the free run.
- Findingcitation
Experience with propafenone and disopyramide is more limited.
“The experience with propafenone and disopyramide is more limited”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [406] Joglar, 2001, Antiarrhythmic drugs in pregnancy, Curr Opin Cardiol source
Not checked in the free run.
- Findingcitation
Intravenous beta blockers are inferior to adenosine in converting episodes of supraventricular tachycardia.
“Beta blockers intravenously are inferior to adenosine in converting episodes but can be used as a second choice.401”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [401] Frishman, 1988, Beta-adrenergic blockers in pregnancy, Am Heart J source
Not checked in the free run.
- Findingcitation
Costs of radiofrequency catheter ablation procedures vary from $5000 to $16000, varying by setting, country, and whether actual costs or billed hospital charges are considered.
“With regard to the costs of radiofrequency catheter ablation procedures, variable data have been reported in literature (from $5000 to $16 000), varying not only according to setting and country but also according to consideration of actual costs or billed hospital charges.258”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [258] Bathina, 1998, Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs, Am J Cardiol source
Not checked in the free run.
- Findingcitation
Many centres have successfully adopted the strategy of performing supraventricular tachycardia ablation without overnight hospital stay if the procedure was uncomplicated and the patient was clinically stable.
“Recently, many centres have successfully adopted the strategy of performing ablation procedures for SVT without overnight hospital stay, provided that the procedure was not complicated and the patient status was clinically stable.”
Quote in the paperNot a substantial claim - Findingreasoning
The latest ACC/AHA/HRS guidelines for supraventricular tachycardia do not make recommendations for ablation or medical therapy on the basis of their effect on patient-reported quality of life.
“As a result the latest ACC/AHA/HRS guidelines for SVT do not make recommendations for ablation or medical therapy on the basis of their effect on patient-reported QoL. 2”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- Findingcitation
With the advent of catheter ablation in the 1990s resulting in successful elimination of accessory pathways in symptomatic patients, atrioventricular reentrant tachycardia nowadays represents less than 30% of all supraventricular tachycardias.
“With the advent of catheter ablation in the 1990s resulting in successful elimination of accessory pathways in symptomatic patients, AVRT nowadays represents less than 30% of all SVTs.9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Porter, 2004, Influence of age and gender on the mechanism of supraventricular tachycardia, Heart Rhythm source
Not checked in the free run.
- Findingcitation
Patients with supraventricular tachycardia may commonly experience symptoms such as dyspnoea, fatigue, palpitations, and pre-syncope/syncope, which vary in frequency, duration, and intensity.
“Patients with SVT may commonly experience symptoms such as dyspnoea, fatigue, palpitations, and pre-syncope/syncope, which vary in frequency, duration, and intensity.1,2,16,420,421”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [1] Blomstrom-Lundqvist, 2003, Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular A. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias), Circulation source
Not checked in the free run.
- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- cites [16] Wood, 1997, Frequency of disabling symptoms in supraventricular tachycardia, Am J Cardiol source
Not checked in the free run.
- cites [420] Wood, 2007, Supraventricular tachycardia and the struggle to be believed, Eur J Cardiovasc Nurs source
Not checked in the free run.
- cites [421] Wood, 2009, Development and initial psychometric evaluation of the Patient Perspective of Arrhythmia Questionnaire, Res Nurs Health source
Not checked in the free run.
- Findingcitation
In patients with symptoms controlled by medications, the upfront cost of ablation therapy is equalled over time by cumulative medical therapy, usually after around 10 years.
“In patients with symptoms that can be controlled with medications, the upfront cost of ablation therapy is equalled, with time, by the cumulative cost of medical therapy, usually after a period of around 10 years.258”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [258] Bathina, 1998, Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs, Am J Cardiol source
Not checked in the free run.
- Findingcitation
Several studies have investigated patient-reported quality of life and may offer some insight into patient preferences where particular therapies result in improvements in quality of life.
“Several studies have investigated patient-reported QoL, 2,245,246,254 -256,258,424,425 and these may offer some insight into patient preferences for treatment where particular therapies result in improvements in QoL.”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- cites [245] Farkowski, 2014, Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study, Europace source
Not checked in the free run.
- cites [246] Wood, 2010, Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia, Heart Lung source
Not checked in the free run.
- cites [254] Goldberg, 2002, Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy), Am J Cardiol source
Not checked in the free run.
- cites [255] Larson, 1999, Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia, Am J Cardiol source
Not checked in the free run.
- cites [256] Bubien, 1996, Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias, Circulation source
Not checked in the free run.
- cites [258] Bathina, 1998, Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs, Am J Cardiol source
Not checked in the free run.
- cites [424] Meissner, 2009, Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. results from a large retrospective patient cohort, Int J Med Sci source
Not checked in the free run.
- cites [425] Yildirim, 2012, The effect of radiofrequency ablation treatment on quality of life and anxiety in patients with supraventricular tachycardia, Eur Rev Med Pharmacol Sci
Not checked in the free run.
- Findingcitation
Every study has demonstrated an improvement in self-reported quality of life following ablation.
“Every study has demonstrated an improvement in self-reported QoL following ablation.2,245,246,254 -256,258,424,425”
Quote in the paperNot a substantial claim0 of 9 sources checked- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- cites [245] Farkowski, 2014, Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study, Europace source
Not checked in the free run.
- cites [246] Wood, 2010, Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia, Heart Lung source
Not checked in the free run.
- cites [254] Goldberg, 2002, Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy), Am J Cardiol source
Not checked in the free run.
- cites [255] Larson, 1999, Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia, Am J Cardiol source
Not checked in the free run.
- cites [256] Bubien, 1996, Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias, Circulation source
Not checked in the free run.
- cites [258] Bathina, 1998, Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs, Am J Cardiol source
Not checked in the free run.
- cites [424] Meissner, 2009, Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. results from a large retrospective patient cohort, Int J Med Sci source
Not checked in the free run.
- cites [425] Yildirim, 2012, The effect of radiofrequency ablation treatment on quality of life and anxiety in patients with supraventricular tachycardia, Eur Rev Med Pharmacol Sci
Not checked in the free run.
- Findingreasoning
To date there is scant evidence to advocate patient values or preferences for particular treatment modalities for supraventricular tachycardia because the patient's perspective has not been specifically explored in research studies in this patient group.
“To date there is scant evidence to advocate patient values or preferences for particular treatment modalities for SVT since the patient's perspective has not been specifically explored in research studies in this patient group.”
Quote in the paperSubstantial claim - Findingcitation
A retrospective study analysed 1142 patients who underwent elective electrophysiology procedures with or without radiofrequency ablation for supraventricular tachycardia.
“This strategy was analysed in a retrospective study of 1142 patients who underwent elective EP procedures with or without RF ablation for SVT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [418] Theodoreson, 2015, Same-day cardiac catheter ablation is safe and cost-effective: experience from a UK tertiary center, Heart Rhythm source
Not checked in the free run.
- Findingcitation
Spontaneous atrioventricular nodal reentrant tachycardia has been identified as a potential first clinical manifestation of concealed Brugada syndrome, particularly in female patients.
“Spontaneous AVNRT has also been identified as a potential first clinical manifestation of concealed Brugada syndrome, particularly in female patients.226”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [226] Hasdemir, 2015, High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia, Heart Rhythm source
Not checked in the free run.
- Findingcitation
The R302Q mutation in PRKAG2 has been associated with Mahaim fibres.
“The R302Q mutation in PRKAG2 has been associated with Mahaim fibres.431”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [431] Tan, 2008, Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development, Circ Arrhythm Electrophysiol source
Not checked in the free run.
- Findingcitation
A novel form of Wolff-Parkinson-White syndrome is associated with microdeletion in the region of gene BMP2, which affects development of the annulus fibrosus.
“A novel form of WPW syndrome is associated with microdeletion in the region of gene BMP2, that encodes the bone morphogenetic protein-2, a member of the transforming growth factor (TGF-b) gene superfamily, and affects the development of annulus fibrosus.432”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [432] Lalani, 2009, 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits, J Med Genet source
Not checked in the free run.
- Premisecitation
Compared with patients with other cardiovascular disease, those with lone paroxysmal SVT were younger (mean 37 vs 69 years).
“Compared with patients with other cardiovascular disease, those with lone paroxysmal SVT were younger (mean 37 vs. 69 years)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Atrial flutter was 3.5-fold more common in subjects with heart failure.
“3.5-fold more common in subjects with heart failure”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
A change in ventricular cycle length preceding the change in subsequent atrial cycle length favours typical AVNRT or AVRT.
“A change in ventricular CL preceding the change in subsequent atrial CL favours typical AVNRT or AVRT.19”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Crawford, 2007, Utility of atrial and ventricular cycle length variability in determining the mechanism of paroxysmal supraventricular tachycardia, J Cardiovasc Electrophysiol source
Not checked in the free run.
- Premisecitation
In MESA, other cardiovascular disease was present in 90% of males and 48% of females with paroxysmal SVT.
“In MESA, other cardiovascular disease was present in 90% of males, and 48% of females.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Syncope may be present in up to 20% of patients presenting with a narrow QRS complex tachycardia.
“Syncope may be present in up to 20% of patients presenting with a narrow QRS complex tachycardia.16”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Wood, 1997, Frequency of disabling symptoms in supraventricular tachycardia, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Not all patients with manifest ventricular preexcitation develop paroxysmal SVT.
“However, not all patients with manifest ventricular preexcitation develop paroxysmal SVT.6,8”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [6] Lu, 2014, Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation, Int J Cardiol source
Not checked in the free run.
- cites [8] Whinnett, 2012, Diagnosis and management of supraventricular tachycardia, BMJ source
Not checked in the free run.
- Premisecitation
Rarely, recording of U waves during typical AVNRT may simulate a long RP tachycardia.
“Rarely, recording of U waves during typical AVNRT may simulate a long RP tachycardia.21”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Bogossian, 2015, U wave during supraventricular tachycardia: simulation of a long RP tachycardia and hiding the common type AVNRT, Ann Noninvasive Electrocardiol source
Not checked in the free run.
- Premisecitation
Most common symptoms during sustained SVT may imitate panic disorders.
“Most common symptoms during sustained SVT imitating panic disorders.12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Lessmeier, 1997, Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder, Arch Intern Med source
Not checked in the free run.
- Premisecitation
Atrial flutter was 1.9-fold more common in subjects with chronic obstructive pulmonary disease.
“and 1.9-fold more common in subjects with chronic obstructive pulmonary disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
In case of relatively delayed retrograde conduction that allows identification of retrograde P waves, a pseudo-R deflection in lead V1 and a pseudo S wave in the inferior leads are more common in typical AVNRT rather than in AVRT due to an accessory pathway or atrial tachycardia.
“In case of relatively delayed retrograde conduction that allows the identification of retrograde P waves, a pseudo-R deflection in lead V1 and a pseudo S wave in the inferior leads are more common in typical AVNRT rather than in AVRT due to an accessory pathway or atrial tachycardia.22,23”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [22] Kalbfleisch, 1993, Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram, J Am Coll Cardiol source
Not checked in the free run.
- cites [23] Tai, 1997, A new electrocardiographic algorithm using retrograde P waves for differentiating atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Compared with patients with other cardiovascular disease, those with lone paroxysmal SVT had a faster paroxysmal SVT heart rate (mean 186 vs 155 beats/min).
“had a faster paroxysmal SVT heart rate (mean 186 vs. 155 beats/min)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Breathlessness may be related to a tachycardia-mediated cardiomyopathy if untreated SVT persists for weeks to months with a fast ventricular response, leading to dilation and impaired left ventricular function.
“Breathlessness may be related to a tachycardia-mediated cardiomyopathy if the untreated SVT persists for weeks to months with a fast ventricular response, leading to dilation and impaired left ventricular function.14”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Ellis, 2013, What about Tachycardia-induced cardiomyopathy?, Arrhythm Electrophysiol Rev source
Not checked in the free run.
- Premisecitation
Onset of symptoms occurred during childbearing years in 58% of females with lone paroxysmal SVT versus 9% of females with other cardiovascular disease.
“The onset of symptoms occurred during the childbearing years in 58% of females with lone paroxysmal SVT, vs. 9% of females with other cardiovascular disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Females had a 2-fold greater relative risk of paroxysmal SVT than males.
“Overall, females had 2-fold greater relative risk (RR) of paroxysmal SVT compared with males.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Compared with patients with other cardiovascular disease, those with lone paroxysmal SVT were more likely to have their condition first documented in the emergency room (69% vs 30%).
“and were more likely to have their condition first documented in the emergency room (69% vs. 30%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
This algorithm has not been validated in other studies.
“but this algorithm has not been validated in other studies.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Steurer, 1994, The differential diagnosis on the electrocardiogram between ventricular tachycardia and preexcited tachycardia, Clin Cardiol source
Not checked in the free run.
- Premisecitation
A RBBB morphology with a R:S ratio in V6 of less than 1 is seen rarely in SVT with aberrancy, mainly when the patient has a left axis deviation during sinus rhythm.
“A RBBB morphology with a R:S ratio in V 6 of less than 1 is seen rarely in SVT with aberrancy, mainly when the patient has a left axis deviation during sinus rhythm.56”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Wellens, 1978, The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex, Am J Med source
Not checked in the free run.
- Premisecitation
The R-wave peak time at lead II ≥50 ms, independent of whether the complex is positive or negative, has been reported to have a sensitivity of 93% and a specificity of 99% for identifying VT.
“The R-wave peak time (RWPT) at lead II ≥50 ms, independent of whether the complex is positive or negative, has been reported to have a sensitivity of 93%, and a specificity of 99%, for identifying VT (Figure 8), 61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Pava, 2010, R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias, Heart Rhythm source
Not checked in the free run.
- Premisecitation
Extreme left axis deviation (axis from -90° to +180°) strongly suggests VT both in the presence of RBBB and LBBB patterns.
“In particular, extreme left axis deviation (axis from 2908 to +1808) strongly suggests VT both in the presence of RBBB and LBBB patterns.56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Wellens, 1978, The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex, Am J Med source
Not checked in the free run.
- Premisecitation
Class Ic and Ia drugs and class III drugs can both result in atypical BBB morphologies during SVT that mimics VT.
“They can both result in atypical BBB morphologies during SVT that mimics VT.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [54] Crijns, 1993, Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [55] Crijns, 1988, Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment, Am J Cardiol source
Not checked in the free run.
- Premisecitation
The Brugada et al. algorithm, when all 4 steps are applied, has a sensitivity and specificity of 98.7% and 96.5%, respectively.
“The Brugada et al. algorithm, when all 4 steps are applied, has a sensitivity and specificity of 98.7% and 96.5%, respectively.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Brugada, 1991, A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex, Circulation source
Not checked in the free run.
- Premisecitation
The prognosis of inappropriate sinus tachycardia is generally considered benign despite limited long-term data.
“Despite limited information about the long-term consequences of inappropriate sinus tachycardia the prognosis is generally considered benign, 95”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Still, 2005, Prevalence, characteristics and natural course of inappropriate sinus tachycardia, Europace source
Not checked in the free run.
- Premisecitation
These results were not verified in the first large external application of this criterion.
“but these results were not verified in the first large external application of this criterion.62”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Jastrzebski, 2012, Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias, Europace source
Not checked in the free run.
- Premisecitation
The Vereckei et al. algorithm has a 91.5% overall accuracy in the diagnosis of VTs.
“The Vereckei et al. algorithm has a 91.5% overall accuracy in the diagnosis of VTs. 60”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Vereckei, 2008, New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia, Heart Rhythm source
Not checked in the free run.
- Premisereasoning
Predominantly negative QRS complexes in leads I, II, and III are a useful criterion for identifying VT.
“Thus, predominantly negative QRS complexes in leads I, II, and III are a useful criterion for identifying VT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Wellens, 1978, The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex, Am J Med source
Not checked in the free run.
- Premisecitation
Amiodarone has been found effective for converting SVTs to sinus rhythm in many but mostly small nonrandomized trials.
“Although amiodarone has been found effective for conversion of SVTs to sinus rhythm in many but mostly very small and non-randomized trials, it should not be used as a first-line agent.80”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Vietti-Ramus, 1992, Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias, Int J Cardiol source
Not checked in the free run.
- Premisecitation
A pseudo-R in aVR was shown to have higher sensitivity and specificity than a pseudo-R in V1.
“while a pseudo-R in aVR was shown to have higher sensitivity and specificity than a pseudo-R in V1. 25”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Haghjoo, 2012, Value of the aVR lead in differential diagnosis of atrioventricular nodal reentrant tachycardia, Europace source
Not checked in the free run.
- Premisecitation
Inappropriate sinus tachycardia has been very rarely associated with tachycardia-induced cardiomyopathy in long-standing cases.
“the arrhythmia has been very rarely associated with tachycardia-induced cardiomyopathy in patients with long-standing inappropriate sinus tachycardia.96,97”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [96] Winum, 2009, A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [97] Sette, 2010, Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction, J Cardiovasc Electrophysiol source
Not checked in the free run.
- Premisecitation
In all of these studies, cases of atrial tachycardia or atypical AVNRT were limited or entirely absent.
“However, in all of these studies, cases of atrial tachycardia or atypical AVNRT were limited or entirely absent.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [22] Kalbfleisch, 1993, Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram, J Am Coll Cardiol source
Not checked in the free run.
- cites [23] Tai, 1997, A new electrocardiographic algorithm using retrograde P waves for differentiating atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway, J Am Coll Cardiol source
Not checked in the free run.
- cites [24] Di Toro, 2009, Utility of the aVL lead in the electrocardiographic diagnosis of atrioventricular node re-entrant tachycardia, Europace source
Not checked in the free run.
- cites [25] Haghjoo, 2012, Value of the aVR lead in differential diagnosis of atrioventricular nodal reentrant tachycardia, Europace source
Not checked in the free run.
- Premisecitation
The presence of a QRS notch in lead aVL has been found as a reliable criterion suggesting AVNRT.
“The presence of a QRS notch in lead aVL has also been found as a reliable criterion suggesting AVNRT, 24”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Di Toro, 2009, Utility of the aVL lead in the electrocardiographic diagnosis of atrioventricular node re-entrant tachycardia, Europace source
Not checked in the free run.
- Premisecitation
Conditions such as myocardial infarction, congestive heart failure, and recent angina pectoris favour VT in the differential diagnosis of wide-QRS tachycardia.
“Differential diagnosis should always be considered in the context of the underlying disease, with conditions such as myocardial infarction, congestive heart failure, and recent angina pectoris favouring VT. 53”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Alzand, 2011, Diagnostic criteria of broad QRS complex tachycardia: decades of evolution, Europace source
Not checked in the free run.
- Premisecitation
In LBBB morphology, the presence of broad R wave, slurred or notched down stroke of the S wave, and delayed nadir of S wave are strong predictors of VT.
“The presence of broad R wave, slurred or notched down stroke of the S wave, and delayed nadir of S wave are strong predictors of VT. 58”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Kindwall, 1988, Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias, Am J Cardiol source
Not checked in the free run.
- Premisecitation
The most effective and rapid means of terminating any haemodynamically unstable narrow or wide QRS-complex tachycardia is direct current synchronized cardioversion.
“The most effective and rapid means of terminating any haemodynamically unstable narrow or wide QRS-complex tachycardia is direct current (DC) synchronized cardioversion.64,65”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Roth, 2003, Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states, Am J Cardiol source
Not checked in the free run.
- cites [65] Wittwer, 2015, A South Australian registry of biphasic cardioversions of atrial arrhythmias: efficacy and predictors of success, Heart Lung Circ source
Not checked in the free run.
- Premisecitation
In sinus node reentrant tachycardia, earliest activation is localized to the sinus node area in the superior crista terminalis, as in sinus rhythm.
“earliest activation is localized to the area of sinus node in the region of superior crista terminalis as happens with sinus rhythm;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
In normal heart and absence of previous ablation, usual ECG localization rules apply for focal AT.
“In normal heart and in absence of previous ablation, the usual ECG localization rules apply.101”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Teh, 2009, Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia, J Cardiovasc Electrophysiol source
Not checked in the free run.
- Premisecitation
Pacing manoeuvres such as entrainment can confirm the reentry mechanism in sinus node reentrant tachycardia.
“pacing manoeuvres such as entrainment can confirm the reentry mechanism;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
The mechanism of sinus node reentrant tachycardia is independent of AV node conduction.
“demonstration of the arrhythmia mechanism independent of the AV node conduction;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Three circuits (cavotricuspid isthmus in the RA, perimitral or roof dependent in the LA) are responsible for more than 90% of macroreentries.
“Three circuits (cavotricuspid isthmus in the RA, perimitral or roof dependent in the LA) are responsible for more than 90% of macroreentries.18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Jais, 2009, A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry, J Cardiovasc Electrophysiol source
Not checked in the free run.
- Premisecitation
Beta-blockers and non-dihydropyridine calcium channel blockers have often been ineffective or required doses high enough to cause intolerable hypotension and bradycardia in IST.
“Beta-blockers and nondihydropyridine calcium channel blockers have been used in inappropriate sinus tachycardia patients for several years, but often have been ineffective or needed at doses high enough to cause intolerable side effects like hypotension and bradycardia.87”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Shen, 2005, How to manage patients with inappropriate sinus tachycardia, Heart Rhythm source
Not checked in the free run.
- Premisecitation
Class Ia, Ic, and III drugs may work by prolonging the action potential or suppressing automaticity.
“Class Ia, Ic, and III drugs may work as well, by prolonging the action potential or suppressing automaticity.107,108,110”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [107] Hohnloser, 1992, Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias, Am J Cardiol source
Not checked in the free run.
- cites [108] Kunze, 1986, Effect of encainide and flecainide on chronic ectopic atrial tachycardia, J Am Coll Cardiol source
Not checked in the free run.
- cites [110] Eidher, 2006, Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia, Pacing Clin Electrophysiol source
Not checked in the free run.
- Premisecitation
Sinus node reentrant tachycardia can be acutely terminated by vagal manoeuvres, adenosine, atrial pacing, and premature atrial stimulation.
“the tachycardia can be acutely terminated by vagal manoeuvres, adenosine, atrial pacing and premature atrial stimulation.92”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Sinus node reentrant tachycardia can be effectively and safely treated with catheter ablation targeting the earliest atrial activation relative to the P wave, with good long-term outcome.
“Sinus node reentrant tachycardia may be effectively and safely treated with catheter ablation targeting the site of earliest atrial activation with respect to the P wave.This treatment has been shown to be feasible with a good long-term outcome (Table 9).91”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Sanders, 1994, Catheter ablation of sinoatrial node reentrant tachycardia, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Ivabradine has been associated with increased tolerance of physical exercise in IST.
“This treatment has been also associated with an increased tolerance of physical exercise.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [85] Cappato, 2012, Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Body surface mapping has been shown accurate in localizing focal ATs, particularly for rare or difficult to induce arrhythmia.
“Body surface mapping has been shown In localized reentry fractionation is present and accounts for a significant part of the cycle lengthy (CL), while in truly focal AT the electrogram at the earliest site is much narrower, with sometimes a preceding sharp activity.accurate in localizing focal ATs, and this is particularly interesting in case of rare or difficult to induce arrhythmia.104”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [104] Shah, 2013, Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Spontaneous echo contrast and LA appendage stunning have been reported in patients undergoing cardioversion of AFL, suggesting high embolic risk.
“Spontaneous echo contrast and LA appendage stunning have been reported in patients undergoing cardioversion of AFL, suggesting a high embolic risk in this situation.133,134”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [133] Grimm, 1997, Left atrial appendage ‘stunning’ after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events, J Am Coll Cardiol source
Not checked in the free run.
- cites [134] Irani, 1997, Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography, Circulation source
Not checked in the free run.
- Premisecitation
The diameter of the circuit necessary to sustain reentry depends on the area or line of block in the posterior RA, consistent with increased thickness and increased capacity to block transverse conduction at the crista terminalis.
“The diameter of the circuit, necessary to sustain reentry is dependent on the presence of the area or line of block in the posterior RA, which is in keeping with an increased thickness, 128,129 and the increased capacity to block transverse conduction at the crista terminalis.123,130”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [128] Ohkubo, 2008, Anatomic and electrophysiologic differences between chronic and paroxysmal atrial flutter: intracardiac echocardiographic analysis, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [129] Morita, 2009, The undetermined geometrical factors contributing to the transverse conduction block of the crista terminalis, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [123] Olgin, 1995, Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography, Circulation source
Not checked in the free run.
- cites [130] Schumacher, 1999, Transverse conduction capabilities of the crista terminalis in patients with atrial flutter and atrial fibrillation, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Male sex is more prevalent in AFL (≈80%) than AF.
“Male sex is more prevalent in AFL (≈80%) than AF.11”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
The Na+ channel blocking effect of class Ia and Ic drugs may slow atrial rate and lead to 1:1 AV conduction at rates ≤200/min, often with QRS widening mimicking VT.
“The Na + channel blocking effect of class Ia and Ic drugs may slow atrial rate and lead to 1:1 AV conduction at rates ≤200/min, often with QRS widening that mimics ventricular tachycardia (Figure 12).150”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] Crozier, 1987, Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Class Ic antiarrhythmic drugs should not be used without AV blocking agents because of risk of slowing atrial rate and leading to 1:1 AV conduction.
“Class Ic antiarrhythmic drugs should not be used in the absence of AV blocking agents because of the risk of slowing atrial rate, and leading to 1:1 AV conduction.150,151”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [150] Crozier, 1987, Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm, Am J Cardiol source
Not checked in the free run.
- cites [151] Murdock, 1990, Atrial flutter in patients treated for atrial fibrillation with propafenone, Am J Cardiol source
Not checked in the free run.
- Premisecitation
AFL is seen in clinical conditions very much alike those seen in AF, including old age, hypertension, diabetes, chronic obstructive lung disease, excessive alcohol consumption, and high intensity sports practice.
“AFL is seen in clinical conditions very much alike those seen in AF, including old age, hypertension, diabetes, chronic obstructive lung disease, excessive alcohol consumption 172 and high intensity sports practice.173”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [172] Marcus, 2008, Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [173] Mont, 2009, Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter, Europace source
Not checked in the free run.
- Premisecitation
Heart failure due to tachycardiomyopathy is not an uncommon presentation of AFL when the arrhythmia is asymptomatic and sustained for weeks or months.
“Heart failure due to tachycardiomyopathy is a not an uncommon presentation of AFL when the arrhythmia is not symptomatic and sustained for weeks or months.155,156”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [155] Luchsinger, 1998, Resolution of cardiomyopathy after ablation of atrial flutter, J Am Coll Cardiol source
Not checked in the free run.
- cites [156] Pizzale, 2009, Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter, Can J Cardiol
Not checked in the free run.
- Premisecitation
Atrial mapping studies have identified the mechanism of typical AFL as a macroreentrant circuit contained in the right atrium with passive activation of the left atrium.
“Atrial mapping studies have identified the mechanism of typical AFL as a macroreentrant circuit contained in the right atrium (RA) with passive activation of the left atrium (Figure 11).122”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [122] Cosio, 1996, Atrial flutter mapping and ablation. I. Studying atrial flutter mechanisms by mapping and entrainment, Pacing Clin Electrophysiol source
Not checked in the free run.
- Premisecitation
An ECG pattern with regular, predominantly negative atrial deflections in inferior leads (saw-tooth) at rates 240-350/min indicates CTI-dependent AFL if there is no prior history of surgery or ablation.
“An ECG pattern with regular, predominantly negative atrial deflections in inferior leads ('saw-tooth pattern') at rates 240 -350/ min indicates CTI-dependent AFL if there is no prior history of surgery or ablation.121,176”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [121] Saoudi, 2001, A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases; a Statement from a Joint Expert Group from The Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, Eur Heart J source
Not checked in the free run.
- cites [176] Milliez, 2002, Variable electrocardiographic characteristics of isthmus-dependent atrial flutter, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
After a first and only well-tolerated episode of atrial flutter, the recurrence rate may be as high as 90%.
“A first and only well tolerated episode of AFL can be followed with or without AAD prophylactic therapy, but the recurrence rate may be up to 90%.189”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [189] Babaev, 2003, Recurrence rate of atrial flutter after initial presentation in patients on drug treatment, Am J Cardiol source
Not checked in the free run.
- Premisecitation
These non-excitable areas may form mixed obstacles by attaching to anatomical obstacles such as the mitral valve or pulmonary veins.
“These non-excitable areas may form mixed obstacles by attaching to anatomical obstacles, such as the mitral valve or the pulmonary veins.118,159,162,191,192”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [118] Jais, 2000, Mapping and ablation of left atrial flutters, Circulation source
Not checked in the free run.
- cites [159] Lukac, 2005, Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?, Heart Rhythm source
Not checked in the free run.
- cites [162] Marrouche, 2004, Left septal atrial flutter: electrophysiology, anatomy, and results of ablation, Circulation source
Not checked in the free run.
- cites [191] Ouyang, 2002, Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence, Circulation source
Not checked in the free run.
- cites [192] Markowitz, 2002, Lesional tachycardias related to mitral valve surgery, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
Extending ablation inappropriately to the septal right atrium can cause atrioventricular block.
“Inappropriate extension of ablation to the septal RA can result in AV block, 183,184”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [183] Anselme, 2000, Randomized comparison of two targets in typical atrial flutter ablation, Am J Cardiol source
Not checked in the free run.
- cites [184] Passman, 2004, Radiofrequency ablation of atrial flutter: a randomized controlled study of two anatomic approaches, Pacing Clin Electrophysiol source
Not checked in the free run.
- Premisecitation
Atypical atrial flutter/macroreentrant tachycardia of the left atrium is generally supported by abnormal, non-excitable areas of myocardium, sometimes from surgical or ablation scars and sometimes of unknown origin.
“Atypical AFL/MRT of the LA is generally supported by abnormal, non-excitable areas of myocardium, sometimes due to surgical or ablation scars and others of unknown origin.”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [118] Jais, 2000, Mapping and ablation of left atrial flutters, Circulation source
Not checked in the free run.
- cites [159] Lukac, 2005, Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?, Heart Rhythm source
Not checked in the free run.
- cites [162] Marrouche, 2004, Left septal atrial flutter: electrophysiology, anatomy, and results of ablation, Circulation source
Not checked in the free run.
- cites [191] Ouyang, 2002, Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence, Circulation source
Not checked in the free run.
- cites [192] Markowitz, 2002, Lesional tachycardias related to mitral valve surgery, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
About 50% of patients with AFL as the only arrhythmia initially will develop AF in an 8-year follow-up.
“About 50% of patients with AFL as the only arrhythmia initially, will develop AF in a 8-year follow-up.This figure is not far from the proportion of patients developing AF in long-term follow-up after CTI ablation for typical AFL.175”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Luria, 2008, Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias, J Cardiovasc Electrophysiol source
Not checked in the free run.
- Premisecitation
Hemopericardium and tamponade can occur when very high-power radiofrequency energy is applied and tissue steam pop occurs.
“Hemopericardium and tamponade may occur if very high power RF is applied, and if tissue 'steam pop' occurs.186”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [186] Hillock, 2005, Radiofrequency ablation for common atrial flutter using an 8-mm tip catheter and up to 150 W, Europace source
Not checked in the free run.
- Premisecitation
Atypical atrial flutter/macroreentrant tachycardia may also occur after antiarrhythmic drug treatment of atrial fibrillation.
“Atypical AFL/ MRT may also occur after AAD treatment of AF. 151”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] Murdock, 1990, Atrial flutter in patients treated for atrial fibrillation with propafenone, Am J Cardiol source
Not checked in the free run.
- Premisecitation
High-output stimulation can also be delivered through the oesophagus to terminate atrial flutter.
“Using high output stimulation this technique can also be applied through the oesophagus.145 -148”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [145] Brockmeier, 2002, Termination of atrial reentrant tachycardias by using transesophageal atrial pacing, J Electrocardiol source
Not checked in the free run.
- cites [146] Doni, 1995, Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone, Am J Cardiol source
Not checked in the free run.
- cites [147] Rhodes, 1995, Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure, Am Heart J source
Not checked in the free run.
- cites [148] Stephenson, 2003, Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Initial presentation of AFL is often alternating with AF.
“Initial presentation of AFL is often alternating with AF. 174”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Elesber, 2006, Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly, Eur Heart J source
Not checked in the free run.
- Premisecitation
In patients with new-onset atrial flutter, electrical cardioversion maintains sinus rhythm more often than in patients with new-onset atrial fibrillation.
“Electrical cardioversion is more successful in maintaining sinus rhythm in patients with new-onset AFL than in patients with new-onset AF, 174”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Elesber, 2006, Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly, Eur Heart J source
Not checked in the free run.
- Premisecitation
Atrial pacing at rates above the flutter rate via a transvenous catheter can terminate atrial flutter in a large proportion of cases.
“Alternatively, AFL interruption can be achieved in a large percentage of cases by atrial pacing at rates above the AFL rate, through a transvenous catheter.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [145] Brockmeier, 2002, Termination of atrial reentrant tachycardias by using transesophageal atrial pacing, J Electrocardiol source
Not checked in the free run.
- cites [146] Doni, 1995, Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone, Am J Cardiol source
Not checked in the free run.
- cites [147] Rhodes, 1995, Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure, Am Heart J source
Not checked in the free run.
- cites [148] Stephenson, 2003, Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease, Am J Cardiol source
Not checked in the free run.
- Premisecitation
The poor outcomes of rhythm-control strategies seen in atrial fibrillation may also apply to atrial flutter when antiarrhythmic drugs are used.
“but with the use of antiarrhythmic drugs, the poor results of rhythm control strategies in AF may also apply to AFL. 152,153”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [152] Crijns, 1997, Long-term outcome of electrical cardioversion in patients with chronic atrial flutter, Heart source
Not checked in the free run.
- cites [153] Da Costa, 2006, Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter, Circulation source
Not checked in the free run.
- Premisecitation
Multiple ECG patterns can sometimes be recorded in atypical atrial flutter/macroreentrant tachycardia, suggesting multiple tachycardia mechanisms, especially with structural heart disease, advanced intra-atrial conduction disturbance, surgical atriotomy, or prior atrial fibrillation ablation.
“In some cases more than one ECG pattern can be recorded, suggesting multiple tachycardia mechanisms, especially in the presence of structural heart disease, advanced intra-atrial conduction disturbance, surgical atriotomy, or after catheter ablation for AF.191 -193”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [191] Ouyang, 2002, Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence, Circulation source
Not checked in the free run.
- cites [192] Markowitz, 2002, Lesional tachycardias related to mitral valve surgery, J Am Coll Cardiol source
Not checked in the free run.
- cites [193] Chugh, 2005, Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation, Heart Rhythm source
Not checked in the free run.
- Premisecitation
Damage to the right coronary artery during cavotricuspid isthmus ablation is rare.
“while damage to the right coronary artery is rare.185”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [185] Weiss, 2002, Can radiofrequency current isthmus ablation damage the right coronary artery? Histopathological findings following the use of a long (8 mm) tip electrode, Pacing Clin Electrophysiol source
Not checked in the free run.
- Premisecitation
In patients whose atrial flutter appears during antiarrhythmic drug treatment for atrial fibrillation, cavotricuspid isthmus ablation may help stabilize sinus rhythm while the drug is continued.
“In patients with AFL appearing during AAD treatment of AF CTI ablation may help stabilize sinus rhythm while maintaining the AAD.188”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [188] Bottoni, 2004, Outcome after cavo-tricuspid isthmus ablation in patients with recurrent atrial fibrillation and drug-related typical atrial flutter, Am J Cardiol source
Not checked in the free run.
- Interpretationreasoning
Cavotricuspid isthmus ablation may allow continued use of flecainide or propafenone, when effective for atrial fibrillation, without the risk of slow atrial flutter with 1:1 atrioventricular conduction.
“It may also allow continued use of flecainide or propafenone, if they are effective against AF, without the risk of slow AFL with 1:1 AV conduction.”
Quote in the paperSubstantial claim - Premisecitation
When macroreentrant tachycardia is diagnosed and treated during antiarrhythmic drug therapy, continuation of the drug may be necessary after the circuit is interrupted by ablation.
“When MRT is diagnosed and treated under the effect of AAD, continuation of the AAD may be necessary after interruption of the MRT circuit by ablation.162”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [162] Marrouche, 2004, Left septal atrial flutter: electrophysiology, anatomy, and results of ablation, Circulation source
Not checked in the free run.
- Premisecitation
About half of patients with minimal symptoms and short-lived, infrequent tachycardia episodes may become asymptomatic within the next 13 years.
“Half of patients with minimal symptoms and short-lived, infrequent episodes of tachycardia may become asymptomatic within the next 13 years.225”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [225] D'Este, 2007, Long-term outcome of patients with atrioventricular node reentrant tachycardia, Int J Cardiol source
Not checked in the free run.
- Premisecitation
The cause of macroreentrant tachycardia after biatrial surgical ablation of atrial fibrillation has been shown to be gaps with conduction across a surgical lesion, most often toward the annular end of the mitral or tricuspid isthmus incision.
“The cause of MRT after biatrial surgical ablation of atrial fibrillation has been shown to be gaps with conduction across a surgical lesion, most of which were found towards the annular end of the mitral or tricuspid isthmus incision.211”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [211] Takahashi, 2016, Mechanisms of postoperative atrial tachycardia following biatrial surgical ablation of atrial fibrillation in relation to the surgical lesion sets, Heart Rhythm source
Not checked in the free run.
- Premisecitation
Intravenous adenosine bolus can terminate AVRT in the emergency room.
“In the emergency room adenosine IV bolus can terminate AVRT.71,72”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Delaney, 2011, The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis, Eur J Emerg Med source
Not checked in the free run.
- cites [72] DiMarco, 1990, Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group, Ann Intern Med source
Not checked in the free run.
- Premisecitation
Specific but only modestly sensitive ECG criteria for AVNRT, as opposed to atrial tachycardia and AVRT, are a pseudo R deflection in lead V1, a pseudo S wave in the inferior leads, a notch in lead aVL, and a pseudo R in aVR.
“Specific, although modestly sensitive, ECG criteria for AVNRT, as opposed to AT and AVRT, are a pseudo R deflection in lead V 1 and a pseudo S wave in the inferior leads, a notch in lead aVL, and a pseudo R in aVR.17”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Katritsis, 2015, Differential diagnosis of regular, narrow-QRS tachycardias, Heart Rhythm source
Not checked in the free run.
- Premisecitation
The onset of atrioventricular nodal reentrant tachycardia appears to occur bimodally over time.
“Onset of AVNRT seems to occur bimodally over time.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [223] Pentinga, 1993, Late onset atrioventricular nodal tachycardia, Int J Cardiol source
Not checked in the free run.
- Premisecitation
Atrioventricular nodal reentrant tachycardia may result in atrial fibrillation, which is usually, though not invariably, eliminated after catheter ablation of AVNRT.
“Atrioventricular nodal reentrant tachycardia may result in AF that usually, although not invariably, is eliminated following catheter ablation of AVNRT.224”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [224] Sauer, 2006, Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification, Circulation source
Not checked in the free run.
- Premisecitation
There is considerable histologic and electrophysiologic evidence that the right and left inferior extensions of the human AV node and the atrio-nodal inputs they facilitate may provide the anatomic substrate of the slow pathway.
“Regarding the slow pathway, there has now been considerable histologic and electrophysiologic evidence that the right and left inferior extensions of the human AV node and the atrio-nodal inputs they facilitate may provide its anatomic substrate.29,221”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [29] Katritsis, 2006, Effect of slow pathway ablation in atrioventricular nodal reentrant tachycardia on the electrophysiologic characteristics of the inferior atrial inputs to the human atrioventricular node, Am J Cardiol source
Not checked in the free run.
- cites [221] Katritsis, 2015, Atypical atrioventricular nodal reentrant tachycardia: prevalence, electrophysiologic characteristics, and tachycardia circuit, Europace source
Not checked in the free run.
- Premisecitation
Atrial fibrillation with a fast ventricular response is potentially life-threatening in patients with WPW syndrome because it can degenerate into ventricular fibrillation.
“Atrial fibrillation with fast ventricular response is a potentially lifethreatening arrhythmia in patients with WPW syndrome due to degeneration in VF. 306,307”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [306] Klein, 1979, Ventricular fibrillation in the Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
- cites [307] Dreifus, 1971, Ventricular fibrillation. A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome, Circulation source
Not checked in the free run.
- Premisecitation
The sinus venosus myocardium has been shown to contribute to the nodal extensions or transitional cells of the AV node.
“It has also been shown that the sinus venosus myocardium contributes to the nodal extensions or transitional cells of the AV node.220”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [220] Kelder, 2015, The sinus venosus myocardium contributes to the atrioventricular canal: potential role during atrioventricular node development?, J Cell Mol Med source
Not checked in the free run.
- Premisecitation
The ECG pattern of interatrial (Bachmann) block has been associated with a high incidence of macroreentrant tachycardia, possibly related to low-voltage non-excitable areas in the left atrium.
“The ECG pattern of interatrial (Bachmann) block has been associated with a high incidence of MRT, that could be related to low-voltage non-excitable areas in the LA.199”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [199] Hinojar, 2013, Bachmann block pattern resulting from inexcitable areas peripheral to the Bachmann's bundle: controversial name or concept?, Europace source
Not checked in the free run.
- Premisecitation
Multivariable analysis showed that only shorter accessory pathway ERP and AVRT triggering AF were associated with VF or malignant arrhythmias.
“Multivariable analysis showed that only shorter accessory pathway ERP and AVRT triggering AF were associated with VF or malignant arrhythmias.322”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [322] Pappone, 2014, Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients, Circulation source
Not checked in the free run.
- Premisecitation
Kaplan-Meier estimates showed that initially asymptomatic individuals were more likely to experience VF than symptomatic individuals.
“Of note, the Kaplan -Meier estimates showed that initially asymptomatic individuals were more likely to experience VF than the symptomatic individuals.322”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [322] Pappone, 2014, Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients, Circulation source
Not checked in the free run.
- Premisecitation
In the Latin American Catheter Ablation Registry, there was one death (0.08% mortality) following ablation of a right accessory pathway.
“In the recently published Latin American Catheter Ablation Registry there was one death (0.08% mortality) following ablation of a right accessory pathway.10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Keegan, 2015, The first Latin American Catheter Ablation Registry, Europace source
Not checked in the free run.
- Premisecitation
In pre-excited atrial fibrillation, amiodarone may not be as safe as previously thought.
“In case of pre-excited AF, amiodarone may not be as a safe as previously thought.316 -319”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [316] Boriani, 1996, Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation, Am Heart J source
Not checked in the free run.
- cites [317] Schützenberger, 1987, Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report, Int J Cardiol source
Not checked in the free run.
- cites [318] Sheinman, 1982, Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome, Br Med J (Clin Res Ed) source
Not checked in the free run.
- Premisecitation
Several randomized and observational studies indicate that risk stratification using invasive electrophysiological testing may be beneficial in the asymptomatic WPW population.
“Several randomized and observational studies indicate that in the asymptomatic WPW population risk stratification using an invasive electrophysiological testing may be beneficial (Table 17).322,336,337,339,341,343”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [322] Pappone, 2014, Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients, Circulation source
Not checked in the free run.
- cites [336] Satoh, 1989, Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [337] Klein, 1989, Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern, N Engl J Med source
Not checked in the free run.
- Premisecitation
Adenosine should be used with caution because it may induce fast atrial fibrillation.
“However it should be used with caution because of potential induction of fast AF. 178”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [178] Strickberger, 1997, Adenosine-induced atrial arrhythmia: a prospective analysis, Ann Intern Med source
Not checked in the free run.
- Premisecitation
Incessant PJRT may result in tachycardia-induced cardiomyopathy that usually resolves after successful treatment by radiofrequency catheter ablation.
“The incessant nature of PJRT may result in tachycardia-induced cardiomyopathy that usually resolves after successful treatment by radiofrequency catheter ablation.328”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [328] Kang, 2014, Permanent junctional reciprocating tachycardia in children: a multicenter experience, Heart Rhythm source
Not checked in the free run.
- Premisecitation
In the first randomized trial, patients 35 years or younger with reproducibly induced arrhythmias were randomized to radiofrequency catheter ablation (37 patients) or no treatment (35 patients); 2 in the ablation group (5%) and 21 in the control group (60%) had arrhythmic events within 9-60 months.
“In the first randomized trial, patients 35 years old or younger in whom arrhythmias were reproducibly induced were randomly assigned to radiofrequency catheter ablation of accessory pathways (37 patients) or no treatment (35 patients).Two patients in the ablation group (5%) and 21 in the control group (60%) had arrhythmic events within the next 9 -60 months.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [343] Pappone, 2003, A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
- Premisecitation
Radiofrequency catheter ablation has become firmly established as first-line therapy for paroxysmal supraventricular tachycardia over the past decade.
“In the past decade, radiofrequency catheter ablation has become firmly established as first-line therapy of paroxysmal SVT.320 -322”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [320] Calkins, 1999, Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group, Circulation source
Not checked in the free run.
- cites [321] Jackman, 1991, Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current, N Engl J Med source
Not checked in the free run.
- cites [322] Pappone, 2014, Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients, Circulation source
Not checked in the free run.
- Premisecitation
In atrial fibrillation, ibutilide, procainamide, propafenone and flecainide act mainly to prevent fast conduction through the accessory pathway.
“In AF, antiarrhythmic drugs as ibutilide, procainamide, propafenone or flecainide, which act mainly to prevent fast conduction through the pathway, are preferable, even if they do not restore sinus rhythm.83,310,311”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [83] Glatter, 2001, Electrophysiological effects of ibutilide in patients with accessory pathways, Circulation source
Not checked in the free run.
- cites [310] Ludmer, 1987, Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up, J Am Coll Cardiol source
Not checked in the free run.
- cites [311] Sellers, 1977, Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome, Circulation source
Not checked in the free run.
- Interpretationcitation
Available large data support the usefulness of electrophysiologic testing to identify asymptomatic WPW patients at high risk of ventricular fibrillation to prevent sudden death.
“Thus, available large data support the usefulness of electrophysiologic testing to identify those asymptomatic WPW patients at high risk of ventricular fibrillation to prevent sudden death, which in many cases can be the first clinical manifestation of the syndrome (Table 17).339 -342”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [339] Pappone, 2003, Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study, J Am Coll Cardiol source
Not checked in the free run.
- cites [340] Pappone, 2005, Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome, Circulation
Not checked in the free run.
- cites [341] Santinelli, 2009, Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients, Circ Arrhythm Electrophysiol source
Not checked in the free run.
- Premisecitation
Patients with WPW syndrome have an increased risk of sudden cardiac death, presumably approaching 4% over a lifetime.
“Patients with WPW syndrome have an increased risk of sudden cardiac death (SCD) presumably approaching to 4% over a lifetime.334”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [334] Munger, 1993, A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989, Circulation source
Not checked in the free run.
- Premisecitation
Quinidine, disopyramide, and sotalol were associated with increased all-cause mortality.
“Quinidine, disopyramide, and sotalol, were also associated with increased all-cause mortality.369”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [369] Lafuente-Lafuente, 2015, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database Syst Rev
Not checked in the free run.
- Premisecitation
The number of high-risk patients needed to treat to prevent arrhythmic events in one high-risk patient has been reported as 7.6 at 1 year, 2.3 at 2 years, and 1.8 at 4 years.
“The number of high-risk patients needed to treat to prevent arrhythmic events in 1 high-risk patient has been reported to be 7.6 at 1 year, 2.3 at 2 years, and 1.8 at 4 years.340”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [340] Pappone, 2005, Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome, Circulation
Not checked in the free run.
- Premisecitation
Surgical ablation of accessory pathways is successful in 92-100%.
“Surgical ablation of accessory pathways is successful in 92 -100%.385,386”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [385] Khositseth, 2004, Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome, J Thorac Cardiovasc Surg source
Not checked in the free run.
- cites [386] Bockeria, 2005, Advantages and disadvantages of one-stage and two-stage surgery for arrhythmias and Ebstein's anomaly, Eur J Cardiothorac Surg source
Not checked in the free run.
- Premisecitation
Documented SVT preceded or coexisted with VT in 50% of patients with appropriate shocks.
“Documented SVT preceded or coexisted with VT in 50% of patients with appropriate shocks.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [367] Khairy, 2008, Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study, Circ Arrhythm Electrophysiol source
Not checked in the free run.
- Premisecitation
Independent predictors for appropriate ICD shocks in a multicentre cohort study of patients with TGA with intra-atrial baffle repair included lack of beta-blockers (HR 16.7; P=0.0301).
“Independent predictors for appropriate ICD shocks in multicentre cohort study of patients with transposition of the great arteries with intra-atrial baffle repair were, among others, lack of beta-blockers (hazard ratio, 16.7; P ¼ 0.0301).367”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [367] Khairy, 2008, Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study, Circ Arrhythm Electrophysiol source
Not checked in the free run.
- Premisecitation
Over 60% of these atrial reentry circuits involve the cavo-tricuspid isthmus.
“Over 60% of these atrial reentry circuits involve the cavo-tricuspid isthmus.349”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [349] Wasmer, 2013, Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair, Int J Cardiol source
Not checked in the free run.
- Premisecitation
Based on retrospective studies comparing AAD for prevention of SVT in CHD patients, only 45% of patients were free from SVT after 2.5 years follow-up.
“Based on retrospective studies comparing AAD for prevention of SVT in CHD patients, only 45% of the patients were free from SVT after 2.5 years follow-up.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [368] Koyak, 2013, Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Atrial-based pacing does not seem to prevent subsequent atrial arrhythmias according to multivariate analysis.
“Atrial-based pacing does not seem to prevent subsequent atrial arrhythmias according to multivariate analysis.371”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [371] Opic, 2013, Atrial-based pacing has no benefit over ventricular pacing in preventing atrial arrhythmias in adults with congenital heart disease, Europace source
Not checked in the free run.
- Premisecitation
Catheter ablation of AT or AFL are associated with lower success rates, 65% to 82%, as compared with those in the absence of CHD.
“Catheter ablation of AT or AFL are associated with lower success rates, 65% to 82%, as compared with those in the absence of CHD, 362,363,365 although higher success rates have been achieved with the advent of advanced mapping and ablation techniques.366”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [362] de Groot, 2010, Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences, Circ Arrhythm Electrophysiol source
Not checked in the free run.
- cites [363] Yap, 2010, Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery, J Am Coll Cardiol source
Not checked in the free run.
- cites [365] Yap, 2012, Evolving electroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery, J Cardiovasc Electrophysiol source
Not checked in the free run.
- Premisecitation
Patients who underwent repair of Ebstein anomaly and preoperative EP study with intraoperative ablation of arrhythmia substrate, in a small series, had a lower risk of SCD than patients without arrhythmia intervention.
“Patients who underwent repair of Ebstein anomaly and preoperative EP study with intraoperative ablation of arrhythmia substrate, in a small series, had a lower risk of SCD than patients without arrhythmia intervention.375”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [375] Huang, 2000, Role of electrophysiological studies and arrhythmia intervention in repairing Ebstein's anomaly, Thorac Cardiovasc Surg source
Not checked in the free run.
- Premisecitation
Catheter ablation is associated with excellent results in patients with repaired ASD.
“Catheter ablation is associated with excellent results.379”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [379] Scaglione, 2014, Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect, Europace source
Not checked in the free run.
- Premisecitation
Class Ic drugs such as encainide and flecainide are proarrhythmic.
“Class Ic drugs such as encainide and flecainide are also proarrhythmic and should not be used in ACHD patients.370”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [370] Fish, 1991, Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
In a recent review, little evidence was found from randomized controlled trials regarding the best management of patients with asymptomatic pre-excitation.
“In a recent review, little evidence was found from randomized, controlled trials with regard to the best management of patients with asymptomatic pre-excitation.344”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [344] Al-Khatib, 2016, Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- Premisecitation
A modified right atrial maze procedure versus CTI ablation was associated with lower recurrence rates.
“A modified right atrial maze procedure vs. CTI ablation was associated with lower recurrence rates, 373 but selection of suitable patients is important.394”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [373] Deal, 2002, Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients, Circulation source
Not checked in the free run.
- Premisecitation
Occurrence of arrhythmias was associated with higher mortality (15.6% vs 8.6%, P=0.001).
“It was recently reported that the occurrence of arrhythmias was associated with higher mortality (15.6% vs. 8.6%, P ¼ 0.001).389”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [389] Wu, 2015, Arrhythmic burdens in patients with tetralogy of Fallot: a national database study, Heart Rhythm source
Not checked in the free run.
- Premisenone given
Management of supraventricular tachycardia in pregnancy is challenging because available data are mainly limited to observational studies and case reports.
“Management of SVT in pregnancy is a challenging, difficult situation, since the available data are mainly limited to observational studies and case reports.”
Quote in the paperSubstantial claim - Interpretationcitation
Metoprolol or acebutolol may, based on their beta1-selective properties, theoretically be advantageous by being less likely to interfere with beta2-mediated uterine relaxation.
“theoretically be of advantage in that they would be less likely to interfere with b 2 -mediated uterine relaxation.401”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [401] Frishman, 1988, Beta-adrenergic blockers in pregnancy, Am Heart J source
Not checked in the free run.
- Interpretationreasoning
The most important determinant of favourable cost-effectiveness of any supraventricular tachycardia treatment, and specifically of ablation, is high efficacy leading to avoidance of hospitalizations due to arrhythmia recurrences.
“The most important determinant of favourable costeffectiveness of any treatment of SVT, and specifically of ablation procedures, is high efficacy, leading to avoidance of hospitalizations due to arrhythmia recurrences.”
Quote in the paperSubstantial claim - Interpretationcitation
A higher frequency of atrial and ventricular premature extrasystoles may trigger episodes of supraventricular tachycardia.
“A higher frequency of atrial and ventricular premature extra systoles may also serve as triggers of SVT episodes.399”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [399] Shotan, 1997, Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Additional support for the safety of flecainide and sotalol has been gained from treatment of foetal arrhythmias.
“Additional support for safety has been gained from treatment of foetal arrhythmias.407”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [407] Jaeggi, 2011, Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study, Circulation source
Not checked in the free run.
- Interpretationreasoning
The high efficacy of ablation in most supraventricular tachycardias means its initial cost can be counterbalanced by long-term effectiveness and improved quality of life.
“In view of the high efficacy of ablation in most SVTs, the initial (relatively substantial) cost of the procedure can be counterbalanced by the high effectiveness in the long-term, coupled with improved QoL.”
Quote in the paperSubstantial claim - Premisecitation
Catheter ablation of AT is associated with a high procedural success rate during long-term follow-up in the vast majority of patients.
“Catheter ablation of AT is associated with a high procedural success rate during long-term follow-up in the vast majority of patients.392”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [392] de Groot, 2012, Long-term outcome of ablative therapy of post-operative atrial tachyarrhythmias in patients with tetralogy of Fallot: a European multi-centre study, Europace source
Not checked in the free run.
- Interpretationreasoning
This results in attractive cost-effectiveness and cost-utility estimates compared with pharmacological treatment.
“This results in attractive cost-effectiveness and cost-utility estimates in comparison with pharmacological treatment.”
Quote in the paperSubstantial claim - Interpretationreasoning
A favourable cost-effectiveness profile has been demonstrated for ablation therapy in supraventricular tachycardia patients with frequent arrhythmia recurrences.
“In conclusion, a favourable cost-effectiveness profile has been demonstrated for ablation therapy in SVT patients with frequent arrhythmia recurrences.”
Quote in the paperSubstantial claim - Interpretationcitation
The uncertain trajectory of supraventricular tachycardia can provoke significant anxiety and fear in anticipation of the next symptomatic episode, leading to avoidance of situations or triggers of symptom onset.
“This uncertain trajectory can provoke significant anxiety and fear in anticipation of when the next symptomatic episode will occur, leading to avoidance of situations or triggers of symptom-onset. 16,420 -423”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [16] Wood, 1997, Frequency of disabling symptoms in supraventricular tachycardia, Am J Cardiol source
Not checked in the free run.
- cites [420] Wood, 2007, Supraventricular tachycardia and the struggle to be believed, Eur J Cardiovasc Nurs source
Not checked in the free run.
- cites [421] Wood, 2009, Development and initial psychometric evaluation of the Patient Perspective of Arrhythmia Questionnaire, Res Nurs Health source
Not checked in the free run.
- cites [422] Walfridsson, 2005, The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [423] Dhala, 1995, Impairment of driving abilities in patients with supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
- Premisecitation
One of the main goals of treatment for supraventricular tachycardia is to reduce symptoms and improve quality of life.
“One of the main goals of treatment for SVT is to reduce symptoms and improve QoL.1,2,419”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Blomstrom-Lundqvist, 2003, Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular A. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias), Circulation source
Not checked in the free run.
- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- cites [419] Lane, 2015, Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace source
Not checked in the free run.
- Premisecitation
Atrial fibrillation occurs at a high incidence after cavotricuspid isthmus ablation for typical atrial flutter.
“Given the high incidence of AF after CTI ablation for typical AFL”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [165] Mohanty, 2014, Long-term outcome of catheter ablation in atrial fibrillation patients with coexistent metabolic syndrome and obstructive sleep apnea: impact of repeat procedures versus lifestyle changes, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [166] Pathak, 2014, Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study, J Am Coll Cardiol source
Not checked in the free run.
- cites [167] Pathak, 2015, Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY), J Am Coll Cardiol source
Not checked in the free run.
- May combine two claims. 149
- Classified as probably not a substantial claim. 35
- The quote only partly states this claim. 1
May combine two claims.
FindingcitationAmong calcium channel blockers, experience is greatest with verapamil, which overall appears relatively safe.
“Among the calcium channel blockers the experience is greatest with verapamil which overall appear to be relatively safe.405”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [405] Weber-Schoendorfer, 2008, The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study, Reprod Toxicol source
Not checked in the free run.
May combine two claims.
FindingcitationThe exact incidence of paroxysmal supraventricular tachycardia during pregnancy is not well established but appears relatively low.
“The exact incidence of PSVT during pregnancy is not well established, but seems to be relatively low.395”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [395] Li, 2008, Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service, Clin Cardiol source
Not checked in the free run.
May combine two claims.
FindingcitationRadiofrequency ablation resulted in substantial improvement of quality of life and cost reduction at long term, with a highly favourable dominant cost-utility profile.
“As shown in Table 20, RF ablation procedures resulted in substantial improvement of QoL and cost reduction at long term, with a highly favourable ('dominant') cost-utility profile.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Cheng, 2000, Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia, Ann Intern Med source
Not checked in the free run.
May combine two claims.
FindingcitationDirect current cardioversion can be performed at all stages of pregnancy and is considered safe.
“Direct current cardioversion can be performed at all stages of pregnancy and is considered safe.402”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [402] Tromp, 2011, Electrical cardioversion during pregnancy: safe or not?, Neth Heart J source
Not checked in the free run.
May combine two claims.
FindingcitationCatheter ablation has been performed in selected cases and reported effective with minimal maternal and foetal complications.
“Catheter ablation has been performed in selected cases and has been reported effective with minimal maternal and foetal complications.408”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [408] Driver, 2015, Catheter ablation of arrhythmia during pregnancy, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
FindingreasoningConsequently, patients with supraventricular tachycardia may restrict normal daily and leisure activities and may be unable to initiate or continue certain high-risk occupations or drive, all of which can adversely affect quality of life.
“Consequently, patients with SVT may restrict their normal daily and leisure activities (social events, sports, and sexual relationships), 16,419 and may be unable to initiate or continue certain 'high-risk' occupations (flying, competitive athletics etc.) 1,2,419 or drive, 422,423 all of which can adversely affect a patient's QoL.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [1] Blomstrom-Lundqvist, 2003, Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular A. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias), Circulation source
Not checked in the free run.
- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
- cites [419] Lane, 2015, Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace source
Not checked in the free run.
- cites [422] Walfridsson, 2005, The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [423] Dhala, 1995, Impairment of driving abilities in patients with supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
May combine two claims.
FindingcitationAlmost all studies examining quality of life with validated questionnaires have been conducted in patients undergoing catheter ablation for supraventricular tachycardia, often without a comparison group.
“Almost all of the studies examining QoL, measured with validated questionnaires, have been conducted in patients undergoing catheter ablation for SVT, 245,246,254 - 256,258,424,425 although often without a comparison group.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [245] Farkowski, 2014, Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study, Europace source
Not checked in the free run.
- cites [246] Wood, 2010, Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia, Heart Lung source
Not checked in the free run.
- cites [254] Goldberg, 2002, Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy), Am J Cardiol source
Not checked in the free run.
- cites [255] Larson, 1999, Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia, Am J Cardiol source
Not checked in the free run.
- cites [256] Bubien, 1996, Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias, Circulation source
Not checked in the free run.
- cites [258] Bathina, 1998, Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs, Am J Cardiol source
Not checked in the free run.
- cites [424] Meissner, 2009, Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. results from a large retrospective patient cohort, Int J Med Sci source
Not checked in the free run.
- cites [425] Yildirim, 2012, The effect of radiofrequency ablation treatment on quality of life and anxiety in patients with supraventricular tachycardia, Eur Rev Med Pharmacol Sci
Not checked in the free run.
May combine two claims.
FindingcitationAvoidance of overnight stay, with an average cost of $450, resulted in important savings for the institution ($365,000), coupled with a reassuring patient safety profile.
“Avoidance of overnight stay, with an average cost of $450, resulted in important savings for the institution ($365 000), and this was coupled with a reassuring patient safety profile.418”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [418] Theodoreson, 2015, Same-day cardiac catheter ablation is safe and cost-effective: experience from a UK tertiary center, Heart Rhythm source
Not checked in the free run.
May combine two claims.
FindingcitationLimitations to participation in social activities and driving are most frequently reported and appear to have the greatest negative impact on quality of life.
“Limitations to participation in social activities and driving are most frequently reported and appear to have the greatest negative impact on QoL. 419”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [419] Lane, 2015, Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationRobotic techniques and sophisticated anatomical navigation systems have been developed, and it is now possible to perform ablation without exposing the operator to radiation and ergonomically unfavourable positions.
“Robotic techniques and sophisticated anatomical navigation systems have been developed, and it is now possible to perform ablation without exposing the operator to radiation and ergonomically unfavourable positions.426”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [426] Nakagawa, 2016, Catheter ablation of complex tachyarrhythmias using remote magnetic catheter navigation system, J Cardiovasc Electrophysiol
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationMathematical modelling and numerical analyses have been employed in the investigation of the circuit of atrioventricular nodal reentrant tachycardia.
“Mathematical modelling and numerical analyses have also been employed in the investigation of the circuit of AVNRT.221,232”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [221] Katritsis, 2015, Atypical atrioventricular nodal reentrant tachycardia: prevalence, electrophysiologic characteristics, and tachycardia circuit, Europace source
Not checked in the free run.
- cites [232] Katritsis, 2015, Coexistent types of atrioventricular nodal re-entrant tachycardia: implications for the tachycardia circuit, Circ Arrhythm Electrophysiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationNew data on the genetics of supraventricular tachycardia continually appear since the identification of a missense mutation in PRKAG2 as a cause of familial Wolff-Parkinson-White syndrome.
“New data on the genetics of SVT continually appear since the identification of a missense mutation in the gene PRKAG2, that encodes the regulatory g-subunit of AMP-activated protein kinase, as a cause of familial Wolff -Parkinson -White syndrome.429,430”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [429] Gollob, 2001, Identification of a gene responsible for familial Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
- cites [430] Wolf, 2008, Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationIn that catheter ablation series, the proportion of AVRT decreased with age, whereas the proportion of AVNRT and AT increased.
“The proportion of AVRT decreased with age, whereas the proportion of AVNRT and AT increased.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Porter, 2004, Influence of age and gender on the mechanism of supraventricular tachycardia, Heart Rhythm source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThese data translate to 200,000 new cases of AFL in the USA annually, with the arrhythmia being more common in men, the elderly, and individuals with pre-existing heart failure or chronic obstructive lung disease.
“These data translate to 200 000 new cases of AFL in the USA annually, the arrhythmia being more common in men, the elderly and individuals with pre-existing heart failure or chronic obstructive lung disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningFrom those older MESA data, an estimated 89,000 new paroxysmal SVT cases occur annually and 570,000 patients have paroxysmal SVT in the USA.
“Based on these old data, it was estimated that there are 89 000 new cases per year, and 570 000 patients with paroxysmal SVT in the USA.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn MESA, only 3 subjects (1.7%) were labelled as having 'lone AFL'.
“Only 3 subjects (1.7%) were labelled as having 'lone AFL'.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationPolyuria may be a symptom supportive of a sustained supraventricular arrhythmia, related to release of atrial natriuretic peptide in response to increased atrial pressures; this is most pronounced in AVNRT.
“Polyuria may be a symptom supportive of a sustained supraventricular arrhythmia, related to the release of atrial natriuretic peptide in response to increased atrial pressures.This is most pronounced in AVNRT.15”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Abe, 1997, Neurohumoral and hemodynamic mechanisms of diuresis during atrioventricular nodal reentrant tachycardia, Pacing Clin Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationPorter et al. described 1754 patients undergoing catheter ablation, where AVNRT was the most common (56%) aetiology, followed by AVRT 27%, and AT 17%.
“Porter et al. described 1754 patients undergoing catheter ablation, where AVNRT was the most common (56%) aetiology, followed by AVRT 27%, and atrial tachycardia (AT) 17%. 9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Porter, 2004, Influence of age and gender on the mechanism of supraventricular tachycardia, Heart Rhythm source
Not checked in the free run.
May combine two claims.
PremisecitationIf irregularity does not exceed 15% of the cycle length, a reentry is possible, while above this threshold, a focal arrhythmia is much more likely.
“If the irregularity does not exceed 15% of the CL, a reentry is possible, while above this threshold, a focal arrhythmia is much more likely.18”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Jais, 2009, A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry, J Cardiovasc Electrophysiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFor AFL, one MESA report of 181 new cases estimated an overall incidence of 88 per 100,000 person-years.
“For AFL, one report from MESA of 181 new cases of AFL estimated an overall incidence of 88/100 000 person-years.11”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn the first Latin American registry on catheter ablation including 15,099 procedures from 120 centres in 13 countries, AVRT was the most frequently ablated arrhythmia (31%), followed by AVNRT (29%), typical AFL (14%), and AF (11%).
“Recently, in the first Latin American registry on catheter ablation including 15 099 procedures from 120 centres in 13 participating countries, AVRT was the group of arrhythmias most frequently ablated (31%), followed by AVNRT (29%), typical AFL (14%), and AF (11%).10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Keegan, 2015, The first Latin American Catheter Ablation Registry, Europace source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn MESA, AFL had an incidence of 0.09% and 58% of patients also had AF.
“In MESA, AFL had an incidence of 0.09% and 58% of the patients also had AF.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAn RP cut-off interval of 90 ms has been shown to be useful for surface ECG measurements and can be used if P waves are visible.
“An cut-off interval of 90 ms has been shown to be useful for surface ECG measurements and can be used if P waves are visible, 20”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Letsas, 2010, Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway, Acta Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAFL incidence rates ranged from 5 per 100,000 in those under 50 years old to 587 per 100,000 in subjects older than 80 years.
“Incidence rates ranged from 5/100 000 in those ,50 years old to 587/100 000 in subjects older than 80 years.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
Premiseown dataA very short RP interval (<70 ms) rules out AVRT and indicates typical AVNRT or, less commonly, AT as the most likely diagnosis.
“A very short RP interval (,70 ms) rules out AVRT and indicates typical AVNRT or, less commonly AT, as the most likely diagnosis.The 70 ms cut-off interval is based on VA intervals that have been examined in electrophysiology studies.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationData from specialized centres on paroxysmal SVT patients referred for electrophysiology procedures indicate that patients tend to be younger, have similar age distribution, and lower prevalence of cardiovascular comorbidities.
“Data from specialized centres reporting on paroxysmal SVT patients referred for electrophysiology procedures, indicate that patients tend to be younger, have similar age distribution, and lower prevalence of cardiovascular comorbidities.5 -7”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [5] Clair, 1993, Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients, Circulation source
Not checked in the free run.
- cites [6] Lu, 2014, Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation, Int J Cardiol source
Not checked in the free run.
- cites [7] Rodriguez, 1992, Age at onset and gender of patients with different types of supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationSymptoms may be minimal and prolonged asymptomatic episodes may lead to a tachycardiomyopathy.
“although symptoms may be minimal and, on certain occasions, prolonged asymptomatic episodes may lead to a tachycardiomyopathy. 14”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Ellis, 2013, What about Tachycardia-induced cardiomyopathy?, Arrhythm Electrophysiol Rev source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAtrial flutter was 2.5-fold more common in men.
“Atrial flutter was 2.5-fold more common in men”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAn ECG taken during tachycardia is of key importance for the proper diagnosis of SVT, although it may fail to lead to a specific diagnosis.
“An ECG taken during tachycardia is of key importance for the proper diagnosis of SVT, although it may fail to lead to a specific diagnosis.17”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Katritsis, 2015, Differential diagnosis of regular, narrow-QRS tachycardias, Heart Rhythm source
Not checked in the free run.
May combine two claims.
PremisecitationIn that series, most patients with AVRT were male (55%), in contrast to patients with AVNRT and AT who were predominantly female (70% and 62%, respectively).
“Most patients with AVRT were male (55%), in contrast to patients with AVNRT and AT who were predominantly female (70% and 62%, respectively).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Porter, 2004, Influence of age and gender on the mechanism of supraventricular tachycardia, Heart Rhythm source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the Marshfield Epidemiologic Study Area, among a 3.5% sample of medical records, paroxysmal SVT prevalence was 2.25 per 1000 persons and incidence was 35 per 100,000 person-years.
“In a 3.5% sample of medical records in the Marshfield (Wisconsin) Epidemiologic Study Area (MESA) the prevalence of paroxysmal SVT was 2.25/1000 persons, and the incidence was 35/100 000 person-years. 4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Orejarena, 1998, Paroxysmal supraventricular tachycardia in the general population, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationParoxysmal AF is often asymptomatic whilst paroxysmal SVT is usually symptomatic.
“Paroxysmal AF is often asymptomatic whilst paroxysmal SVT is usually symptomatic, 13”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Page, 1994, Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationWide-QRS tachycardias can be ventricular tachycardias, supraventricular tachycardias conducting with bundle-branch block aberration, or over an accessory pathway, with a reported proportion of 80%, 15% and 5%, respectively.
“Wide-QRS tachycardias can be ventricular tachycardias, and supraventricular tachycardias conducting with bundle-branch block aberration, or over an accessory pathway, with a reported proportion of 80%, 15% and 5%, respectively (Figure 4).53”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Alzand, 2011, Diagnostic criteria of broad QRS complex tachycardia: decades of evolution, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationMost VTs, as opposed to SVTs, do not respond to carotid sinus massage, although a narrow-QRS VT originating from the left bundle branch and terminated with carotid sinus massage has been reported.
“Most VTs, as opposed to SVTs, do not respond to carotid sinus massage, although a narrow-QRS VT originating from the left bundle branch, and terminated with carotid sinus massage has been reported.26”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Alzand, 2009, An ‘almost wide’ QRS tachycardia, Circ Arrhythm Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationThe mechanism of inappropriate sinus tachycardia remains poorly understood and is likely multifactorial.
“The underlying mechanism of inappropriate sinus tachycardia remains poorly understood and is likely to be multifactorial.94”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Olshansky, 2013, Inappropriate sinus tachycardia, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationVagal manoeuvres terminate SVT in 19.4-54% of cases, with higher success when the patient is supine.
“Effectiveness of vagal manoeuvres in terminating SVT has been reported as between 19.4 -54%, 66 -68 with higher success rates in the supine position.69”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [66] Lim, 1998, Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage, Ann Emerg Med source
Not checked in the free run.
- cites [67] Smith, 2015, Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia, Cochrane Database Syst Rev
Not checked in the free run.
- cites [68] Wen, 1998, Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia, Circulation source
Not checked in the free run.
- cites [69] Appelboam, 2015, Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial, Lancet source
Not checked in the free run.
May combine two claims.
PremisecitationThe morphology criteria are not fulfilled in any lead in 4% of SVTs and 6% of VTs, and in a third of cases when one lead (V1 or V6) favours one diagnosis, the other one favours the opposite diagnosis.
“The morphology criteria are not fulfilled in any lead in 4% of SVTs and 6% of VTs, and in a third of cases when one lead (V 1 or V 6 ) favours one diagnosis, the other one favours the opposite diagnosis (VT in one lead and SVT the other one and vice versa).59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Brugada, 1991, A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationClass Ic and Ia drugs cause use-dependent slowing of conduction, and class III drugs prolong refractoriness at His-Purkinje tissue more than in the ventricular myocardium.
“Class Ic and Ia drugs cause use-dependent slowing of conduction, and class III drugs prolong refractoriness at His-Purkinje tissue more than in the ventricular myocardium.54,55”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [54] Crijns, 1993, Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [55] Crijns, 1988, Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment, Am J Cardiol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningElectrocardiographic criteria may provide clues suggestive of typical, slow-fast AVNRT, but are of limited value for appropriate differential diagnosis.
“Thus, electrocardiographic criteria may provide clues suggestive of typical, slow-fast AVNRT, but are of limited value for appropriate differential diagnosis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThis pattern suggests VT with a specificity of more than 90%, but this criterion has low sensitivity being present in <20% of all VTs.
“This pattern suggests VT with a specificity of more than 90%, but this criterion has low sensitivity being present in ,20% of all VTs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Alzand, 2011, Diagnostic criteria of broad QRS complex tachycardia: decades of evolution, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationPositive concordance may occur during antidromic SVT using a left posterior or left lateral accessory pathway, but a negative concordance is nearly always VT.
“While positive concordance may occur during antidromic SVT using a left posterior or left lateral accessory pathway a negative concordance is nearly always VT. 53”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Alzand, 2011, Diagnostic criteria of broad QRS complex tachycardia: decades of evolution, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationAdenosine has advantages over IV calcium channel blockers: rapid onset, short half-life, and avoidance of hypotension.
“The advantages of adenosine relative to IV calcium channel are its rapid onset, the short half-life, and the avoidance of hypotension.71”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Delaney, 2011, The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis, Eur J Emerg Med source
Not checked in the free run.
May combine two claims.
PremisecitationInappropriate sinus tachycardia tends to be persistent, and most affected patients are young and female, though not limited to that population.
“The tachycardia tends to be persistent and most of the affected patients are young and female, but this disorder is not limited to that population.95”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Still, 2005, Prevalence, characteristics and natural course of inappropriate sinus tachycardia, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationA taller right rabbit ear characterizes RBBB aberrancy but does not exclude VT.
“A taller right rabbit ear characterizes the RBBB aberrancy but does not exclude VT. 57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Garner, 2013, Wide complex tachycardia—ventricular tachycardia or not ventricular tachycardia, that remains the question, Arrhythm Electrophysiol Rev source
Not checked in the free run.
May combine two claims.
PremisecitationIn true LBBB, no Q wave is present in the lateral precordial leads; therefore, the presence of any Q or QS wave in lead V6 favours VT.
“In true LBBB, no Q wave is present in the lateral precordial leads.Therefore, the presence of any Q or QS wave in lead V6 favours VT. 56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Wellens, 1978, The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex, Am J Med source
Not checked in the free run.
May combine two claims.
PremisecitationThere has been one report on the analysis of 267 wide-QRS tachycardias, consisting of VT and antidromic AVRT; the derived criteria were found to offer sensitivity of 75% and specificity of 100%.
“There has been one report on the analysis of 267 wide-QRS tachycardias, consisting of VT and antidromic AVRT.The derived criteria were found to offer sensitivity of 75% and specificity of 100%, 63”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Steurer, 1994, The differential diagnosis on the electrocardiogram between ventricular tachycardia and preexcited tachycardia, Clin Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn POTS, tachycardia occurs gradually when moving from supine to upright, in the absence of orthostatic hypotension, unlike IST.
“as opposed to inappropriate sinus tachycardia, in POTS the tachycardia occurs gradually moving from supine to upright position in the absence of orthostatic hypotension.93”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Sheldon, 2015, 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope, Heart Rhythm source
Not checked in the free run.
May combine two claims.
PremisecitationThese criteria are specific (91-100%) but modestly sensitive (58-14%).
“These criteria are specific (91-100%) but modestly sensitive (58-14%).22”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Kalbfleisch, 1993, Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn sinus node reentrant tachycardia, heart rate can shift suddenly at initiation, as opposed to the gradual increase in inappropriate sinus tachycardia.
“the heart rate can shift suddenly at initiation of sinus node reentrant tachycardia, as opposed to the gradual increase of the inappropriate sinus tachycardia rate;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationBeta blockers and calcium-channel blockers may be effective for chronic AT with low risk of side effects.
“Beta blockers and calcium-channel blockers may be effective and there is a low risk of side effects.113,114”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [113] Mehta, 1988, Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up, J Am Coll Cardiol source
Not checked in the free run.
- cites [114] Yamabe, 2014, Demonstration of anatomic reentrant circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus other than the vicinity of the atrioventricular node, Am J Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost studies report no gender impact on focal AT prevalence.
“Most studies reported no gender impact on prevalence.7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Rodriguez, 1992, Age at onset and gender of patients with different types of supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationMultifocal atrial tachycardia is not a good indication for catheter ablation, and metoprolol has been found superior to verapamil, but should be used with caution because pulmonary disease is frequent in MAT.
“Multifocal atrial tachycardia is not a good indication for catheter ablation, and metoprolol has been found superior to verapamil, but should be used with caution as pulmonary disease is frequent in MAT (Table 11).106,117”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [106] Arsura, 1988, A randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardia, Am J Med source
Not checked in the free run.
- cites [117] Hazard, 1987, Treatment of multifocal atrial tachycardia with metoprolol, Crit Care Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn centrifugal arrhythmias such as focal AT and localized reentry, activation originates from a source and spreads centrifugally; in macro-reentries, activation follows a large path around a central obstacle and reenters.
“In centrifugal arrhythmias, (such as focal AT and localized reentry) the activation originates from a source and spreads centrifugally to the rest of the atria, while in macro-reentries, it follows a large path around a central obstacle and reenters.18”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Jais, 2009, A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationComplications of sinus node modification may occur in up to 14% and include cardiac tamponade, SVC syndrome, diaphragmatic paralysis due to phrenic nerve palsy, and sinus node dysfunction requiring permanent pacing.
“Complications of sinus node modification may occur in up to 14% of cases, and include cardiac tamponade, SVC syndrome, diaphragmatic paralysis due to phrenic nerve palsy, and sinus node dysfunction with the need for permanent pacing.88 -90”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [88] Gianni, 2016, Catheter ablation of inappropriate sinus tachycardia, J Interv Card Electrophysiol source
Not checked in the free run.
- cites [89] Jacobson, 2014, Epicardial/endocardial sinus node ablation after failed endocardial ablation for the treatment of inappropriate sinus tachycardia, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [90] Leonelli, 2000, Frequency of superior vena cava syndrome following radiofrequency modification of the sinus node and its management, Am J Cardiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFocal atrial tachycardia prevalence in asymptomatic young people is 0.34%, and 0.46% in symptomatic patients.
“In asymptomatic young people the prevalence of focal AT has been reported to be as low as 0.34%, with an increased prevalence of 0.46% in symptomatic patients.99”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] Poutiainen, 1999, Prevalence and natural course of ectopic atrial tachycardia, Eur Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationVerapamil, digoxin, and amiodarone have variable success in sinus node reentrant tachycardia; beta-blockers are often ineffective; ivabradine likely has minimal benefit.
“Verapamil, digoxin, and amiodarone have demonstrated variable success while beta-blockers are often ineffective, and the potential benefit of ivabradine is likely to be minimal.92,98”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
- cites [98] Yusuf, 2003, Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?, J Cardiovasc Pharmacol Ther source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationClass Ia, Ic, and III drugs may be effective for chronic AT if first-line therapy failed, but Ia and Ic agents should ideally be combined with AV node blocking agents.
“Class Ia, Ic, and III drugs may be effective if first-line therapy has failed, but Ia and Ic agents should be ideally combined associated with AV node blocking agents.107 -109,115,116”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [107] Hohnloser, 1992, Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias, Am J Cardiol source
Not checked in the free run.
- cites [108] Kunze, 1986, Effect of encainide and flecainide on chronic ectopic atrial tachycardia, J Am Coll Cardiol source
Not checked in the free run.
- cites [109] Coumel, 1980, Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases, Am Heart J source
Not checked in the free run.
- cites [115] Heusch, 1994, Clinical experience with propafenone for cardiac arrhythmias in the young, Eur Heart J source
Not checked in the free run.
- cites [116] Colloridi, 1992, Oral sotalol in pediatric atrial ectopic tachycardia, Am Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationAT is considered a benign condition, but cases of tachycardiomyopathy have been described.
“AT is considered a benign condition, but cases of tachycardiomyopathy have been described.102”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Chen, 1998, Focal atrial tachycardia: reanalysis of the clinical and electrophysiologic characteristics and prediction of successful radiofrequency ablation, J Cardiovasc Electrophysiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLocalized reentries are small reentrant circuits with diameter less than 2-3 cm.
“Localized reentries are small reentrant circuits, with a diameter that is less than 2 -3 cm.118”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Jais, 2000, Mapping and ablation of left atrial flutters, Circulation source
Not checked in the free run.
May combine two claims.
Premisecitation24-h Holter monitoring in IST characteristically shows a mean heart rate above 90 bpm with an exaggerated heart rate response above 100 bpm during waking hours.
“The 24-h Holter monitoring characteristically demonstrates a mean HR .90bpm with an exaggerated HR response .100bpm during the waking hours.95”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Still, 2005, Prevalence, characteristics and natural course of inappropriate sinus tachycardia, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationIntravenous adenosine has been shown to terminate AT, particularly focal, but the tachycardia may continue with AV block.
“Intravenous adenosine has been shown to terminate AT, particularly when there is a focal origin, but the tachycardia may continue with AV block.103,105”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationFocal AT may arise from any site in both atria, but crista terminalis, tricuspid and mitral valve annulus, and thoracic veins joining the atria are sites of predilection.
“Focal AT may arise from any site in both atria, but crista terminalis, tricuspid and mitral valve annulus, and within the thoracic veins joining to the atria, are sites of predilection.101”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [101] Teh, 2009, Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationSinus node reentrant tachycardia is easily and reproducibly induced with programmed atrial stimulation, unlike inappropriate sinus tachycardia.
“sinus node reentrant tachycardia is easily and reproducibly induced with programmed atrial stimulation differently from inappropriate sinus tachycardia;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Gomes, 1985, Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn a double-blind randomized placebo-controlled crossover trial of 21 patients, ivabradine eliminated 75% of IST-related symptoms, with nearly 50% experiencing prompt complete resolution in short-term follow-up.
“In a double-blind, randomized, placebo-controlled trial with a crossover design on 21 patients, 75% of inappropriate sinus tachycardia-related symptoms were eliminated in the ivabradine cohort, with nearly 50% of patients experiencing prompt and complete resolution of all symptoms in a short-term follow-up.85”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Cappato, 2012, Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIvabradine is a selective If current blocker that slows heart rate without affecting intraventricular conduction, contractility, or haemodynamics, and has been found safe and effective in multiple small trials.
“ivabradine, a selective If current blocker that directly slows the HR without influence on intraventricular conduction, contractility, or haemodynamics, has been found safe and effective in multiple small trials (Table 9).85,86”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [85] Cappato, 2012, Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation, J Am Coll Cardiol source
Not checked in the free run.
- cites [86] Ptaszynski, 2013, Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationAtrial overdrive pacing can localize the focus of focal AT because the post-pacing interval increases with increasing distance from the source.
“Atrial overdrive pacing can be used to localize the focus of these tachycardias, since the PPI increases with increasing distance from the source.100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Mohamed, 2007, A novel pacing maneuver to localize focal atrial tachycardia, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of 20 patients, ivabradine had a similar effect on resting heart rate as metoprolol but was more effective in relieving symptoms during exercise or daily activity and was better tolerated.
“In a more recent study of 20 patients, ivabradine had a similar effect on resting heart rate as metoprolol but was more effective in relieving symptoms during exercise or daily activity, and was better tolerated.86”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Ptaszynski, 2013, Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationAdenosine injection can help by terminating focal AT or by slowing the ventricular rate.
“Adenosine injection can help by terminating focal AT or by slowing the ventricular rate.103”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Markowitz, 1999, Differential effects of adenosine on focal and macroreentrant atrial tachycardia, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationThe reentry mechanism of typical AFL is supported by a line of conduction block in the posterior RA extending from IVC toward SVC, most often related to anisotropic conduction at the crista terminalis, though other posterior RA structures may play a role.
“The reentry mechanism is supported by a line of conduction block in the posterior RA, extending from the IVC toward the SVC, most often related to anisotropic conduction at the crista terminalis, 123 although other structures of the posterior RA may also play a role.124”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [123] Olgin, 1995, Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography, Circulation source
Not checked in the free run.
- cites [124] Friedman, 2000, Global right atrial mapping of human atrial flutter: the presence of posteromedial (sinus venosa region) functional block and double potentials : a study in biplane fluoroscopy and intracardiac echocardiography, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationAmiodarone may not be very effective acutely to reestablish sinus rhythm in AFL, but helps control ventricular rate if it is too fast.
“Amiodarone may not be very effective acutely to reestablish sinus rhythm, but it does help control ventricular rate if it is too fast.143,144”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [143] Bianconi, 2000, Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study, Eur Heart J source
Not checked in the free run.
- cites [144] Kafkas, 2007, Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter, Int J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationSystemic embolism occurs in AFL about 30% as frequently as in AF, a difference that disappears when AFL is associated with AF episodes.
“Systemic embolism occurs in AFL about 30% as frequently as in AF, 168 -170 a difference that disappears when AFL is associated with AF episodes.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [168] Biblo, 2001, Risk of stroke in patients with atrial flutter, Am J Cardiol source
Not checked in the free run.
- cites [169] Wood, 1997, Risk of thromboembolism in chronic atrial flutter, Am J Cardiol source
Not checked in the free run.
- cites [170] Seidl, 1998, Risk of thromboembolic events in patients with atrial flutter, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationRate control is a particularly difficult goal in AFL, and even combination of AV node blocking drugs may fail, making cardioversion necessary.
“This is a particularly difficult goal in AFL and even the combination of AV node blocking drugs (digoxin, b blockers, calcium channel blockers) 135 -137 may fail, making cardioversion to sinus rhythm necessary.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [135] Ellenbogen, 1991, A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study, J Am Coll Cardiol source
Not checked in the free run.
- cites [136] Platia, 1989, Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter, Am J Cardiol source
Not checked in the free run.
- cites [137] Salerno, 1989, Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAdenosine can produce a rebound increase of AV conduction to 1:1 and may precipitate AF.
“However, adenosine can produce a rebound increase of AV conduction to 1:1, and may also precipitate AF. 177,178”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [177] Brodsky, 1994, Enhanced atrioventricular conduction during atrial flutter after intravenous adenosine, N Engl J Med source
Not checked in the free run.
- cites [178] Strickberger, 1997, Adenosine-induced atrial arrhythmia: a prospective analysis, Ann Intern Med source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationIn scar-related areas of block, the ECG pattern may not be typical, and conversely a typical AFL ECG may be produced by atypical MRT even due to LA circuits.
“In these cases with scar-related areas of block the ECG pattern may not Table 12 Therapy of atrial flutter/ macro-reentrant tachycardia Recommendation Reference Acute therapy Synchronised DC cardioversion is recommended for haemodynamically unstable patients with AFL/MRT a 131,132 IV anticoagulation may be considered in case emergency cardioversion is necessary.Anticoagulation should be continued”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [159] Lukac, 2005, Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?, Heart Rhythm source
Not checked in the free run.
- cites [160] Coffey, 2013, Catheter ablation of scar-related atypical atrial flutter, Europace source
Not checked in the free run.
- cites [171] Bochoeyer, 2003, Surface electrocardiographic characteristics of right and left atrial flutter, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationCatheter ablation for focal AT has a reported success rate of 75-100% and has been shown superior to antiarrhythmic drugs in a randomized study in the context of AF ablation.
“Catheter ablation is reported to have a 75 -100% success rate, 111,120 and has been shown superior to antiarrhythmic drugs in a randomized study in the context of AF ablation.112”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [111] Anguera, 2001, Outcomes after radiofrequency catheter ablation of atrial tachycardia, Am J Cardiol source
Not checked in the free run.
- cites [120] Hoffmann, 2002, Clinical experience with electroanatomic mapping of ectopic atrial tachycardia, Pacing Clin Electrophysiol source
Not checked in the free run.
- cites [112] Zhang, 2014, Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial, Eur Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationIf complete block is present, the superior turning point is the atrial roof between SVC and tricuspid ring; otherwise it may be at different levels of the postero-lateral wall across the crista terminalis.
“If complete block is present, the superior turning point is the atrial roof, between the superior vena cava (SVC) and the tricuspid ring, but in other cases the turning point may be at different levels of the postero-lateral wall, across the crista terminalis.125 -127”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [125] Cheng, 1999, Right atrial flutter due to lower loop reentry: mechanism and anatomic substrates, Circulation source
Not checked in the free run.
- cites [126] Dixit, 2011, Noncontact electroanatomic mapping to characterize typical atrial flutter: participation of right atrial posterior wall in the reentrant circuit, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [127] Santucci, 2009, Electroanatomic mapping of postpacing intervals clarifies the complete active circuit and variants in atrial flutter, Heart Rhythm source
Not checked in the free run.
May combine two claims.
PremisecitationLocalized reentries are localized in one segment of the atrium and depend on a very slow conduction area showing long-duration fragmented signal encompassing more than half the cycle length, which is the target for ablation.
“They are localized in one segment of the atrium and depend on a very slow conduction area showing a very long duration and fragmented signal which usually encompass more than half the cycle length and are the target for ablation.119”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Takahashi, 2009, Electrophysiological characteristics of localized reentrant atrial tachycardia occurring after catheter ablation of long-lasting persistent atrial fibrillation, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationMultiple circuits are possible in AFL, including CTI-dependent AFL which remains the most common type even after surgery or ablation.
“Multiple circuits are possible, including CTI-dependent AFL which still is the most common type even in these situations.11,159,160”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [11] Granada, 2000, Incidence and predictors of atrial flutter in the general population, J Am Coll Cardiol source
Not checked in the free run.
- cites [159] Lukac, 2005, Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?, Heart Rhythm source
Not checked in the free run.
- cites [160] Coffey, 2013, Catheter ablation of scar-related atypical atrial flutter, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationIn AFL lasting >48h, risk of thromboembolism appears high at the time of cardioversion to sinus rhythm by DC shock, atrial stimulation, or CTI ablation, and anticoagulation is recommended as in AF.
“In patients with AFL lasting .48h the risk of thromboembolism would appear high at the time of cardioversion to sinus rhythm, either by DC shock, atrial stimulation or CTI ablation, 133,134 and anticoagulation is recommended as in AF.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [133] Grimm, 1997, Left atrial appendage ‘stunning’ after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events, J Am Coll Cardiol source
Not checked in the free run.
- cites [134] Irani, 1997, Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationDofetilide and ibutilide, pure class III AADs, are very effective for interrupting AFL intravenously, while class Ia and Ic drugs have little or no effect.
“Dofetilide and ibutilide, pure class III AADs, are very effective for interrupting AFL in intravenous administration, while Class Ia and Ic drugs have little or no effect.138 -142,149”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [138] Crijns, 1994, Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug, Eur Heart J source
Not checked in the free run.
- cites [139] Falk, 1997, Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators, J Am Coll Cardiol source
Not checked in the free run.
- cites [140] Stambler, 1997, Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy, Circulation source
Not checked in the free run.
- cites [141] Volgman, 1998, Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation, J Am Coll Cardiol source
Not checked in the free run.
- cites [142] Vos, 1998, Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group, Heart source
Not checked in the free run.
- cites [149] Singh, 2000, Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study, Circulation source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe 'lower loop' circuit can be considered a variant of typical atrial flutter in which activation crosses the posterior right atrium and crista terminalis at a lower level than usual, and the ECG often shows a typical flutter pattern.
“the so called 'lower loop' circuit could be considered a variation of typical AFL in which the activation crosses the posterior RA and TC at a lower level than usual, and the ECG tends to show a typical AFL pattern.125”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125] Cheng, 1999, Right atrial flutter due to lower loop reentry: mechanism and anatomic substrates, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationPeri-mitral or roof-dependent macroreentrant tachycardia may occur in 4% to 20% of atrial fibrillation ablation cases, with higher rates after linear or fractionated electrogram ablation techniques.
“Peri-mitral or roof-dependent MRT may occur in 4-20% of AF ablation cases, being higher with linear or fractionated electrogram ablation techniques.119,197,198”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [119] Takahashi, 2009, Electrophysiological characteristics of localized reentrant atrial tachycardia occurring after catheter ablation of long-lasting persistent atrial fibrillation, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [197] Wasmer, 2012, Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation, Heart Rhythm source
Not checked in the free run.
- cites [198] Rostock, 2013, Prognostic role of subsequent atrial tachycardias occurring during ablation of persistent atrial fibrillation: a prospective randomized trial, Circ Arrhythm Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationTwo randomized studies found catheter ablation superior to antiarrhythmic drugs for atrial flutter recurrence, quality of life, repeat hospitalization, and drug side effects.
“Two randomized studies have shown the superiority of catheter ablation over AAD in terms of AFL recurrence, quality of life, repeat hospitalization and AAD side effects.153,154”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [153] Da Costa, 2006, Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter, Circulation source
Not checked in the free run.
- cites [154] Natale, 2000, Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAtypical, surgery-related atrial flutter/macroreentrant tachycardia often occurs years after surgery, suggesting that atrial remodeling may be needed for stable reentry around the surgical obstacle.
“Atypical, surgery-related AFL/MRT often occurs years after the procedure, suggesting that an atrial remodelling process may be necessary to make reentry stable around the surgical obstacle.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAtrial fibrillation after flutter ablation is more likely in patients with prior atrial fibrillation episodes and in those with a dilated left atrium.
“AF is more likely in patients having had AF episodes before ablation and in those with a dilated LA. 187”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [187] Ellis, 2007, Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationThe ECG pattern of atypical flutter is difficult to relate to its mechanism because slow conduction segments in reentry pathways can produce isoelectric lines and atrial waves may reflect activation outside the circuit.
“The ECG pattern is difficult to relate to the mechanism, since slow conduction segments in reentry pathways may produce isoelectric lines and the atrial waves may reflect activation outside the circuit.171”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [171] Bochoeyer, 2003, Surface electrocardiographic characteristics of right and left atrial flutter, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationComplete, persistent, bidirectional cavotricuspid isthmus block is the procedural endpoint, and when achieved, arrhythmia recurrence occurs in less than 10% of cases.
“Complete, persistent, bidirectional CTI block is the procedure endpoint, and, if attained, recurrence of the arrhythmia is seen in ,10% of cases.181,182”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [181] Shah, 2000, Differential pacing for distinguishing block from persistent conduction through an ablation line, Circulation source
Not checked in the free run.
- cites [182] Schwartzman, 1996, Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with complex congenital heart disease who undergo Mustard, Senning, or Fontan procedures, complex suture lines and extensive myocardial damage create multiple substrates, while the cavotricuspid isthmus often remains a critical isthmus in the reentry circuit with difficult access for ablation.
“In patients with complex congenital heart disease undergoing the Mustard, Senning, or Fontan procedures, complex suture lines and large areas of myocardial damage create multiple substrates while in many cases the CTI is still a critical isthmus in the reentry circuit, with a difficult access for ablation.195,196”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [195] Collins, 2000, Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease, Am J Cardiol source
Not checked in the free run.
- cites [196] Zrenner, 2003, Delineation of intra-atrial reentrant tachycardia circuits after mustard operation for transposition of the great arteries using biatrial electroanatomic mapping and entrainment mapping, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationMacroreentrant tachycardia circuits may rotate around the superior vena cava and upper crista terminalis ('upper loop') or around a lateral right atrial surgical scar or a septal patch.
“MRT circuits may turn around the SVC and the upper portions of the crista terminalis ('upper loop') or around a lateral RA surgical scar or a septal patch.159,194”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [159] Lukac, 2005, Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?, Heart Rhythm source
Not checked in the free run.
- cites [194] Kall, 2000, Atypical atrial flutter originating in the right atrial free wall, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationDofetilide is moderately effective for converting atrial fibrillation or flutter to sinus rhythm and significantly effective for maintaining sinus rhythm, but in-hospital initiation and dose adjustment based on QTc and renal function are needed to minimize a small but not negligible proarrhythmic risk.
“Dofetilide is moderately effective in cardioverting AF or AFL to SR, and significantly effective in maintaining SR but in-hospital initiation and dosage adjustment based on QTc and renal function are necessary to minimize a small but not negligible proarrhythmic risk.149”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [149] Singh, 2000, Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationComplications of cavotricuspid isthmus ablation are infrequent and usually limited to vascular access, though in-hospital mortality of 0.17% has been reported.
“Complications of CTI ablation are infrequent, and usually limited to the vascular access, although a 0.17% in-hospital mortality has been reported.161”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [161] Patel, 2016, Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: analysis of 89,638 procedures, Heart Rhythm source
Not checked in the free run.
May combine two claims.
PremisecitationAfter cavotricuspid isthmus ablation, long-term prognosis is affected by atrial fibrillation, which can occur in 30% to 50% of patients over 5 to 8 years.
“However, post-ablation prognosis is affected by the incidence of AF that can be 30 -50% in the long term (5-8 years).175”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Luria, 2008, Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationThis high incidence has been related to inflammatory changes in the atrial myocardium, similar to experimental pericarditis animal models, and may be prevented by anti-inflammatory corticosteroid or colchicine treatment.
“This high incidence has been related to inflammatory changes in the atrial myocardium, 213 not unlike the experimental pericarditis animal models, and it may be prevented by anti-inflammatory corticosteroid or colchicine treatment.214”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [213] Ishii, 2005, Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation, Circulation source
Not checked in the free run.
- cites [214] Ho, 2009, Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationAfter atrial fibrillation maze surgery, macroreentrant tachycardia may depend on breaks in the surgical ablation lines that can be localized by endocardial mapping, allowing interruption by localized ablation at those sites.
“After AF 'maze' surgery, MRT may depend on breaks of the surgical ablation lines that can be localized by endocardial mapping allowing interruption of the MRT by localized ablation at these sites.201,202”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [201] Akar, 2007, Surface electrocardiographic patterns and electrophysiologic characteristics of atrial flutter following modified radiofrequency MAZE procedures, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [202] McElderry, 2008, Proarrhythmic aspects of atrial fibrillation surgery: mechanisms of postoperative macroreentrant tachycardias, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationExtensive left atrial ablation beyond pulmonary vein isolation carries a potentially increased risk of macroreentrant or focal iatrogenic atrial tachycardias, and its value is not well established in patients with paroxysmal or persistent atrial fibrillation.
“However, these techniques carry a potentially increased risk of macroreentrant or focal iatrogenic atrial tachycardias, 197,207 and their value is rather not established in patients with paroxysmal or persistent AF. 208 -210”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [197] Wasmer, 2012, Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation, Heart Rhythm source
Not checked in the free run.
- cites [207] O'Neill, 2009, Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint, Eur Heart J source
Not checked in the free run.
- cites [208] McLellan, 2015, A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study), Eur Heart J source
Not checked in the free run.
- cites [209] Verma, 2015, Catheter Ablation for Persistent Atrial Fibrillation, N Engl J Med
Not checked in the free run.
- cites [210] Vogler, 2015, Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAblation of atypical atrial flutter/macroreentrant tachycardia is more challenging and has a lower success rate and higher recurrence rate than cavotricuspid isthmus ablation.
“Atypical AFL/MRT ablation can be very challenging and has a lower success rate and a higher recurrence rate than CTI ablation.163,164,204 -206”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [163] Bai, 2007, Radiofrequency ablation of atypical atrial flutter after cardiac surgery or atrial fibrillation ablation: a randomized comparison of open-irrigation-tip and 8-mm-tip catheters, Heart Rhythm source
Not checked in the free run.
- cites [164] Matsuo, 2010, Peri-mitral atrial flutter in patients with atrial fibrillation ablation, Heart Rhythm source
Not checked in the free run.
- cites [204] Miyazaki, 2015, Recurrent spontaneous clinical perimitral atrial tachycardia in the context of atrial fibrillation ablation, Heart Rhythm source
Not checked in the free run.
- cites [205] Aktas, 2010, Higher rate of recurrent atrial flutter and atrial fibrillation following atrial flutter ablation after cardiac surgery, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [206] Bai, 2012, Ablation of perimitral flutter following catheter ablation of atrial fibrillation: impact on outcomes from a randomized study (PROPOSE), J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationVagal manoeuvres for orthodromic AVRT can be first-line treatment with a success rate of approximately 50%.
“Non-invasive approaches for orthodromic AVRT with vagal manoeuvres, including Valsalva and carotid sinus massage, could represent the first-line treatment with a success rate of approximately 50% (Table 16).66 -68”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [66] Lim, 1998, Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage, Ann Emerg Med source
Not checked in the free run.
- cites [67] Smith, 2015, Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia, Cochrane Database Syst Rev
Not checked in the free run.
- cites [68] Wen, 1998, Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia, Circulation source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThese findings suggest that some remodeling or maturation process may be necessary before a macroreentrant tachycardia circuit becomes stable, and that a new ablation procedure early after atrial fibrillation ablation should not be indicated unless tachycardia does not respond to antiarrhythmic drugs.
“This would suggest that some kind of remodelling or maturation process may be necessary before a MRT tachycardia circuit becomes stable, and that a new ablation procedure early after AF ablation should not be indicated, unless tachycardia does not respond to antiarrhythmic drugs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn atrial flutter after atrial fibrillation ablation, more than one tachycardia mechanism often coexists, both macroreentrant and focal, sometimes making circuit identification difficult, particularly when entrainment maneuvers change activation.
“In post-AF ablation AFL, more than one tachycardia mechanisms often coexist, both MRT and focal, 157,203 making sometimes difficult to identify the circuits' structures, particularly when entrainment manoeuvres result in changes in activation.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [157] Chae, 2007, Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence, J Am Coll Cardiol source
Not checked in the free run.
- cites [203] Gerstenfeld, 2004, Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation, Circulation source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThus, multiple cell sources participating in the AV node may contribute to its heterogeneity and form the substrate underlying AV nodal reentrant tachycardia.
“Thus, multiple sources of cells that participate in the AV node may play a role in its heterogeneity, and form the substrate underlying AV nodal reentrant tachycardia.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe incidence of atrial arrhythmias in the early postoperative period after coronary artery bypass surgery is 20% to 30%.
“The incidence of atrial arrhythmias in the early postoperative period (days) after coronary artery by-pass surgery, is 20-30%.212”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [212] Frost, 1992, Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials, Int J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn many patients, attacks manifest early in life, while in a substantial proportion atrioventricular nodal reentrant tachycardia starts only in the fourth or fifth decade.
“In many patients attacks indeed manifest early in life, whereas in a substantial proportion of patients AVNRT starts only in the 4th or 5th decade.223”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [223] Pentinga, 1993, Late onset atrioventricular nodal tachycardia, Int J Cardiol source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThere is very little evidence on anticoagulation indications for patients with atypical right atrial flutter/macroreentrant tachycardia, but associated heart disease could increase embolic risk, making anticoagulation a reasonable alternative.
“There is very little evidence regarding indications for anticoagulation in patients with atypical FL/ MRT of the RA, but the associated heart disease could make embolic risk higher, making anticoagulation, as proposed above, a reasonable alternative.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMost accessory pathways conduct in both directions (about 60%); some conduct in only one direction; anterograde-only conduction is uncommon (<5%), while retrograde-only conduction is more frequent (17-37%).
“although the majority of APs conduct both anterogradely and retrogradely ( 60%), some of them are able of propagating impulses in only one direction.Those that conduct in the anterograde direction only are uncommon (,5%), whereas those that conduct in the retrograde direction only are more frequent (17-37%).303”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [303] Issa, 2012, Atrioventricular reentrant tachycardia source
Not checked in the free run.
May combine two claims.
PremisecitationThe AV node is a three-dimensional structure with greater variability in tissue space constant and poor gap junction connectivity due to differential connexin isoform expression, conditions that explain dual conduction and nodal reentrant arrhythmogenesis.
“The AV node is a three-dimensional structure with greater variability in the space constant of tissue, and poor gap junction connectivity due to differential expression of connexin isoforms, conditions that provide an explanation of dual conduction and nodal reentrant arrhythmogenesis.218,219”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [218] Nikolaidou, 2012, Structure-function relationship in the sinus and atrioventricular nodes, Pediatr Cardiol source
Not checked in the free run.
- cites [219] Hucker, 2008, Connexin 43 expression delineates two discrete pathways in the human atrioventricular junction, Anat Rec (Hoboken) source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the general population, the prevalence of the WPW pattern on surface ECG is 0.15%-0.25%, rising to 0.55% among first-degree relatives of affected patients.
“In the general population, the prevalence of WPW pattern on surface ECG is from 0.15% to 0.25%, 304 increasing to 0.55% among first-degree relatives of affected patients.305”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [304] Krahn, 1992, The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study, Ann Intern Med source
Not checked in the free run.
- cites [305] Vidaillet, 1987, Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome), N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn early studies, predictors of ventricular fibrillation in WPW syndrome were an R-R interval during spontaneous or induced AF below 180 ms, a history of symptomatic tachycardia, inducibility of AVRT, and multiple accessory pathways.
“In early studies, identified predictors of ventricular fibrillation in patients with WPW syndrome were R-R interval during spontaneous or induced AF , 180 ms, history of symptomatic tachycardia and inducibility of AVRT, and multiple accessory pathways.308,309”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [308] Beckman, 1990, The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome, J Am Coll Cardiol source
Not checked in the free run.
- cites [309] Montoya, 1991, Ventricular fibrillation in the Wolff-Parkinson-White syndrome, Eur Heart J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenType II atrial flutter is likely related to functional reentrant rhythms induced by rapid pacing under acetylcholine in dogs, and in most cases is probably a laboratory, pacing-induced artifact of little clinical significance.
“Type II AFL is likely related to the functional reentrant rhythms induced by rapid pacing under acetylcholine in the dog, and in most cases is probably a laboratory, pacing-induced artefact of little clinical significance.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHeterogeneity of both fast and slow conduction patterns has been well described, and all forms of AVNRT may display anterior, posterior, middle, or even left atrial retrograde activation patterns.
“Heterogeneity of both fast and slow conduction patterns has been well described, and all forms of AVNRT may display anterior, posterior and middle or even left atrial retrograde activation patterns.228”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [228] Katritsis, 2010, Atrioventricular nodal reentrant tachycardia, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationTachycardia inducibility at the end of the procedure does not predict long-term occurrence of macroreentrant tachycardia, and most tachycardias appearing in the first 6 to 8 weeks of follow-up resolve with antiarrhythmic drugs.
“Tachycardia inducibility at the end of the procedure is not predictive of the long-term occurrence of MRT, and most of tachycardias appearing in the initial 6-8 weeks of follow-up disappear under AAD.158,193”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [158] Daoud, 2006, Proarrhythmia of circumferential left atrial lesions for management of atrial fibrillation, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [193] Chugh, 2005, Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation, Heart Rhythm source
Not checked in the free run.
May combine two claims.
PremisecitationThe superior transseptal surgical approach to mitral valve repair or replacement is more arrhythmogenic than direct posterior left atrial atriotomy, leading to macroreentrant tachycardia circuits involving both atria that are difficult to eliminate by ablation.
“The superior transseptal surgical approach to mitral valve repair or replacement is more arrhythmogenic than direct posterior LA atriotomy, leading to the appearance of MRT circuits involving both atria, and that are difficult to eliminate by ablation.160,200”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationA posteroseptal location of accessory pathways was found in almost all patients with VF, whereas the rate of multiple accessory pathways was similar in patients with or without VF.
“A posteroseptal location of accessory pathways was found in almost all patients with VF, whereas the rate of multiple accessory pathways was similar in patients with or without VF, as reported by other investigators.335”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [335] Timmermans, 1995, Aborted sudden death in the Wolff-Parkinson-White syndrome, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn that registry, benign arrhythmias including AVRT and AF developed in 15.6%, while 21.6% of older patients (median age 42 years) lost ventricular preexcitation and remained asymptomatic.
“Benign arrhythmias including AVRT and AF developed in 15.6%, while 21.6% of older patients (median age, 42 years) lost ventricular preexcitation remaining asymptomatic.322”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [322] Pappone, 2014, Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationIn the latest meta-analysis, AVRT carried a mortality rate of 0.1% after radiofrequency ablation, while there was no procedural-related mortality for AFL or AVNRT.
“Although these rates are higher than most experienced electrophysiologists have in daily practice, in the latest meta-analysis AVRT still carried a mortality rate of 0.1% after radiofrequency ablation, whereas there was no procedural-related mortality for AFL or AVNRT.244”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [244] Spector, 2009, Meta-analysis of ablation of atrial flutter and supraventricular tachycardia, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAsymptomatic patients who developed VF had short accessory pathway anterograde ERP less than 200-220 ms, and a shorter pre-excited RR interval during AF (SPERRI) less than 200-230 ms.
“Asymptomatic patients who developed VF had short accessory pathway anterograde ERP less than 200 -220 ms, and a shorter pre-excited RR interval during AF (SPERRI) less than 200 -230 ms.339,341”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [339] Pappone, 2003, Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study, J Am Coll Cardiol source
Not checked in the free run.
- cites [341] Santinelli, 2009, Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients, Circ Arrhythm Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn that first trial, 5-year Kaplan-Meier estimates of arrhythmic events were 7% after ablation and 77% in controls (P<0.001), with a risk reduction of 92% (RR 0.08; 95% CI 0.02-0.33; P<0.001).
“The 5-year Kaplan -Meier estimates of the incidence of arrhythmic events were 7% among patients who underwent ablation, and 77% among the controls (P , 0.001 by the log-rank test); the risk reduction with ablation was 92% (relative risk, 0.08; 95% CI, 0.02 to 0.33; P , 0.001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [343] Pappone, 2003, A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationConcealed pathways are more frequently localized along the left free wall (64%), and less frequently at septal (31%) and right free wall locations.
“Concealed pathways are more frequently localized along the left free wall (64%), and less frequently at septal (31%) and right free wall locations.327”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [327] Kuck, 1990, Sites of conduction block in accessory atrioventricular pathways. Basis for concealed accessory pathways, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationIn a recent review, data from observational studies on 833 patients who did not undergo ablation showed that up to 9% developed malignant arrhythmias, and up to 2% developed VF during follow-up.
“In a recent review, data from observational studies on 833 patients who did not undergo ablation showed that up to 9% of patients developed malignant arrhythmias, and up to 2% developed VF during follow-up.344”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [344] Al-Khatib, 2016, Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn that second study, during follow-up, 1 child in the ablation group (5%) and 12 in the control group (44%) had arrhythmic events; two control children had VF and one died suddenly.
“During follow-up, 1 child in the ablation group (5%), and 12 in the control group (44%) had arrhythmic events.Two children in the control group had ventricular fibrillation, and one died suddenly.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [345] Pappone, 2004, Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn an 8-year prospective study on 2169 symptomatic or asymptomatic WPW patients, those who developed VF showed more inducible pre-excited sustained AF triggered by AVRT (73.3% vs 44.9%) and shorter median accessory pathway ERP (220 vs 240 ms) than subjects without ventricular arrhythmias.
“In an 8-year prospective study on 2169 symptomatic or asymptomatic WPW patients, electrophysiologic testing revealed that patients who developed VF, showed more inducible pre-excited sustained AF triggered by AV reciprocating tachycardia (73.3% vs. 44.9%),and shorter median accessory pathway ERP (220 vs. 240 ms) than subjects not experiencing ventricular arrhythmias.322”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [322] Pappone, 2014, Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationIn that first trial, EP study complications developed in 3 patients (1%) (2 pneumothorax and 1 large femoral haematoma), and an ablation-related complication (permanent RBBB) developed in 1 (3%) of 37 patients.
“Complications related to EP study developed in three patients (1%) (2 pneumothorax and 1 large femoral haematoma).An ablation-related complication (permanent RBBB) developed in 1 (3%) of 37 patients.343”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [343] Pappone, 2003, A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn the second randomized study of asymptomatic children (age 5-12) with WPW and inducible AVRT or AF, after randomization of 60 children, parents withdrew 13; of the remaining, 20 underwent prophylactic ablation and 27 had no treatment.
“The second randomized study was conducted on asymptomatic children (age range, 5 to 12 years) with WPW syndrome and in whom AVRT or AF were reproducibly inducible.After randomization of 60 children, but before any ablation had been performed, the parents withdrew 13 of them from the study.Of the remaining children, 20 underwent prophylactic ablation and 27 had no treatment.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [345] Pappone, 2004, Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationMahaim conduction is usually antegrade only, but concealed fibres have also been described.
“Mahaim conduction is usually antegrade only, but concealed fibres have also been described.332”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [332] Hluchy, 1999, Radiofrequency ablation of a concealed nodoventricular Mahaim fiber guided by a discrete potential, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationNo gender predilection was found for concealed accessory pathways, and they tend to occur more frequently in younger patients than in those with AVNRT, with significant overlap.
“Moreover, no gender predilection was found and these pathways tend to occur more frequently in younger patients than in those with AVNRT; however significant overlap exists.303”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [303] Issa, 2012, Atrioventricular reentrant tachycardia source
Not checked in the free run.
May combine two claims.
PremisecitationIn a large retrospective series of 690 WPW patients, 15 (2.2%) had aborted sudden death, and in 8 of them (>50%) VF was the first clinical manifestation of the syndrome.
“In a large retrospective series of 690 WPW patients, 15 (2.2%) had aborted sudden death, and in 8 of them (.50%) VF was the first clinical manifestation of the syndrome.335”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [335] Timmermans, 1995, Aborted sudden death in the Wolff-Parkinson-White syndrome, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationThe 2015 ACC/AHA/HRS guideline reports major complication rates after radiofrequency catheter ablation of 3.0% for AVNRT and 2.8% for AVRT.
“The 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia report major complication rates after radiofrequency catheter ablation of 3.0% and 2.8% for AVNRT and AVRT, respectively.2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Page, 2016, 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationSmall trials have reported safety and efficacy of Class Ic antiarrhythmic drugs with beta blockers in WPW syndrome, but no randomized trials in this setting have been performed.
“Small trials have reported the safety and efficacy of this drug therapy in the context of WPW syndrome, 323,324 but no randomized trials in this setting have been performed.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [323] Breithardt, 1984, Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up, Am J Cardiol source
Not checked in the free run.
- cites [324] Vassiliadis, 1990, Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome, Int J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationPJRT is a rare form of atrioventricular reciprocating tachycardia using a concealed accessory pathway, usually located in the posteroseptal region, with retrograde decremental conduction properties.
“Permanent Junctional Reciprocating Tachycardia (PJRT) represents a rare form of atrioventricular reciprocating tachycardia using a concealed accessory pathway, usually located in the posteroseptal region, with retrograde decremental conduction properties.328”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [328] Kang, 2014, Permanent junctional reciprocating tachycardia in children: a multicenter experience, Heart Rhythm source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMahaim fibers are nodoventricular or atriofascicular decrementally conducting connections between the right atrium or AV node and the right ventricle in or close to the right bundle branch.
“Mahaim fibers are nodoventricular (as initially described) or atriofascicular (more often) decrementally conducting connections between the right atrium or the AV node and the right ventricle in or close to the right bundle branch.329 -332”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [329] Kottkamp, 1996, Variants of preexcitation--specialized atriofascicular pathways, nodofascicular pathways, and fasciculoventricular pathways: electrophysiologic findings and target sites for radiofrequency catheter ablation, J Cardiovasc Electrophysiol source
Not checked in the free run.
- cites [330] Gandhavadi, 2013, Characterization of the distal insertion of atriofascicular accessory pathways and mechanisms of QRS patterns in atriofascicular antidromic tachycardia, Heart Rhythm source
Not checked in the free run.
- cites [331] Haissaguerre, 1995, Characteristics of the ventricular insertion sites of accessory pathways with anterograde decremental conduction properties, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationIn that second study, the cumulative rate of arrhythmic events was lower among high-risk children who underwent ablation than among those who did not, and the reduction remained significant after adjustment in a Cox regression analysis.
“The cumulative rate of arrhythmic events was lower among children at high risk who underwent ablation than among those at high risk who did not.The reduction in risk associated with ablation remained significant after adjustment in a Cox regression analysis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [345] Pappone, 2004, Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn recent years, trans-baffle access has been described, and was successful in 96% of 74 attempted cases and does not seem to be associated with a higher incidence of adverse events.
“In recent years, trans-baffle access has been described, and was successful in 96% of 74 attempted cases and does not seem to be associated with a higher incidence of adverse events.361”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [361] Correa, 2013, Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations, J Am Heart Assoc source
Not checked in the free run.
May combine two claims.
PremisecitationIncisional related AFL is common (20%) as is sustained VT (11%) and risk of SCD (8%).
“Incisional related AFL is common (20%) as is sustained VT (11%) and risk of SCD (8%).387,388”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [387] Gatzoulis, 2000, Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study, Lancet source
Not checked in the free run.
- cites [388] Biviano, 2010, Atrial flutter catheter ablation in adult patients with repaired tetralogy of Fallot: mechanisms and outcomes of percutaneous catheter ablation in a consecutive series, J Interv Card Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationThe acute success rates of catheter ablation procedures of SVT in ACHD patients range from 65 to 100%, with a higher recurrence rate, 20-60% within 2 years, than seen in other cohorts for routine SVT ablation.
“The acute success rates of catheter ablation procedures of SVT in ACHD patients ranges from 65 to 100%, with a higher recurrence rate, 20 -60% within 2 years, than seen in other cohorts for routine SVT ablation.362 -364,379”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [362] de Groot, 2010, Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences, Circ Arrhythm Electrophysiol source
Not checked in the free run.
- cites [363] Yap, 2010, Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery, J Am Coll Cardiol source
Not checked in the free run.
- cites [364] Wu, 2013, Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationIn that second study, respiratory arrest and femoral vein thrombosis were seen in two patients, while ablation-related complications were seen in three patients (RBBB, transient AV block and pericardial effusion).
“Respiratory arrest and femoral vein thrombosis were seen in two patients, while ablation-related complications were seen in three patients (RBBB, transient AV block and pericardial effusion).345”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [345] Pappone, 2004, Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationAtrial tachycardias and impaired ventricular function are important and consistent risk factors for SCD in CHD; corrected Tetralogy of Fallot, post-atrial switch Mustard or Senning, left heart obstructed lesions and univentricular hearts have the highest (2-9% per decade) risk of SCD.
“Atrial tachycardias and impaired ventricular function are important and consistent risk factors for SCD in patients with CHD, of which corrected Tetralogy of Fallot, post-atrial switch operation Mustard or Senning, left heart obstructed lesions and univentricular hearts have the highest (2 -9% per decade) risk of SCD.352 -354”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [352] Koyak, 2012, Sudden cardiac death in adult congenital heart disease, Circulation source
Not checked in the free run.
- cites [353] Nieminen, 2007, Causes of late deaths after pediatric cardiac surgery: a population-based study, J Am Coll Cardiol source
Not checked in the free run.
- cites [354] Gallego, 2012, Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with repaired ASD, both CTI-dependent and 'incisional' AFL can occur and coexist in the same patient.
“In patients with repaired ASD, both CTI-dependent and 'incisional' AFL can occur and coexist in the same patient.349”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [349] Wasmer, 2013, Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair, Int J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationLong-term outcomes after secundum ASD closure using transcatheter closure and surgical closure are excellent without significant differences with regard to atrial arrhythmias (9.3%), survival, or thromboembolism.
“Long-term outcomes after secundum ASD closure using transcatheter closure and surgical closure are excellent without significant differences with regard to atrial arrhythmias (9.3%), survival, or thromboembolism.382”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [382] Kutty, 2012, Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationIn that second study, independent predictors of arrhythmic events were the absence of prophylactic ablation and the presence of multiple accessory pathways.
“In both ablation and control groups, the independent predictors of arrhythmic events were the absence of prophylactic ablation and the presence of multiple accessory pathways.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [345] Pappone, 2004, Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIncisional-related AFL or IART are the most common type of SVT (75%) in ACHD patients, and occur most frequently in patients with Ebstein anomaly, Tetralogy of Fallot, single-ventricle, Fontan procedures, TGA, and atrial septal defects.
“These incisional-related AFL or intra-atrial re-entrant tachycardia (IART) are the most common type of SVT (75%) in adult congenital heart disease (ACHD) patients, and occur most frequently in patients with Ebstein anomaly, Tetralogy of Fallot, single-ventricle, Fontan procedures, transposition of the great arteries (TGA), and atrial septal defects.349,350”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [349] Wasmer, 2013, Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair, Int J Cardiol source
Not checked in the free run.
- cites [350] Khairy, 2010, Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEven though the incidence of SCD is low (0.09% per year) in the CHD population, it is higher than in age-matched controls, and related to arrhythmias in 14% of all deaths after initial repair.
“Even though the incidence of SCD is low (0.09% per year) in the CHD population, it is higher than in age-matched controls, 351 and related to arrhythmias in 14% of all deaths after initial repair.352,353”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [351] Silka, 1998, A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects, J Am Coll Cardiol source
Not checked in the free run.
- cites [352] Koyak, 2012, Sudden cardiac death in adult congenital heart disease, Circulation source
Not checked in the free run.
- cites [353] Nieminen, 2007, Causes of late deaths after pediatric cardiac surgery: a population-based study, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough Class III AADs such as sotalol and amiodarone were most effective, adverse effects were common (22%).
“Although Class III AADs such as sotalol and amiodarone were most effective, adverse effects were common (22%).368”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [368] Koyak, 2013, Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationArrhythmia surgery can be integrated into a surgical repair with high efficacy and without evidence of increased surgical morbidity.
“Arrhythmia surgery can be integrated into a surgical repair with high efficacy and without evidence of increased surgical morbidity.372”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [372] Mavroudis, 2008, Arrhythmia surgery in patients with and without congenital heart disease, Ann Thorac Surg source
Not checked in the free run.
May combine two claims.
PremisecitationCatheter ablation of IART and AVNRT in patients following Mustard or Senning operation for d-TGA has a high primary success rate albeit high 30% recurrence rates for IART but excellent long-term results after a second ablation.
“Catheter ablation of IART and AVNRT in patients following Mustard or Senning operation for d-TGA has a high primary success rate albeit high 30% recurrence rates for IART but excellent longterm results after a second ablation.364”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [364] Wu, 2013, Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationAtrial flutters are drug-refractory and/or severely symptomatic in more than half of patients, and the CTI-dependent mechanism underlies approximately half of sustained, symptomatic AFLs.
“The atrial flutters are drug-refractory and/or severely symptomatic in more than half of the patients, and the CTI-dependent mechanism underlies approximately half of the sustained, symptomatic AFLs.388”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [388] Biviano, 2010, Atrial flutter catheter ablation in adult patients with repaired tetralogy of Fallot: mechanisms and outcomes of percutaneous catheter ablation in a consecutive series, J Interv Card Electrophysiol source
Not checked in the free run.
May combine two claims.
PremisecitationSignificant ASDs in adults can be closed even later in life with consequent improved morbidity and survival, although new or recurrent ATs are frequent.
“However, significant ASDs in adults can be closed even later in life with consequent improved morbidity and survival, 359 albeit new or recurrent ATs are frequent.360”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [359] Konstantinides, 1995, A comparison of surgical and medical therapy for atrial septal defect in adults, N Engl J Med source
Not checked in the free run.
- cites [360] Murphy, 1990, Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationIn Ebstein's anomaly, accessory pathways are frequent (15-30%), more often right sided and multiple than in other patients.
“In Ebstein's anomaly, accessory pathways are frequent (15 -30%) more often right sided and multiple than in other patients, 383 and other SVTs that can occur include AF, AFL and focal AT.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [383] Wei, 2014, Features of accessory pathways in adult Ebstein's anomaly, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationAblation of CTI-dependent flutter results in high acute success rates, 96%, depending on the type of anomaly, although the recurrence rate after 45±15 months follow-up is 18%.
“Ablation of CTI-dependent flutter results in high acute success rates, 96%, depending on the type of anomaly although the recurrence rate after 45 + 15 months follow-up is 18%.380”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [380] Dallaglio, 2016, Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation, Europace source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough amiodarone is less often associated with proarrhythmia, its severe side effects (thyroid and pulmonary disorders) limit its long-term use in ACHD patients.
“Although amiodarone is less often associated with proarrhythmia, the severe side effects (thyroid and pulmonary disorders) limit its long-term use in these patients.368”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [368] Koyak, 2013, Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationAtrial incisions in childhood with subsequent myocardial scarring result in development of macroreentrant AT, and there is also an increased risk of pump failure, stroke and SCD.
“The atrial incisions in childhood with subsequent myocardial scarring, however, result in the development of macroreentrant AT, and there is also an increased risk of pump failure, stroke and SCD.348”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [348] Engelfriet, 2005, The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease, Eur Heart J source
Not checked in the free run.
May combine two claims.
PremisecitationAtrial flutter or AF can develop in up to 42% of patients, whereas the most common atrial tachyarrhythmia is an incision-related (incisional) atrial tachycardia (66%).
“Atrial flutter or AF can develop in up to 42% of patients, whereas the most common atrial tachyarrhythmia is an incision-related (incisional) atrial tachycardia (66%).393”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [393] Quinton, 2015, Prevalence of atrial tachyarrhythmia in adults after Fontan operation, Heart source
Not checked in the free run.
May combine two claims.
PremisecitationPharmacokinetics of antiarrhythmic drugs change during different stages of pregnancy, including changes in gastrointestinal absorption, increased blood volume, lower protein binding with increased free fraction, and increased renal and hepatic elimination.
“These includes changes in gastrointestinal absorption, an increased blood volume, a lower binding to proteins with an increased free fraction of drug, and an increased renal and hepatic elimination.411”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [411] Mitani, 1987, The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation, Clin Pharmacokinet source
Not checked in the free run.
May combine two claims.
PremisecitationRight bundle branch block is present during sinus rhythm in the majority of patients, and may cause differential diagnostic difficulties requiring electrophysiology testing for a correct diagnosis.
“Right bundle branch block is present during sinus rhythm in the majority of patients, and may cause differential diagnostic difficulties requiring electrophysiology testing for a correct diagnosis.390”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [390] Harrison, 1997, Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationBoth Fontan and Mustard repairs have been associated with less successful ablation results as compared to other ACHD anomalies, related to low success rate (54% vs 83% for other CHD) and high recurrence rate (50% vs 32%) after an initial successful ablation procedure.
“Both Fontan and Mustard repairs have been associated with less successful ablation results as compared to other ACHD anomalies, related not only to the low success rate of catheter ablation (54% vs. 83% for other CHD) but also to a high recurrence rate (50% vs. 32%) after an initial successful ablation procedure.363,365”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [363] Yap, 2010, Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery, J Am Coll Cardiol source
Not checked in the free run.
- cites [365] Yap, 2012, Evolving electroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery, J Cardiovasc Electrophysiol source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenThe data on catheter ablation in pregnancy are based on small case series with no long-term follow-up of risk for the infant.
“These data are however based on small case series with no long time follow-up of risk for the infant.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenThe foetus may suffer from the direct haemodynamic effect of tachycardia and from adverse effects of treatment.
“The foetus may suffer from both the direct haemodynamic effect of the tachycardia as well as adverse effects from the treatment.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationEffective treatments may have a positive impact on disease-related hospitalizations with a favourable economic profile in mid- or long-term cost-effectiveness.
“Thus, effective treatments (interventional or pharmacological) may have a positive impact on disease-related hospitalizations, with a consequent favourable economic profile in terms of mid-or long-term cost-effectiveness.413,414”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [413] Boriani, 2013, Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association, Eur Heart J source
Not checked in the free run.
- cites [414] Fattore, 2011, Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology, Europace
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe ESC 2011 guidelines on pregnancy provide detailed recommendations on the safe use of antiarrhythmic drugs during pregnancy and breastfeeding.
“Detailed recommendations on the safe use of antiarrhythmic drugs during pregnancy and breastfeeding have been provided by the ESC 2011 guidelines on pregnancy.412”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [412] Regitz-Zagrosek, 2011, ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC), Eur Heart J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningPatient education can help facilitate greater patient participation in treatment decisions because informed choices require patients to understand the natural trajectory of their condition, treatment options, and likely impact on symptoms and quality of life.
“Patient education can help to facilitate greater patient participation in treatment decisions since informed choices about therapy requires patients to understand the natural trajectory of their condition, what the treatment options are and what they can offer, and the likely impact of these treatments on their symptoms and QoL.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe proliferation of atrial fibrillation ablation will unavoidably result in more iatrogenic left atrial flutters.
“the proliferation of AF ablation, will unavoidably result in more iatrogenic left AFLs.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe perspective of a curative treatment and patient preferences have expanded the indication of ablation therapy in supraventricular tachycardia outside drug refractory arrhythmic episodes, and ablation is currently proposed as a first-line treatment option in these patients.
“The perspective of a curative treatment and patient preferences have expanded the indication of ablation therapy in SVT outside of the setting of drug refractory arrhythmic episodes, and ablation is currently proposed as a first-line treatment option in SVT patients.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThis improvement is perhaps not surprising given that ablation often significantly reduces or eliminates symptoms.
“This is perhaps not surprising given that ablation often significantly reduces or eliminates symptoms.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenThese quality-of-life studies are limited by small sample sizes, highly selected populations, short follow-up periods, often lacking a suitable control group, and frequent recall and responder bias.
“However, these studies are limited by their small sample sizes, in highly selected populations, with short follow-up periods, often lacking a suitable control group, and are frequently hampered by recall and responder bias.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenSeveral important advances in anatomic and electrical mapping, appreciation of scar tissue, and transmurality of ablation lesions should improve efficiency in treating these patients.
“Several and important advances in the field of anatomic and electrical mapping, as well as appreciation of scar tissue and transmurality of ablation lesions, should improve our efficiency in treating these patients.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAvailable evidence on patient experiences of supraventricular tachycardia has recently been reviewed in a European Heart Rhythm Association position document.
“The available evidence on patient's experiences of SVT has recently been reviewed in a European Heart Rhythm Association (EHRA) position document.419”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [419] Lane, 2015, Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe prolonged survival of adults with congenital heart disease is expected to impose a further challenge for adult electrophysiologists who will have to deal with even more complex atrial macroreentrant tachycardias.
“Moreover, the prolonged survival of ACHD patients is expected to impose a further challenge for the adult electrophysiologists who will have to deal with even more complex atrial macroreentrant tachycardias.”
Quote in the paperNot a substantial claim- Rests on an assumption: The prolonged survival of adults with congenital heart disease is expected.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAdvice and recommendations for key discussion points between physicians and patients with supraventricular tachycardia have recently been outlined in another European Heart Rhythm Association document.
“Advice and recommendations for key discussion points between physicians and patients with SVT have recently been outlined in another EHRA document.419”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [419] Lane, 2015, Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationcitationThe vision of a fully radiation-free, magnetic laboratory in the future is not science fiction anymore.
“The vision of a fully radiation-free, magnetic laboratory in the future is not science fiction any more.427”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [427] Hilbert, 2016, Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: initial results from a consecutive patient series, Europace source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenFurther analysis of recorded ECGs using fast Fourier and Gaussian models might provide useful diagnostic information about the nature of the tachycardia.
“It might be possible that further analysis of recorded ECGs using fast Fourier and Gaussian models might be able to provide useful diagnostic information about the nature of the tachycardia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThe revolution in computer technology offers improved mapping and electrode moving systems, and enhances specific supraventricular tachycardia classification schemes by fully automated algorithms that may greatly assist emergency departments, ambulances, and monitored patients.
“The revolution in computer technology offers not only improved mapping and electrode moving systems, but also enhances specific SVT classification schemes by fully automated algorithms that may greatly assist emergency departments, ambulances, and monitored patients.428”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [428] Perlman, 2015, Supraventricular tachycardia classification in the 12-lead ECG using atrial waves detection and a clinically based tree scheme, IEEE J Biomed Health Inform
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThese developments may have important implications for a more specific diagnosis and personalized therapeutic approach in supraventricular tachycardia.
“These developments may have important implications for a more specific diagnosis, and personalized therapeutic approach in SVT.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationCoupling whole exome sequencing with cellular electrophysiologic functional analysis may elucidate the underlying pathophysiologic mechanism responsible for certain phenotypes.
“Coupling whole exome sequencing with cellular electrophysiologic functional analysis may elucidate the underlying pathophysiologic mechanism responsible for certain phenotypes.433”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [433] Weyhrauch, 2016, Whole exome sequencing and heterologous cellular electrophysiology studies elucidate a novel loss-of-function mutation in the CACNA1A-encoded neuronal P/Q-type calcium channel in a child with congenital hypotonia and developmental delay, Pediatr Neurol source
Not checked in the free run.
The paper relies on this without support.
The Valsalva manoeuvre is more effective than carotid sinus massage for terminating SVT in adults.
“The Valsalva manoeuver has generally been shown to be most effective in adults, having a superior effect on SVT termination compared to carotid sinus massage.”
The paper relies on this without support.
Carotid sinus massage carries a risk of carotid atheroembolism and stroke even when no audible bruit is present.
“It should be always unilateral, as there is a risk of carotid atheroembolism and stroke even in the absence of an audible bruit.”
The paper relies on this without support.
Rapid IV adenosine can cause transient side effects including flush, bronchospasm, dyspnoea, and temporary AV block.
“Rapid intravenous injection of adenosine may result in unpleasant but transient side effects (flush, bronchospasm, shortness of breath, temporary AV block).”
The paper relies on this without support.
Theophylline may require higher adenosine doses, and dipyridamole potentiates adenosine effects.
“Patients treated with theophylline may require higher doses of adenosine and adenosine effects are potentiated by dipyridamole.”
The paper relies on this without support.
Concomitant adenosine and carbamazepine may cause higher rates of heart block.
“In addition, higher rates of heart block may be seen when adenosine is concomitantly administered with carbamazepine.”
The paper relies on this without support.
Adenosine may induce AF in 1–15% of cases, usually transient but potentially problematic in patients with ventricular pre-excitation.
“Adenosine may also induce AF (1% to 15%), which is usually transient but may be particularly problematic in patients with ventricular pre-excitation.”
The paper relies on this without support.
No randomized trials have compared DC cardioversion with IV drugs for conversion in hemodynamically compromised patients.
“No randomized trials have been conducted comparing DC with IV drugs for conversion in this situation.”
The paper relies on this without support.
Catheter ablation for IST has limited efficacy, with long-term clinical success ranging from 23% to 83%.
“This approach has limited efficacy, with a very modest long-term clinical success ranging from 23 to 83%.”
The paper relies on this without support.
Medical treatment of sinus node reentrant tachycardia is empirical, and no drugs have been studied in controlled trials.
“Therapy Medical treatment is empirical, and no drugs have been studied in controlled trials.”
The paper relies on this without support.
The three putative mechanisms of focal AT are automaticity, triggered activity, and microreentry.
“The three putative mechanisms of focal AT are automaticity, triggered activity, and microreentry.”
The paper relies on this without support.
Adenosine usually has no impact on macro-reentries, although termination has been rarely reported.
“Usually, adenosine has no impact on macro-reentries, although termination has been rarely reported.”
The paper relies on this without support.
DC cardioversion is usually effective in acutely terminating AT irrespective of mechanism.
“Direct current (DC) cardioversion is usually effective in acutely terminating the tachycardia, irrespective of the mechanism.”
The paper relies on this without support.
Reentry is very sensitive to DC shocks, and energy as low as 50 J may terminate it, a striking difference from AF.
“However, reentry is very sensitive to DC shocks and energy as low as 50 J may terminate it, which is a striking difference when compared with AF.”
The paper relies on this without support.
One-to-one AV conduction is rare in AFL; there is usually some AV block, most often 2:1 with regular ventricular rates typically 130–160/min.
“One-to-one AV conduction is rare and there is usually a degree of AV block, most often 2:1 with regular ventricular rates typically 130 -160/min.”
The paper relies on this without support.
RA dilatation is present in AFL but can be reversible after AFL interruption by CTI ablation.
“RA dilatation is present in AFL, but it can be reversible after AFL interruption by CTI ablation.”
The paper relies on this without support.
In about 90% of typical AFL cases, activation courses supero-inferiorly in the anterior and lateral RA and infero-superiorly in the septal RA.
“In about 90% of typical AFL cases, activation courses supero-inferiorly in the anterior and lateral RA and inferosuperiorly in the septal RA.”
The paper relies on this without support.
Conduction through the CTI is anterior to posterior in counterclockwise AFL.
“Conduction through the CTI is anterior to posterior in what is often called counterclockwise AFL (Figure 11).”
The paper relies on this without support.
The ECG in typical AFL shows rounded or bimodal positive deflections in inferior leads and a very characteristic bimodal negative wave in V1 shaped like a W.
“The ECG shows rounded or bimodal positive deflections in the inferior leads and in V 1 a very characteristic bimodal negative wave in the shape of a W (Figure 11).”
The paper relies on this without support.
Clockwise AFL is considered also typical (reverse typical AFL).
“This clockwise AFL is considered also typical (reverse typical AFL).”
The paper relies on this without support.
Typical AFL may be paroxysmal or persistent.
“Typical AFL may be paroxysmal or persistent.”
The paper relies on this without support.
Clinical presentation of typical AFL depends in large part on ventricular rate, which tends to be rapid in the majority of cases.
“Its clinical presentation will depend in large part on the ventricular rate, which tends to be rapid in the majority of cases.”
The paper relies on this without support.
When atrial flutter has lasted more than 48 hours, the risk of thromboembolism is increased regardless of the cardioversion technique, unless transesophageal echocardiography has excluded intra-atrial thrombi.
“If AFL has been present for .48h, the risk of thromboembolism is higher, no matter the technique used for cardioversion, unless trans-oesophageal echocardiography has ruled out intra-atrial thrombi.”
The paper relies on this without support.
In patients with both atrial fibrillation and atrial flutter, the embolic risk appears to be the same as in atrial fibrillation, and the same indications for chronic anticoagulation apply when stroke risk factors are present.
“In patients with episodes of both AF and AFL the embolic risk appears the same as in AF and the same indications for chronic anticoagulation should be considered, in the presence of stroke risk factors.”
The paper relies on this without support.
No direct evidence from randomized trials specifically in atrial flutter exists for the risk-benefit ratio of chronic anticoagulation.
“There is no direct evidence of the risk vs. benefit ratio of chronic anticoagulation in patients with AFL, as no specific randomized trials in AFL per se have been conducted.”
The paper relies on this without support.
Transthoracic electrical cardioversion is the fastest and most effective way to restore sinus rhythm.
“Transthoracic electrical cardioversion is the quickest and most effective method to recover sinus rhythm.”
The paper relies on this without support.
Atrioventricular reentrant tachycardias are the most common tachycardias associated with WPW syndrome, accounting for 80%.
“Atrioventricular reentrant tachycardias are the most common (80%) tachycardias associated with WPW syndrome.”
The paper relies on this without support.
Orthodromic AVRT accounts for 95% of AVRTs and 35% of all sustained paroxysmal SVTs.
“Orthodromic AVRT accounts for 95% of AVRTs, and 35% of all sustained paroxysmal SVTs.”
The paper relies on this without support.
Antidromic AVRT occurs in approximately 5% of patients with WPW syndrome.
“Antidromic AVRT occurs in approximately 5% of patients with WPW syndrome.”
The paper relies on this without support.
Up to 50-75% of patients with spontaneous antidromic AVRT have multiple accessory pathways.
“Up to 50-75% of patients with spontaneous antidromic AVRT have multiple AP (manifest or concealed), which could act or not as the retrograde limb during the AVRT.”
The paper relies on this without support.
Paroxysmal atrial fibrillation has been found in 50% of patients with WPW, and is the presenting arrhythmia in 20%.
“Paroxysmal atrial fibrillation (AF) has been found in 50% of patients with WPW, and is the presenting arrhythmia in 20%.”
The paper relies on this without support.
In antidromic AVRT with multiple bypass tracts, drugs acting on the AV node are ineffective.
“In case of antidromic AVRT with multiple bypass tracts, one acting as the anterograde limb and one as the retrograde, drugs acting on the AVN are ineffective.”
The paper relies on this without support.
The commonest tachycardia in patients with concealed accessory pathways is orthodromic AVRT.
“The commonest tachycardia in patients with concealed accessory pathways is orthodromic AVRT, with a reentrant circuit using the AV node and His Purkinje system in the anterograde direction, followed by conduction through the ventricle, retrograde conduction over the concealed accessory pathway, and completion of the circuit by conduction through the atrium back into the AV node.”
The paper relies on this without support.
In some cases, patients can be readily identified as having an accessory pathway with a long refractory period, and therefore very low risk of sudden death, when they demonstrate intermittent loss of pre-excitation during sinus rhythm.
“In some cases, patients can be readily identified as having an accessory pathway that has a long refractory period, and therefore are a very low risk of sudden death, when they demonstrate intermittent loss of pre-excitation during sinus rhythm.”
The paper relies on this without support.
The efficacy and safety of antiarrhythmic drugs in ACHD patients have not been evaluated in randomized clinical trials.
“The efficacy and safety of AADs in ACHD patients have not been evaluated in randomized clinical trials (Table 19).”
The paper relies on this without support.
All antiarrhythmic drugs have an increased risk of proarrhythmia, and may exacerbate sinus node dysfunction as well as heart failure, and thus require in-hospital observation.
“All AADs have an increased risk of proarrhythmia, and may exacerbate sinus node dysfunction as well as heart failure, and thus require in-hospital observation.”
The paper relies on this without support.
The majority of antiarrhythmic drugs are classified as FDA category C, meaning that risk of adverse foetal effect cannot be ruled out.
“According to the recently abandoned FDA classification system of drugs during pregnancy, the majority of AADs are classified as category C, meaning that risk cannot be ruled out for adverse effect on the foetus”
The paper relies on this without support.
None of the antiarrhythmic drugs has been proven completely safe in pregnancy.
“and none of the AADs has been proven completely safe.”
The paper relies on this without support.
The risk of teratogenic effects is highest during organogenesis, which takes place during the first 8-10 weeks of gestation.
“The risk of teratogenic effects is highest during the organogenesis which takes place during the first 8 -10 weeks of gestation.”
The paper relies on this without support.
Beta-blockers have been used extensively in pregnancy without evidence of teratogenicity.
“Beta-blockers have been used extensively in pregnancy without evidence of teratogenicity”
The paper relies on this without support.
Procainamide can cause a lupus-like syndrome with long-term use.
“Procainamide has been used in pregnant women for acute treatment of pre-excited tachycardia but can cause lupus-like syndrome with long-term use.”
The paper relies on this without support.
In experienced hands, the use of 3-D mapping systems allows completely x-ray free ablation, obviating the foetal risk of radiation.
“In experienced hands, the use of 3-D Mapping Systems allows completely x-ray free ablation, thus obviating the foetal risk of radiation.”
The paper relies on this without support.
Many arrhythmic conditions induce substantial costs.
“As shown in cost of illness studies, many arrhythmic conditions induce substantial costs.”
The paper relies on this without support.
Drug therapy for supraventricular tachycardia is characterized by continuous diluted costs, variable patient adherence, limited efficacy, and poor long-term patient satisfaction.
“Drug therapy is characterized by continuous diluted costs, variable patient adherence (sometimes very low), limited efficacy, and poor patient satisfaction in the long-term.”
The paper relies on this without support.
Atrioventricular nodal reentrant tachycardia accounts for 50% of all supraventricular tachycardia cases and is seen with the same frequency as before.
“AVNRT that accounts for 50% of all cases is seen with the same frequency as before”
The paper relies on this without support.
The prolonged survival of adults with congenital heart disease is expected.
“Moreover, the prolonged survival of ACHD patients is expected to impose a further challenge”
The paper relies on this without support.
The last decade has witnessed a rapid evolution of ablation equipment and electrode guiding systems that have resulted in more controllable and safer procedures.
“The last decade has witnessed a rapid evolution of ablation equipment and electrode guiding systems that have resulted in more controllable and safer procedures.”
The paper relies on this without support.
New materials for electrodes and other equipment have allowed the concept of a radiation-free electrophysiology laboratory with the use of MRI.
“New materials for electrodes and other equipment have allowed the concept of radiation-free EP laboratory with the use of MRI.”
The paper relies on this without support.
Supraventricular tachycardias are an everyday clinical problem, with atrioventricular nodal reentrant tachycardia being the most common regular arrhythmia in humans.
“SVTs are not only an everyday clinical problem, with AVNRT being the most common regular arrhythmias in the human”
The paper relies on this without support.
Worsening factors such as electrolytic imbalance, hyperthyroidism and anaemia occur more often during pregnancy.
“Worsening factors, occurring more often during pregnancy, such as electrolytic imbalance, hyperthyroidism and anaemia should be evaluated”
The paper relies on this without support.
Procainamide has been used in pregnant women for acute treatment of pre-excited tachycardia.
“Procainamide has been used in pregnant women for acute treatment of pre-excited tachycardia”
Cites
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893 · see citing works
Self-citationESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924 · see citing works
Self-citationGatzoulis, M. A., Balaji, S., Webber, S. A., Siu, S. C., Hokanson, J. S., Poile, C., Rosenthal, M., Nakazawa, M., Moller, J. H., Gillette, P. C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02714-8 · Cited by 1,779 · see citing works
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,667 · see citing works
Self-citationJackman, W. M., Wang, X., Friday, K. J., Roman, C. A., Moulton, K. P., Beckman, K. J., McClelland, J. H., Twidale, N., Hazlitt, H. A., Prior, M. I., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242301 · Cited by 1,422 · see citing works
Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort
Pathak, R. K., Middeldorp, M. E., Meredith, M., Mehta, A. B., Mahajan, R., Wong, C. X., Twomey, D., Elliott, A. D., Kalman, J. M., Abhayaratna, W. P., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.002 · Cited by 1,036 · see citing works
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013 · see citing works
Blomstrom-Lundqvist (2003) · doi:10.1161/01.cir.0000091380.04100.84 · Cited by 955 · see citing works
Self-citationPathak, R. K., Middeldorp, M. E., Lau, D. H., Mehta, A. B., Mahajan, R., Twomey, D., Alasady, M., Hanley, L., Antic, N. A., McEvoy, R. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.028 · Cited by 949 · see citing works
Ventricular fibrillation in the Wolff-Parkinson-White syndrome
Klein, G. J., Bashore, T. M., Sellers, T. D., Pritchett, E. L. C., Smith, W. M., & Gallagher, J. J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911153012003 · Cited by 830 · see citing works
Murphy, J. G., Gersh, B. J., McGoon, M. D., Mair, D. D., Porter, C.-B. J., Ilstrup, D. M., McGoon, D. C., Puga, F. J., Kirklin, J. W., & Danielson, G. K. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012133232401 · Cited by 776 · see citing works
A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex
Brugada, P., Brugada, J., Mont, L., Smeets, J., & Andries, E. W. (1991) · Circulation · doi:10.1161/01.cir.83.5.1649 · Cited by 738 · see citing works
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome
Gollob, M. H., Green, M. S., Tang, A. S.-L., Gollob, T., Karibe, A., Hassan, A.-S., Ahmad, F., Lozado, R., Shah, G., Fananapazir, L., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106143442403 · Cited by 671 · see citing works
Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627 · see citing works
Calkins, H., Yong, P., Miller, J. M., Olshansky, B., Carlson, M., Saul, J. P., Huang, S. K. S., Liem, L. B., Klein, L. S., Moser, S. A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.262 · Cited by 611 · see citing works
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595 · see citing works
Silka, M. J., Hardy, B. G., Menashe, V. D., & Morris, C. D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00187-9 · Cited by 560 · see citing works
Wellens, H. J. J., Bär, F. W. H. M., & Lie, K. I. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90176-6 · Cited by 538 · see citing works
Khairy, P., Aboulhosn, J., Gurvitz, M. Z., Opotowsky, A. R., Mongeon, F.-P., Kay, J., Valente, A. M., Earing, M. G., Lui, G., Gersony, D. R., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.928481 · Cited by 531 · see citing works
Munger, T. M., Packer, D. L., Hammill, S. C., Feldman, B. J., Bailey, K. R., Ballard, D. J., Holmes, D. R., & Gersh, B. J. (1993) · Circulation · doi:10.1161/01.cir.87.3.866 · Cited by 500 · see citing works
Olgin, J. E., Kalman, J. M., Fitzpatrick, A. P., & Lesh, M. D. (1995) · Circulation · doi:10.1161/01.cir.92.7.1839 · Cited by 500 · see citing works
Gelder, I. C. V., Crijns, H. J. G. M., van Gilst, W. H., Verwer, R., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90707-r · Cited by 466 · see citing works
Self-citationSaoudi, N., Cosío, F., Waldo, A., Chen, S. A., Iesaka, Y., Lesh, M., Saksena, S., Salerno, J., & Schoels, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2658 · Cited by 464 · see citing works
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente‐Lafuente, C., Valembois, L., Bergmann, J., & Belmin, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub4 · Cited by 441 · see citing works
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439 · see citing works
Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433 · see citing works
Paroxysmal supraventricular tachycardia in the general population
Orejarena, L. A., Vidaillet, H., DeStefano, F., Nordstrom, D. L., Vierkant, R. A., Smith, P. N., & Hayes, J. J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00422-1 · Cited by 432 · see citing works
Arruda, M. S., McClelland, J. H., Wang, X., et al. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00861.x · Cited by 423 · see citing works
Natale, A., Newby, K. H., Pisanó, E., Leonelli, F., Fanelli, R., Potenza, D., Beheiry, S., & Tomassoni, G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00635-5 · Cited by 414 · see citing works
Engelfriet, P., Boersma, E., Oechslin, E., Tijssen, J., Gatzoulis, M. A., Thilén, U., Kaemmerer, H., Moons, P., Meijboom, F., Popelová, J., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi396 · Cited by 413 · see citing works
A comparison of surgical and medical therapy for atrial septal defect in adults
Konstantinides, S., Geibel, A., Olschewski, M., Görnandt, L., Roskamm, H., Spillner, G., Just, H., & Kasper, W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330801 · Cited by 406 · see citing works
Mapping and ablation of left atrial flutters
Jaïs, P., Shah, D. C., Haïssaguerre, M., Hocini, M., Peng, J. T., Takahashi, A., Garrigue, S., Le Métayer, P., & Clémenty, J. (2000) · Circulation · doi:10.1161/01.cir.101.25.2928 · Cited by 380 · see citing works
Sudden cardiac death in adult congenital heart disease
Koyak, Z., Harris, L., de Groot, J. R., Silversides, C. K., Oechslin, E. N., Bouma, B. J., Budts, W., Zwinderman, A. H., Van Gelder, I. C., & Mulder, B. J. M. (2012) · Circulation · doi:10.1161/circulationaha.112.104786 · Cited by 378 · see citing works
Incidence and predictors of atrial flutter in the general population
Granada, J., Uribe, W., Chyou, P.-H., Maassen, K., Vierkant, R., Smith, P. N., Hayes, J., Eaker, E., & Vidaillet, H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00982-7 · Cited by 375 · see citing works
The 1998 NASPE Prospective Catheter Ablation Registry
Scheinman, M. M., & HUANG, S. (2000) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2000.tb00891.x · Cited by 370 · see citing works
Atrial Tachycardia After Circumferential Pulmonary Vein Ablation of Atrial Fibrillation
Chae, S., Oral, H., Good, E., Dey, S., Wimmer, A., Crawford, T., Wells, D., Sarrazin, J.-F., Chalfoun, N., Kuhne, M., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.044 · Cited by 355 · see citing works
Self-citationPulmonary Vein Isolation Versus Defragmentation
Vogler, J., Willems, S., Sultan, A., Schreiber, D., Lüker, J., Servatius, H., Schäffer, B., Moser, J., Hoffmann, B. A., & Steven, D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.088 · Cited by 349 · see citing works
Chugh, A., Oral, H., Lemola, K., Hall, B., Cheung, P., Good, E., Tamirisa, K., Han, J., Bogun, F., Pelosi, F., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.027 · Cited by 338 · see citing works
Self-citationO'Neill, M. D., Wright, M., Knecht, S., Jais, P., Hocini, M., Takahashi, Y., Jonsson, A., Sacher, F., Matsuo, S., Lim, K. T., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp063 · Cited by 333 · see citing works
Self-citationAtenolol and fetal growth in pregnancies complicated by hypertension
Lydakis, C. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00031-x · Cited by 325 · see citing works
Ishii, Y., Schuessler, R. B., Gaynor, S. L., Yamada, K., Fu, A. S., Boineau, J. P., & Damiano, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.475194 · Cited by 319 · see citing works
DREIFUS, L. S., HAIAT, R., WATANABE, Y., ARRIAGA, J., & REITMAN, N. (1971) · Circulation · doi:10.1161/01.cir.43.4.520 · Cited by 316 · see citing works
DiMarco, J. P., Miles, W., Akhtar, M., Milstein, S., Sharma, A. D., Platia, E., McGovern, B., Scheinman, M. M., & Govier, W. C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-2-104 · Cited by 306 · see citing works
Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation
Gerstenfeld, E. P., Callans, D. J., Dixit, S., Russo, A. M., Nayak, H., Lin, D., Pulliam, W., Siddique, S., & Marchlinski, F. E. (2004) · Circulation · doi:10.1161/01.cir.0000141369.50476.d3 · Cited by 300 · see citing works
A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory
Knight, B. P., Zivin, A. H., Souza, J. J., Flemming, M. A., Pelosi, F., Goyal, R., Man, K. C., Strickberger, S. A., & Morady, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00614-7 · Cited by 293 · see citing works
Self-citationMichaud, G. F., Tada, H., Chough, S. P., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01480-2 · Cited by 293 · see citing works
Self-citationSurgical treatment for secundum atrial septal defects in patients >40 years old
Attié, F., Rosas, M., Granados, N., Zabal, C., Buendía-Hernández, A., & Calderón, J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01635-7 · Cited by 293 · see citing works
Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter
Mont, L., Elosua, R., & Brugada, J. (2008) · Europace · doi:10.1093/europace/eun289 · Cited by 287 · see citing works
Bubien, R. S., Knotts-Dolson, S. M., Plumb, V. J., & Kay, G. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1585 · Cited by 284 · see citing works
Hirao, K., Otomo, K., Wang, X., Beckman, K. J., McClelland, J. H., Widman, L. E., Gonzalez, M. D., Arruda, M. S., Nakagawa, H., Lazzara, R., et al. (1996) · Circulation · doi:10.1161/01.cir.94.5.1027 · Cited by 282 · see citing works
New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia
Vereckei, A., Duray, G., Szénási, G., Altemose, G. T., & Miller, J. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2007.09.020 · Cited by 280 · see citing works
Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot
Harrison, D. A., Harris, L., Siu, S. C., MacLoghlin, C. J., Connelly, M. S., Webb, G. D., Downar, E., McLaughlin, P. R., & Williams, W. G. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00316-1 · Cited by 277 · see citing works
Pappone, C., Santinelli, V., Rosanio, S., Vicedomini, G., Nardi, S., Pappone, A., Tortoriello, V., Manguso, F., Mazzone, P., Gulletta, S., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02706-7 · Cited by 276 · see citing works
Self-citationBohnen, M., Stevenson, W. G., Tedrow, U. B., Michaud, G. F., John, R. M., Epstein, L. M., Albert, C. M., & Koplan, B. A. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.017 · Cited by 275 · see citing works
Aborted sudden death in the Wolff-Parkinson-White syndrome
Timmermans, C., Smeets, J. L. R. M., Rodriguez, L.-M., Vrouchos, G., van den Dool, A., & Wellens, H. J. J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80136-2 · Cited by 274 · see citing works
Khairy, P., Harris, L., Landzberg, M. J., Fernandes, S. M., Barlow, A., Mercier, L.-A., Viswanathan, S., Chetaille, P., Gordon, E., Dore, A., et al. (2008) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.776120 · Cited by 269 · see citing works
Meta-analysis of ablation of atrial flutter and supraventricular tachycardia
Spector, P., Reynolds, M. R., Calkins, H., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.040 · Cited by 268 · see citing works
Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope
Shotan, A., Ostrzega, E., Mehra, A., Johnson, J. V., & Elkayam, U. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00047-7 · Cited by 267 · see citing works
Initiating Reentry: The Role of Nonuniform Anisotropy in Small Circuits
SPACH, M. S., & JOSEPHSON, M. E. (1994) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1994.tb01157.x · Cited by 266 · see citing works
Self-citationRinkenberger, R. L., Prystowsky, E. N., Heger, J. J., Troup, P. J., Jackman, W. M., & Zipes, D. P. (1980) · Circulation · doi:10.1161/01.cir.62.5.996 · Cited by 263 · see citing works
Influence of age and gender on the mechanism of supraventricular tachycardia
Porter, M. J., Morton, J. B., Denman, R., Lin, A. C., Tierney, S., Santucci, P. A., Cai, J. J., Madsen, N., & Wilber, D. J. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.05.007 · Cited by 258 · see citing works
JAÏS, P., MATSUO, S., KNECHT, S., WEERASOORIYA, R., HOCINI, M., SACHER, F., WRIGHT, M., NAULT, I., LELLOUCHE, N., KLEIN, G., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01373.x · Cited by 255 · see citing works
Self-citationKindwall, K. E., Brown, J., & Josephson, M. E. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91169-1 · Cited by 253 · see citing works
Self-citationHo, K. M., & Tan, J. A. (2009) · Circulation · doi:10.1161/circulationaha.108.848218 · Cited by 245 · see citing works
Villain, E., Vetter, V. L., Garcia, J. M., Herre, J. M., Cifarelli, A., & Garson, A. (1990) · Circulation · doi:10.1161/01.cir.81.5.1544 · Cited by 243 · see citing works
Volgman, A. S., Carberry, P. A., Stambler, B., Lewis, W. R., Dunn, G. H., Perry, K. T., VanderLugt, J. T., & Kowey, P. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00078-3 · Cited by 242 · see citing works
Differential pacing for distinguishing block from persistent conduction through an ablation line
Shah, D., Haïssaguerre, M., Takahashi, A., Jaïs, P., Hocini, M., & Clémenty, J. (2000) · Circulation · doi:10.1161/01.cir.102.13.1517 · Cited by 242 · see citing works
Self-citationJaeggi, E. T., Carvalho, J. S., De Groot, E., Api, O., Clur, S.-A. B., Rammeloo, L., McCrindle, B. W., Ryan, G., Manlhiot, C., & Blom, N. A. (2011) · Circulation · doi:10.1161/circulationaha.111.026120 · Cited by 237 · see citing works
Causes of Late Deaths After Pediatric Cardiac Surgery
Nieminen, H. P., Jokinen, E. V., & Sairanen, H. I. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.040 · Cited by 236 · see citing works
Pappone, C., Santinelli, V., Manguso, F., Augello, G., Santinelli, O., Vicedomini, G., Gulletta, S., Mazzone, P., Tortoriello, V., Pappone, A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035345 · Cited by 236 · see citing works
Self-citationFitzpatrick, A. P., Gonzales, R. P., Lesh, M. D., odin, G. W., Lee, R. J., & Scheinman, M. M. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90508-8 · Cited by 233 · see citing works
Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
Sellers, T. D., Bashore, T. M., & Gallagher, J. J. (1977) · Circulation · doi:10.1161/01.cir.56.2.260 · Cited by 232 · see citing works
Appelboam, A., Reuben, A., Mann, C., Gagg, J., Ewings, P., Barton, A., Lobban, T., Dayer, M., Vickery, J., & Benger, J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61485-4 · Cited by 226 · see citing works
Walsh, E. P., Saul, J. P., Sholler, G. F., Triedman, J. K., Jonas, R. A., Mayer, J. E., & WESSEL, D. L. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00040-5 · Cited by 220 · see citing works
Falk, R. H., Pollak, A., Singh, S. N., & Friedrich, T. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00506-2 · Cited by 215 · see citing works
Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome
Pappone, C., Manguso, F., Santinelli, R., Vicedomini, G., Sala, S., Paglino, G., Mazzone, P., Lang, C. C., Gulletta, S., Augello, G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040625 · Cited by 214 · see citing works
Self-citationEsmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter
Platia, E. V., Michelson, E. L., Porterfield, J. K., & Das, G. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90141-0 · Cited by 213 · see citing works
Ouyang, F., Ernst, S., Vogtmann, T., Goya, M., Volkmer, M., Schaumann, A., Bänsch, D., Antz, M., & Kuck, K.-H. (2002) · Circulation · doi:10.1161/01.cir.0000015077.12680.2e · Cited by 212 · see citing works
Pappone, C., Vicedomini, G., Manguso, F., Saviano, M., Baldi, M., Pappone, A., Ciaccio, C., Giannelli, L., Ionescu, B., Petretta, A., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011154 · Cited by 212 · see citing works
Self-citationVentricular fibrillation in the Wolff-Parkinson-White syndrome
TORNER, P., BRUGADA, P., SMEETS, J., TALAJIC, M., DELLA BELLA, P., LEZAUN, R., DOOL, A. V. D., WELLENS, H. J. J., DE LUNA, A. B., OTER, R., et al. (1991) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059860 · Cited by 206 · cited 3× · see citing works
“Analysis of timedependent receiver operating curves for the prediction of VF showed an optimal accessory pathway ERP cut-off point at 240 ms,(322) which confirms the key role of a very short effective refractory period of the accessory pathway to facilitate degeneration of AF into VF.(306,322,335,337) –342 In a recent…”
BackgroundResultSelf-citationVos, M. A., Golitsyn, S. R., Stangl, K., Ruda, M. Y., Van Wijk, L., Harry, J. D., Perry, K. T., Touboul, P., Steinbeck, G., & Wellens, H. J. J. (1998) · Heart · doi:10.1136/hrt.79.6.568 · Cited by 200 · see citing works
Self-citationSchwartzman, D., Callans, D. J., Gottlieb, C. D., Dillon, S. M., Movsowitz, C., & Marchlinski, F. E. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00345-2 · Cited by 197 · see citing works
Collins, K. K., Love, B. A., Walsh, E. P., Saul, J. P., Epstein, M. R., & Triedman, J. K. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01132-2 · Cited by 194 · see citing works
Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide
Fish, F. A., Gillette, P. C., & Benson, D. W. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90586-x · Cited by 193 · see citing works
Radiofrequency Current Catheter Ablation of Accessory Atrioventricular Pathways in Ebstein's Anomaly
Cappato, R., Schlu¨ter, M., Weiß, C. H., Antz, M., Koschyk, D. H., Hofmann, T., & Kück, K. (1996) · Circulation · doi:10.1161/01.cir.94.3.376 · Cited by 189 · see citing works
Leitch, J. W., Klein, G. J., Yee, R. K., & Murdock, C. (1990) · Circulation · doi:10.1161/01.cir.82.5.1718 · Cited by 186 · see citing works
Inappropriate sinus tachycardia
Olshansky, B., & Sullivan, R. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.074 · Cited by 182 · see citing works
“Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia”
Navarese, E. P., Lupi, A., Buffon, A., & Luca, G. D. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.011 · Cited by 179 · see citing works
Lim, S., Anantharaman, V, Teo, W., Goh, P., & Tan, A. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70277-x · Cited by 176 · see citing works
Pappone, C., Santinelli, V., & Manguso, F. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.12.058 · Cited by 175 · see citing works
Self-citationKalbfleisch, S. J., Strickberger, S. A., Williamson, B. D., VORPERIAN, V. R., Man, C., Hummel, J. D., Langberg, J. J., & Morady, F. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90759-5 · Cited by 173 · see citing works
Deisenhofer, I., Zrenner, B., Yin, Y., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.970350 · Cited by 171 · see citing works
Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome
Khositseth, A., Danielson, G. K., Dearani, J. A., Munger, T. M., & Porter, C. J. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.02.012 · Cited by 166 · see citing works
Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases
Coumel, P., & Fidelle, J. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90214-8 · Cited by 166 · see citing works
Li, J., Nguyen, C., Joglar, J. A., Hamdan, M. H., & Page, R. L. (2008) · Clinical Cardiology · doi:10.1002/clc.20326 · Cited by 165 · see citing works
A novel pacing maneuver to localize focal atrial tachycardia
MOHAMED, U., SKANES, A. C., GULA, L. J., LEONG‐SIT, P., KRAHN, A. D., YEE, R., SUBBIAH, R., & KLEIN, G. J. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00664.x · Cited by 164 · see citing works
Ellenbogen, K. A., Dias, V. C., Plumb, V. J., Heywood, J. T., & Mirvis, D. M. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90743-s · Cited by 160 · see citing works
Risk of stroke in patients with atrial flutter
Biblo, L. A., Yuan, Z., Quan, K. J., Mackall, J. A., & Rimm, A. A. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01374-6 · Cited by 160 · see citing works
Clinical Efficacy of Ivabradine in Patients With Inappropriate Sinus Tachycardia
Cappato, R., Castelvecchio, S., Ricci, C., Bianco, E., Vitali-Serdoz, L., Gnecchi-Ruscone, T., Pittalis, M., De Ambroggi, L., Baruscotti, M., Gaeta, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.031 · Cited by 159 · see citing works
The Pediatric Radiofrequency Ablation Registry's Experience with Ebstein's Anomaly
Reich, J. D., Auld, D., HULSE, E., Sullivan, K. M., CAMPBELL, R., & FOR THE PEDIATRIC ELECTROPHYSIOLOGY SOCIETY (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00113.x · Cited by 158 · see citing works
Unrecognized Paroxysmal Supraventricular Tachycardia: Potential for Misdiagnosis as Panic Disorder
Lessmeier, T. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440260085013 · Cited by 157 · see citing works
Stambler, B. S., Wood, M. A., & Ellenbogen, K. A. (1997) · Circulation · doi:10.1161/01.cir.96.12.4298 · Cited by 156 · see citing works
Klein, G. J., Yee, R., & Sharma, A. D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905113201901 · Cited by 156 · see citing works
Age at onset and gender of patients with different types of supraventricular tachycardias
Rodriguez, L.-M., de Chillou, C., Schläpfer, J., Metzger, J., Baiyan, X., van den Dool, A., Smeets, J. L. R. M., & Wellens, H. J. J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90060-c · Cited by 153 · see citing works
Peri-mitral atrial flutter in patients with atrial fibrillation ablation
Matsuo, S., Wright, M., Knecht, S., Nault, I., Lellouche, N., Lim, K.-T., Arantes, L., O'Neill, M. D., Hocini, M., Jaïs, P., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.09.067 · Cited by 153 · see citing works
Right Atrial Flutter Due to Lower Loop Reentry: Mechanism and Anatomic Substrates
Cheng, J., Cabeen, W. R., & Scheinman, M. M. (1999) · Circulation · doi:10.1161/01.cir.99.13.1700 · Cited by 152 · see citing works
Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter
Salerno, D. M., Dias, V. C., Kleiger, R. E., Tschida, V. H., Sung, R. J., Sami, M., & Giorgi, L. V. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90076-3 · Cited by 152 · see citing works
González‐Torrecilla, E., Arenal, Á., Atienza, F., Osca, J., Fernandez, F., Puchol, A., Sánchez, A., & Almendral, J. M. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.02.019 · Cited by 152 · see citing works
Irani, W. N., Grayburn, P. A., & Afridi, I. (1997) · Circulation · doi:10.1161/01.cir.95.4.962 · Cited by 151 · see citing works
Grimm, R. A., Stewart, W. J., Arheart, K. L., Thomas, J. D., & Klein, A. L. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00551-7 · Cited by 150 · see citing works
Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome)
Vidaillet, H. J., Pressley, J. C., Henke, E., Harrell, F. E., & German, L. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707093170201 · Cited by 147 · see citing works
Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia
Shih-Huang, L., Shih-Ann, C., Tsu-Juey, W., Chern-En, C., Chen-Chuen, C., Ching-Tai, T., Chuen-Wang, C., Kwo-Chang, U., & Mau-Song, C. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80195-7 · Cited by 146 · see citing works
Haı̈ssaguerre, M., Cauchemez, B., Marcus, F., Le Métayer, P., Lauribe, P., Poquet, F., Gencel, L., & Clémenty, J. (1995) · Circulation · doi:10.1161/01.cir.91.4.1077 · Cited by 146 · see citing works
Effect of pregnancy on paroxysmal supraventricular tachycardia
Tawam, M., Levine, J., Mendelson, M., Goldberger, J., Dyer, A., & Kadish, A. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91078-v · Cited by 144 · see citing works
Cryoablation Versus RF Ablation for AVNRT: A Meta‐Analysis and Systematic Review
Hanninen, M., YEUNG‐LAI‐WAH, N., Massel, D. R., Gula, L. J., Skanes, A. C., Yee, R. K., Klein, G. J., Manlucu, J., & Leong‐Sit, P. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12247 · Cited by 142 · see citing works
Lane, D. A., Aguinaga, L., Blomström-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M. T., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., et al. (2015) · Europace · doi:10.1093/europace/euv233 · Cited by 142 · see citing works
Atrioventricular nodal reentrant tachycardia
Katritsis, D. G., & Camm, A. J. (2010) · Circulation · doi:10.1161/circulationaha.110.936591 · Cited by 141 · see citing works
Self-citationStephenson, E. A., Casavant, D., Tuzi, J., Alexander, M. E., Law, I., Serwer, G., Strieper, M., Walsh, E. P., & Berul, C. I. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00905-6 · Cited by 141 · see citing works
R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias
Pava, L. F., Perafán, P., Badiel, M., Arango, J. J., Mont, L., Morillo, C. A., & Brugada, J. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.03.001 · Cited by 140 · see citing works
Da Costa, A., Thévenin, J., Roche, F., Romeyer-Bouchard, C., Abdellaoui, L., Messier, M., Denis, L., Faure, E., Gonthier, R., Kruszynski, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.638395 · Cited by 140 · see citing works
Yap, S.-C., Harris, L., Silversides, C. K., Downar, E., & Chauhan, V. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.061 · Cited by 136 · see citing works
Frost, L., Mølgaard, H., Christiansen, E. H., Hjortholm, K., Paulsen, P. K., & Thomsen, P. E. B. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90293-c · Cited by 136 · see citing works
Risk of thromboembolic events in patients with atrial flutter
Seidl, K., Hauer, B., Schwick, N. G., Zellner, D., Zahn, R., & Senges, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00419-6 · Cited by 135 · see citing works
ELLIS, K., WAZNI, O., MARROUCHE, N., MARTIN, D., GILLINOV, M., McCARTHY, P., SAAD, E. B., BHARGAVA, M., SCHWEIKERT, R., SALIBA, W., et al. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00885.x · Cited by 134 · see citing works
Prevalence, characteristics and natural course of inappropriate sinus tachycardia
STILL, A., RAATIKAINEN, P., YLITALO, A., KAUMA, H., IKAHEIMO, M., ANTEROKESANIEMI, Y., & HUIKURI, H. (2005) · Europace · doi:10.1016/j.eupc.2004.12.007 · Cited by 134 · see citing works
Electrophysiologic Effects of Adenosine in Patients With Supraventricular Tachycardia
Glatter, K. A., Cheng, J., Dorostkar, P. C., Modin, G. W., Talwar, S., Alnimri, M., Lee, R. J., Saxon, L. A., Lesh, M. D., & Scheinman, M. M. (1999) · Circulation · doi:10.1161/01.cir.99.8.1034 · Cited by 133 · see citing works
Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up
Mehta, A. V., Sanchez, G. R., Sacks, E. J., Casta, A., Dunn, J. M., & Donner, R. M. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90106-4 · Cited by 132 · see citing works
CHEN, S., TAI, C., CHIANG, C., DING, Y., & CHANG, M. S. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00924.x · Cited by 127 · see citing works
WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias
Widerhorn, J., Widerhorn, A. L. M., Rahimtoola, S. H., & Elkayam, U. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90526-2 · Cited by 127 · see citing works
Bianconi, L. (2000) · European Heart Journal · doi:10.1053/euhj.1999.2039 · Cited by 126 · see citing works
Wolff-Parkinson-White Syndrome in the Era of Catheter Ablation
CarloPappone, GabrieleVicedomini, FrancescoManguso, et al. (2014) · Circulation · Cited by 125 · see citing works
Adenosine-induced atrial arrhythmia: a prospective analysis
Strickberger, S. A., Man, K. C., Daoud, E. G., Goyal, R., Brinkman, K., Knight, B. P., Weiss, R., Bahu, M., & Morady, F. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-6-199709150-00001 · Cited by 124 · cited 4× · see citing works
“The presence of pre-excitation in a patient with a history of regular paroxysmal palpitations is strongly suggestive of AVRT, while irregular palpitations are suggestive of AF.”
BackgroundInfluentialSelf-citationSurface electrocardiographic characteristics of right and left atrial flutter
Bochoeyer, A., Yang, Y., Cheng, J., Lee, R. J., Keung, E. C., Marrouche, N. F., Natale, A., & Scheinman, M. M. (2003) · Circulation · doi:10.1161/01.cir.0000079140.35025.1e · Cited by 123 · see citing works
Lukac, P., Pedersen, A. K., Mortensen, P. T., Jensen, H. K., Hjortdal, V., & Hansen, P. S. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2004.10.034 · Cited by 123 · see citing works
Hwang, C., Martin, D. J., Goodman, J. S., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00114-9 · Cited by 121 · see citing works
Resolution of cardiomyopathy after ablation of atrial flutter
Luchsinger, J. A., & Steinberg, J. S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00183-1 · Cited by 121 · see citing works
Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment
Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90282-2 · Cited by 120 · see citing works
Self-citationAdenosine therapy for supraventricular tachycardia during pregnancy
Elkayam, U., & Goodwin, T. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80597-9 · Cited by 118 · see citing works
Friedman, P. A., Luria, D., Fenton, A. M., Munger, T. M., Jahangir, A., Shen, W. K., Rea, R. F., Stanton, M. S., Hammill, S. C., & Packer, D. L. (2000) · Circulation · doi:10.1161/01.cir.101.13.1568 · Cited by 117 · see citing works
Kuck, K. H., Friday, K. J., Kunze, K. P., Schlüter, M., Lazzara, R., & Jackman, W. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.407 · Cited by 117 · see citing works
Miles, W. M., Yee, R., Klein, G. J., et al. (1986) · Circulation · doi:10.1161/01.cir.74.3.493 · Cited by 116 · see citing works
Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome
Sellers, T. D., Campbell, R. W., Bashore, T. M., & Gallagher, J. J. (1977) · Circulation · doi:10.1161/01.cir.55.1.15 · Cited by 116 · see citing works
Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram
Kalbfleisch, S. J., El-Atassi, R., Calkins, H., Langberg, J. J., & Morady, F. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90720-l · Cited by 115 · see citing works
Atrial flutter in patients treated for atrial fibrillation with propafenone
Murdock, C. J., Kyles, A. E., Yeung-Lai-Wah, J. A., Qi, A., Vorderbrugge, S., & Kerr, C. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91144-u · Cited by 114 · see citing works
Risk of Malignant Arrhythmias in Initially Symptomatic Patients With Wolff-Parkinson-White Syndrome
Pappone, C., Vicedomini, G., Manguso, F., Baldi, M., Pappone, A., Petretta, A., Vitale, R., Saviano, M., Ciaccio, C., Giannelli, L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.065722 · Cited by 112 · see citing works
Self-citationAtrial Flutter Mapping and Ablation I: Studying Atrial Flutter Mechanisms by Mapping and Entrainment
COSIO, F. G., ARRIBAS, F., LÓPEZ‐GIL, M., & PALACIOS, J. (1996) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1996.tb03368.x · Cited by 111 · see citing works
Anatomic-Electrophysiological Correlations Concerning the Pathways for Atrioventricular Conduction
Mazgalev, T. N., Ho, S. Y., & Anderson, R. H. (2001) · Circulation · doi:10.1161/01.cir.103.22.2660 · Cited by 111 · see citing works
Alboni, P., Tomasi, C., Menozzi, C., Bottoni, N., Paparella, N., Fucă, G., Brignole, M., & Cappato, R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01128-1 · Cited by 111 · see citing works
Left Septal Atrial Flutter: Electrophysiology, Anatomy, and Results of Ablation
Marrouche, N. F., Natale, A., Wazni, O. M., Cheng, J., Yang, Y., Pollack, H., Verma, A., Ursell, P., & Scheinman, M. M. (2004) · Circulation · doi:10.1161/01.cir.0000129439.03836.96 · Cited by 110 · see citing works
Wasmer, K., Mönnig, G., Bittner, A., Dechering, D., Zellerhoff, S., Milberg, P., Köbe, J., & Eckardt, L. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.06.007 · Cited by 109 · see citing works
Bathina, M., Mickelsen, S., Brooks, C., Jaramillo, J., Hepton, T., & Kusumoto, F. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00416-0 · Cited by 109 · see citing works
Catheter Ablation of Arrhythmias in Ebstein's Anomaly: A Multicenter Study
Roten, L., Lukáč, P., de Groot, N. M. S., Nielsen, J. C., Szili‐Törok, T., Jensen, H. K., Zimmermann, M., & Delacrétaz, E. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02161.x · Cited by 109 · see citing works
Almahameed, S., Buxton, A. E., & Michaud, G. F. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.931311 · Cited by 109 · see citing works
de Groot, N. M. S., Atary, J. Z., Blom, N. A., & Schalij, M. J. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.909838 · Cited by 108 · see citing works
Lalani, S. R., Thakuria, J. V., Cox, G. F., Wang, X., Bi, W., Bray, M. S., Shaw, C., Cheung, S. W., Chinault, A. C., Boggs, B. A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061002 · Cited by 108 · see citing works
Risk of thromboembolism in chronic atrial flutter
Wood, K. A., Eisenberg, S. J., Kalman, J. M., Drew, B. J., Saxon, L. A., Lee, R. J., Lesh, M. D., & Scheinman, M. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00044-1 · Cited by 108 · see citing works
Self-citationThe Natural History of Electrocardiographic Preexcitation in Men: The Manitoba Follow-up Study
Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-456 · Cited by 107 · see citing works
Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., & Wranicz, J. K. (2013) · Europace · doi:10.1093/europace/eus204 · Cited by 106 · see citing works
Gallego, P., Gonzalez, A. E., Sanchez-Recalde, A., Peinado, R., Polo, L., Gomez-Rubin, C., Lopez-Sendon, J. L., & Oliver, J. M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.057 · Cited by 106 · see citing works
Feltes, T. F., & Friedman, R. A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90121-x · Cited by 106 · see citing works
Connexin 43 expression delineates two discrete pathways in the human atrioventricular junction
Hucker, W. J., Mccain, M. L., Laughner, J. I., Iaizzo, P. A., & Efimov, I. R. (2008) · The Anatomical Record · doi:10.1002/ar.20631 · Cited by 106 · see citing works
Sauer, W. H., Alonso, C., Zado, E., Cooper, J. M., Lin, D., Dixit, S., Russo, A., Verdino, R., Ji, S., Gerstenfeld, E. P., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.621896 · Cited by 106 · see citing works
Clair, W. K., Wilkinson, W. E., McCarthy, E. A., Page, R. L., & Pritchett, E. L. (1993) · Circulation · doi:10.1161/01.cir.87.4.1114 · Cited by 105 · see citing works
Gallagher, M. M., Guo, X., Poloniecki, J. D., Yap, Y. G., Ward, D. E., & Camm, A. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01540-6 · Cited by 105 · see citing works
Atypical atrial flutter originating in the right atrial free wall
Kall, J. G., Rubenstein, D. S., Kopp, D. E., Burke, M. C., Verdino, R. J., Lin, A. C., Johnson, C. T., Cooke, P. A., Wang, Z. G., Fumo, M., et al. (2000) · Circulation · doi:10.1161/01.cir.101.3.270 · Cited by 105 · see citing works
Contemporary Outcomes of Supraventricular Tachycardia Ablation in Congenital Heart Disease
Ueda, A., Horduna, I., Mantziari, L., Gujic, M., Marchese, P., Ho, S. Y., Babu‐Narayan, S. V., & Ernst, S. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000415 · Cited by 105 · see citing works
Schumacher, B., Jung, W., Schmidt, H., Fischenbeck, C., Lewalter, T., Hagendorff, A., Omran, H., Wolpert, C., & Lüderitz, B. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00211-9 · Cited by 104 · see citing works
Frequency of disabling symptoms in supraventricular tachycardia
Wood, K. A., Drew, B. J., & Scheinman, M. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00701-1 · Cited by 104 · see citing works
Self-citationWeber-Schoendorfer, C., Hannemann, D., Meister, R., Eléfant, E., Cuppers-Maarschalkerweerd, B., Arnon, J., Vial, T., Rodriguez-Pinilla, E., Clementi, M., Robert-Gnansia, E., et al. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.05.065 · Cited by 104 · see citing works
Oral Verapamil for Paroxysmal Supraventricular Tachycardia
Mauritson, D. R., Winniford, M. D., Walker, W. S. G., Rude, R. E., CARY, J. R., & Hillis, L. D. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-409 · Cited by 103 · see citing works
Ersbøll, A., Hedegaard, M., Søndergaard, L., Ersbøll, M., & Johansen, M. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12522 · Cited by 102 · see citing works
Katritsis, D. G., & Josephson, M. E. (2013) · EP Europace · doi:10.1093/europace/eut100 · Cited by 102 · see citing works
Self-citationClinical and electrophysiologic characterization of automatic junctional tachycardia in adults.
Ruder, M. A., Davis, J. C., Eldar, M., Abbott, J. A., Griffin, J. C., Seger, J. J., & Scheinman, M. M. (1986) · Circulation · doi:10.1161/01.cir.73.5.930 · Cited by 101 · see citing works
Hasdemir, C., Payzin, S., Kocabas, U., Sahin, H., Yildirim, N., Alp, A., Aydin, M., Pfeiffer, R., Burashnikov, E., Wu, Y., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.015 · Cited by 101 · see citing works
Wen, Z.-C., Chen, S.-A., Tai, C.-T., Chiang, C.-E., Chiou, C.-W., & Chang, M.-S. (1998) · Circulation · doi:10.1161/01.cir.98.24.2716 · Cited by 101 · see citing works
Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm
Xie, B., HEALD, S. C., Bashir, Y., Katritsis, D. G., MURGATROYD, F. D., Camm, A. J., Rowland, E., & Ward, D. E. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90090-6 · Cited by 100 · see citing works
Self-citationChen, S., Chiang, C., Wu, T.-J., TAI, C., Lee, S.-H., Cheng, C., Chiou, C.-W., Ueng, K.-C., Wen, Z., & Chang, M.-S. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00565-x · Cited by 99 · see citing works
The atrioventricular nodal reentrant tachycardia circuit: A proposal
Katritsis, D. G., & Becker, A. E. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.05.026 · Cited by 98 · see citing works
Self-citationLesional tachycardias related to mitral valve surgery
Markowitz, S. M., Brodman, R. F., Stein, K. M., Mittal, S., Slotwiner, D. J., Iwai, S., Das, M. K., & Lerman, B. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01905-8 · Cited by 97 · see citing works
Barnes, E. J., Eben, F., & Patterson, D. (2002) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2002.02113.x · Cited by 95 · see citing works
Catheter ablation of scar-related atypical atrial flutter
Coffey, J. O., d'Avila, A., Dukkipati, S., Danik, S. B., Gangireddy, S. R., Koruth, J. S., Miller, M. A., Sager, S. J., Eggert, C. A., & Reddy, V. Y. (2013) · EP Europace · doi:10.1093/europace/eus312 · Cited by 95 · see citing works
Shah, A. J., Hocini, M., Xhaet, O., Pascale, P., Roten, L., Wilton, S. B., Linton, N., Scherr, D., Miyazaki, S., Jadidi, A. S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.082 · Cited by 94 · see citing works
Breithardt, G., Borggrefe, M., Wiebringhaus, E., & Seipel, L. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80283-0 · Cited by 94 · see citing works
Shivapour, J., Sherwin, E. D., Alexander, M. E., Cecchin, F., Mah, D. Y., Triedman, J. K., Marx, G. R., del Nido, P. J., & Walsh, E. P. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.045 · Cited by 93 · see citing works
Anselme, F., Hook, B. G., Monahan, K. M., et al. (1996) · Circulation · doi:10.1161/01.cir.93.5.960 · Cited by 93 · see citing works
Self-citationDiagnostic criteria of broad QRS complex tachycardia: decades of evolution
Alzand, B. S. N., & Crijns, H. J. G. M. (2011) · Europace · doi:10.1093/europace/euq430 · Cited by 93 · see citing works
Self-citationKOTTKAMP, H., HINDRICKS, G., SHENASA, H., CHEN, X., WICHTER, T., BORGGREFE, M., & BREITHARDT, G. (1996) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1996.tb00466.x · Cited by 91 · see citing works
Self-citationDelaney, B., Loy, J., & Kelly, A.-M. (2011) · European Journal of Emergency Medicine · doi:10.1097/mej.0b013e3283400ba2 · Cited by 91 · cited 7× · see citing works
“Termination with a QRS complex is often seen in AT, and possibly in atypical AVNRT, and AVRT.”
BackgroundInfluentialReversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
Myerburg, R. J., Kessler, K. M., Cox, M. M., Huikuri, H. V., Terracall, E., Interian, A., Fernandez, P., & Castellanos, A. (1989) · Circulation · doi:10.1161/01.cir.80.6.1571 · Cited by 91 · see citing works
Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias
Jastrzebski, M., Kukla, P., Czarnecka, D., & Kawecka-Jaszcz, K. (2012) · EP Europace · doi:10.1093/europace/eus015 · Cited by 91 · see citing works
Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children.
Raja, P., Hawker, R. E., Chaikitpinyo, A., Cooper, S. G., Lau, K. C., Nunn, G. R., Cartmill, T. B., & Sholler, G. F. (1994) · Heart · doi:10.1136/hrt.72.3.261 · Cited by 91 · see citing works
Prevalence and natural course of ectopic atrial tachycardia
Poutiainen, A. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1313 · Cited by 90 · see citing works
Dandamudi, G., Mokabberi, R., Assal, C., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.05.033 · Cited by 90 · see citing works
Differential diagnosis of regular, narrow-QRS tachycardias
Katritsis, D. G., & Josephson, M. E. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.046 · Cited by 89 · see citing works
Self-citationElectrical cardioversion during pregnancy: safe or not?
Tromp, C. H. N., Nanne, A. C. M., Pernet, P. J. M., Tukkie, R., & Bolte, A. C. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0077-5 · Cited by 89 · see citing works
Wolf, C. M., Arad, M., Ahmad, F., Sanbe, A., Bernstein, S. A., Toka, O., Konno, T., Morley, G., Robbins, J., Seidman, J. G., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.726752 · Cited by 89 · see citing works
Prevalence of atrial tachyarrhythmia in adults after Fontan operation
Quinton, E., Nightingale, P., Hudsmith, L., Thorne, S., Marshall, H., Clift, P., & de Bono, J. (2015) · Heart · doi:10.1136/heartjnl-2015-307514 · Cited by 88 · see citing works
Ludmer, P. L., McGowan, N. E., Antman, E. M., & Friedman, P. L. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80478-3 · Cited by 88 · see citing works
Koyak, Z., Kroon, B., de Groot, J. R., Wagenaar, L. J., van Dijk, A. P., Mulder, B. A., Van Gelder, I. C., Post, M. C., Mulder, B. J. M., & Bouma, B. J. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.07.029 · Cited by 88 · see citing works
Radiofrequency catheter ablation of atriofascicular and nodoventricular Mahaim tracts.
Grogin, H. R., Lee, R. J., Kwasman, M. A., et al. (1994) · Circulation · doi:10.1161/01.cir.90.1.272 · Cited by 88 · see citing works
Flagged first, then by citations
1 of the 447 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 2,605 · see citing works
Self-citationGelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,338 · see citing works
Self-citation2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292 · see citing works
Self-citationBrugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,278 · see citing works
Self-citationHernández‐Madrid, A., Paul, T., Abrams, D. J., Aziz, P. F., Blom, N. A., Chen, J., Chessa, M., Combes, N., Dagres, N., Diller, G., et al. (2018) · EP Europace · doi:10.1093/europace/eux380 · Cited by 327 · see citing works
Self-citationLinde, C. M., Bongiorni, M. G., Birgersdotter-Green, U. M., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Gelder, I. C. V., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 298 · see citing works
“Orthodromic re-entrant tachycardia is twice as common in men as in women.(30,73,77) This correlates to the doubled incidence of accessory pathways in men as compared with women, and consequently, VF due to an antegradely conducting accessory pathway occurs less often in women than men.”
BackgroundSelf-citationDan, G., Martínez‐Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaïta, F., Gelder, I. C. V., Görenek, B., Kaski, J. C., Kjeldsen, K. P., et al. (2018) · EP Europace · doi:10.1093/europace/eux373 · Cited by 234 · see citing works
Self-citationAn Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease
Linhart, A., Germain, D. P., Olivotto, I., Akhtar, M. M., Anastasakis, A., Hughes, D. A., Namdar, M., Pieroni, M., Hagège, A. A., Cecchi, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1960 · Cited by 233 · see citing works
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T., Steffel, J., Marín, F. R., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 225 · see citing works
Self-citation2023 HRS expert consensus statement on the management of arrhythmias during pregnancy
Joglar, J. A., Kapa, S., Saarel, E. V., Dubin, A. M., Görenek, B., Hameed, A. B., de Melo, S. L., Leal, M. A., Mondesert, B. A., Pacheco, L. D., et al. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.05.017 · Cited by 165 · see citing works
Self-citationThe role of amiodarone in contemporary management of complex cardiac arrhythmias
Mujović, N. M., Dobrev, D., Marinković, M. M., Russo, V., & Potpara, T. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104521 · Cited by 127 · see citing works
Management of atrial high-rate episodes detected by cardiac implanted electronic devices
Freedman, B., Boriani, G., Glotzer, T. V., Healey, J. S., Kirchhof, P. F., & Potpara, T. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.94 · Cited by 120 · see citing works
Self-citationArnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H. G., Chin, A., Coats, A. J. S., Deharo, J., Svendsen, J. H., Heidbüchel, H., Isa, R., et al. (2019) · EP Europace · doi:10.1093/europace/euz046 · Cited by 120 · see citing works
Self-citationNielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 102 · see citing works
Self-citationNielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98 · see citing works
Self-citationMerino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 105 · see citing works
Self-citationSupraventricular tachycardia: An overview of diagnosis and management
Kotadia, I., Williams, S. E., & O'Neill, M. D. (2020) · Clinical Medicine · doi:10.7861/clinmed.cme.20.1.3 · Cited by 95 · see citing works
Boriani, G., Fauchier, L., Aguinaga, L., Beattie, J. M., Lundqvist, C. B., Cohen, A. A., Dan, G., Genovesi, S., Israel, C. W., Joung, B., et al. (2018) · EP Europace · doi:10.1093/europace/euy110 · Cited by 92 · see citing works
Self-citationInappropriate sinus tachycardia
Olshansky, B., & Sullivan, R. M. (2019) · EP Europace · doi:10.1093/europace/euy128 · Cited by 80 · see citing works
Management of ventricular electrical storm: a contemporary appraisal
Kowlgi, G. N., & Cha, Y. (2020) · EP Europace · doi:10.1093/europace/euaa232 · Cited by 80 · see citing works
Atrial Flutter, Typical and Atypical: A Review
Cosío, F. G. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2017.5.2 · Cited by 143 · see citing works
Self-citationJunctional ectopic tachycardia in infants and children
Kylat, R. I., & Samson, R. A. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12282 · Cited by 70 · see citing works
Arrhythmia-Induced Cardiomyopathy
Sossalla, S. T., & Vollmann, D. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0335 · Cited by 70 · see citing works
Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter
Çelikyurt, U., Knecht, S., Kuehne, M., Reichlin, T., Muehl, A., Spies, F., Osswald, S., & Sticherling, C. (2016) · EP Europace · doi:10.1093/europace/euw343 · Cited by 52 · see citing works
Katritsis, D. G., Wellens, H. J. J., & Josephson, M. E. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:35:1 · Cited by 50 · see citing works
Self-citationBravo, L., Atienza, F., Eídelman, G., Ávila, P., Pelliza, M., Castellanos, E., Loughlin, G., Datino, T., Torrecilla, E. G., Almendral, J. M., et al. (2017) · EP Europace · doi:10.1093/europace/eux269 · Cited by 49 · see citing works
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.004 · Cited by 42 · see citing works
Self-citationThomas, D., Christ, T., Fabritz, L., Goette, A., Hammwöhner, M., Heijman, J., Kockskämper, J., Linz, D., Odening, K. E., Schweizer, P. A., et al. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1377-1 · Cited by 40 · see citing works
Clinical and Electrophysiological Correlates of Incessant Ivabradine-Sensitive Atrial Tachycardia
Banavalikar, B., Shenthar, J., Padmanabhan, D., Valappil, S. P., Singha, S., Kottayan, A., Ghadei, M. K., & Ali, M. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007387 · Cited by 39 · see citing works
Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study
Holt, A., Nouhravesh, N., Strange, J. E., Nielsen, S. K., Schjerning, A.-M., Rasmussen, P. V., Torp-Pedersen, C. T., Gislason, G., Schou, M., McGettigan, P., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad834 · Cited by 40 · see citing works
Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
Plastiras, S. C., & Moutsopoulos, H. Μ. (2021) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.43 · Cited by 35 · see citing works
Supraventricular arrhythmia in pregnancy
Ramlakhan, K. P., Kauling, R. M., Schenkelaars, N., Segers, D., Yap, S., Post, M. C., Cornette, J. M. J., & Roos‐Hesselink, J. W. (2022) · Heart · doi:10.1136/heartjnl-2021-320451 · Cited by 36 · see citing works
Steenkiste, G. V., Boussy, T., Duytschaever, M. F., et al. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16473 · Cited by 34 · see citing works
Symptom challenges after atrial fibrillation ablation
Wood, K., Barnes, A. H., Paul, S., Hines, K. A., & JACKSON, K. P. (2017) · Heart & Lung · doi:10.1016/j.hrtlng.2017.08.007 · Cited by 32 · see citing works
Self-citationNatural history and clinical outcomes of inappropriate sinus tachycardia
Shabtaie, S. A., Witt, C. M., & Asirvatham, S. J. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14288 · Cited by 32 · see citing works
Aksu, U., Kalkan, K., Gülcü, O., et al. (2019) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22736 · Cited by 30 · see citing works
Common Supraventricular and Ventricular Arrhythmias in Children
Kafali, H. C., & Ergül, Y. (2022) · Turkish Archives of Pediatrics · doi:10.5152/turkarchpediatr.2022.22099 · Cited by 29 · see citing works
Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence
Shah, S. R., Luu, S.-W., Calestino, M., David, J., & Bray, C. (2018) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2018.1514932 · Cited by 26 · see citing works
“patient before, during and after cardioversion [47].”
BackgroundInfluentialCardiac Arrhythmias and Pregnancy
Macintyre, C. J., Iwuala, C., & Parkash, R. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0660-9 · Cited by 26 · see citing works
Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias
Lavalle, C., Magnocavallo, M., Straito, M., Santini, L., Forleo, G. B., Grimaldi, M., Badagliacca, R., Lanata, L., & Ricci, R. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071456 · Cited by 24 · see citing works
Giehm-Reese, M., Kronborg, M. B., Lukáč, P., Kristiansen, S. B., Nielsen, J. M., Johannessen, A. C., Jacobsen, P. K., Djurhuus, M. S., Riahi, S., HANSEN, P. S., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.077 · Cited by 23 · see citing works
Hill, A. C., Silka, M. J., & Bar‐Cohen, Y. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13662 · Cited by 21 · see citing works
Non-coding RNA and arrhythmias: expression, function, and molecular mechanism
Zeng, Y., Wu, N., Zhang, Z., Zhong, L., Li, G., & Li, Y. (2023) · EP Europace · doi:10.1093/europace/euad047 · Cited by 21 · see citing works
Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease
Lundqvist, C. B., Potpara, T., & Malmborg, H. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:29:3 · Cited by 20 · see citing works
Self-citationPharmacotherapeutic strategies for atrial fibrillation in pregnancy
Georgiopoulos, G. A., Tsiachris, D., Kordalis, A., Kontogiannis, C., Spartalis, Μ., Pietri, P., Magkas, N., & Stefanadis, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1621290 · Cited by 22 · see citing works
Vio, R., Zorzi, A., & Corrado, D. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-09996-1 · Cited by 20 · see citing works
“Inflammatory-mediated increase of ectopic activity arising from the pulmonary vein, which is a well-recognized trigger of AF [48, 50–52], may also induce focal atrial tachycardia and in patients with dual AV node pathways or accessory pathways, paroxysmal supraventricular tachycardia [53].”
BackgroundDifferential Diagnosis of Wide QRS Tachycardias
Katritsis, D. G., & Brugada, J. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.20 · Cited by 19 · see citing works
Self-citationAtypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes
Ko, N. L. K., Sriramoju, A., Khetarpal, B. K., & Srivathsan, K. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000924 · Cited by 21 · see citing works
Klaver, M. N., Potter, T. J. R. D., Iliodromitis, K. E., Babkin, A., Cabrita, D., Fabbricatore, D., & Boersma, L. V. A. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15142 · Cited by 18 · see citing works
Modified Valsalva maneuver for treatment of supraventricular tachycardias: A Meta-analysis
Lan, Q., Han, B., Wu, F., Yu, P., & Zhang, Z. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.08.067 · Cited by 18 · see citing works
Sacks, N. C., Everson, K., Emden, M. R., Cyr, P. L., Wood, D., Raza, S., Wood, K., & Pokorney, S. D. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015910 · Cited by 16 · see citing works
Self-citationSupraventricular tachycardia diagnosed by smartphone ECG
Tabing, A. K., Harrell, T., Romero, S. C., & Francisco, G. M. (2017) · BMJ Case Reports · doi:10.1136/bcr-2016-217197 · Cited by 16 · see citing works
Glover, B. M., Chen, J., Hong, K. L., Bovéda, S., Baranchuk, A. M., Haugaa, K. H., Dorian, P., Potpara, T., Crystal, E., Mitchell, B., et al. (2016) · EP Europace · doi:10.1093/europace/euw402 · Cited by 17 · see citing works
Self-citationRandomized trial of intracardiac echocardiography-guided slow pathway ablation
Kupó, P., Sághy, L., Bencsik, G., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01126-y · Cited by 14 · see citing works
Management of pregnant patients with pulmonary arterial hypertension
Zhang, X., & Huangfu, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1029057 · Cited by 15 · see citing works
“By the same token, since patients with congenital heart disease do not typically tolerate atrial flutter effectively, electrical cardioversion should be performed to restore sinus rhythm (94).”
BackgroundBrazilian Guideline for Exercise Test in the Adult Population – 2024
de Carvalho, T., de Freitas, O. G. A., Chalela, W. A., Hossri, C. A. C., Milani, M., Buglia, S., Précoma, D. B., Falcão, A. M. G. M., Mastrocola, L. E., Castro, I., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240110i · Cited by 15 · see citing works
Hu, J., Yu, J., Chen, Q., Hu, J., Huang, Q., Xia, Z., Xia, Z., Ju, Z., Yuan, P., Fan, S. L., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012511 · Cited by 14 · see citing works
Schultz, K. E., Lui, G. K., McElhinney, D. B., Long, J., Balasubramanian, V., Sakarovitch, C., Fernandes, S. M., Dubin, A. M., Rogers, I. S., Romfh, A., et al. (2019) · Congenital Heart Disease · doi:10.1111/chd.12736 · Cited by 14 · see citing works
Evans, J. M., Withers, K. L., Lencioni, M., et al. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13675 · Cited by 14 · see citing works
Self-citationHu, T., Chen, T., Maduray, K., Han, W., & Zhong, J. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2506191 · Cited by 12 · see citing works
Chen, J., Lenarczyk, R., Bovéda, S., Tilz, R. R., Hernández‐Madrid, A., Ptaszynski, P. A., Pudulis, J., & Dagres, N. (2017) · EP Europace · doi:10.1093/europace/eux001 · Cited by 13 · see citing works
Self-citationUnderuse of Catheter Ablation as First‐Line Therapy for Supraventricular Tachycardia
Oliveira, L. H., Viana, M. S., Luize, C. M., de Carvalho, R. S., Cirenza, C., Dietrich, C. D. O., Correia, L. C. L., das Virgens, C., Filgueiras, J. M., Barreto, M. A., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022648 · Cited by 14 · see citing works
2025 Clinical practice guidelines for Supraventricular tachycardias
Popov, S. V., Davtyan, K. V., Shubik, Y. V., Artyukhina, Е. А., Базаев, В. А., Batalov, R. E., Bokeria, L. A., Bubnova, M. G., Vygovsky, A. B., Sp, G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6448 · Cited by 12 · see citing works
Turkish Society of Cardiology Consensus Paper on Management of Arrhythmia-Induced Cardiomyopathy
Ulus, T. (2019) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2019.60687 · Cited by 11 · see citing works
Podolec, P. S., Baranchuk, A. M., Brugada, J., Kukla, P., Lelakowski, J., Kopeć, G., Rubiś, P., Stępniewski, J., Podolec, J., Komar, M., et al. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4451 · Cited by 11 · see citing works
Electrical Storm: Current Evidence, Clinical Implications, and Future Perspectives
Kontogiannis, C., Tampakis, K., Georgiopoulos, G. A., Bartoletti, S., Papageorgiou, C., Anninos, H., Kapelouzou, A., Spartalis, Μ., PARASKEVAIDIS, I. A., & Chatzidou, S. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1190-0 · Cited by 11 · see citing works
Glover, B. M., Chen, J., Hong, K. L., Bovéda, S., Baranchuk, A. M., Haugaa, K. H., Dorian, P., Potpara, T., Crystal, E., Mitchell, B., et al. (2017) · EP Europace · doi:10.1093/europace/euw392 · Cited by 11 · see citing works
Self-citationRetractedMaury, P., Thambo, J. B., Maltret, A., Combes, N., Hascoët, S., Derval, N., Ladouceur, M., Acar, P., Amédro, P., Anselm, F., et al. (2020) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2020.02.002 · Cited by 10 · see citing works
Katritsis, D. G., Chokesuwattanaskul, R., Zografos, T. A., Jamé, S., Paxinos, G., & Morady, F. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00935-3 · Cited by 10 · see citing works
Self-citationFrey, M. K., Richter, B., Gwechenberger, M., Marx, M., Pezawas, T., Schrutka, L., & Gössinger, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-47980-1 · Cited by 12 · see citing works
Shabtaie, S. A., Witt, C. M., & Asirvatham, S. J. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14942 · Cited by 11 · see citing works
Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system
Qian, Y., Zheng, Y., Leng, L., Liu, Q., Tian, X., Chen, S., Zhang, S., & Xie, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1538680 · Cited by 9 · see citing works
Wongcharoen, W., Lin, Y., Chung, F., Chen, Y., Chao, T., Chen, P., Chien, K., & Chen, S. (2017) · EP Europace · doi:10.1093/europace/eux115 · Cited by 9 · see citing works
Warchoł, I., Bińkowski, B. J., Kucejko, T., Sobiczewska, J., & Lubiński, A. (2019) · Medical Science Monitor · doi:10.12659/msm.912918 · Cited by 9 · see citing works
Kaneko, Y., Nakajima, T., Tamura, S., Nagashima, K., Kobari, T., Hasegawa, H., & Ishii, H. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14540 · Cited by 8 · see citing works
ASHRAF, H., FATIMA, T., ASHRAF, I., & MAJEED, S. (2023) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.39.3.6725 · Cited by 8 · see citing works
Selvaraj, R. J., Dukiya, S., Pillai, A. A., et al. (2018) · EP Europace · doi:10.1093/europace/euy146 · Cited by 8 · see citing works
Jirak, P., Shomanova, Z., Larbig, R. K., Dankl, D., Frank, N., Seelmaier, C., Butkiene, D., Lichtenauer, M., Mirna, M., Strohmer, B., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab724.0287 · Cited by 8 · see citing works
Electro‐vectorcardiographic and electrophysiological aspects of Ebstein's anomaly
Pérez‐Riera, A. R., Barbosa‐Barros, R., Raimundo, R. D., et al. (2018) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12590 · Cited by 8 · see citing works
Contractor, T. A., Swamy, P. M., Prasad, V. S., et al. (2020) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2020.06.010 · Cited by 8 · see citing works
Nikoo, M. H., Attar, A., Pourmontaseri, M., et al. (2017) · EP Europace · doi:10.1093/europace/euw434 · Cited by 8 · see citing works
Sp, G., Панченко, Е. П., Mironov, N. Y., Михайловна, Б. М., Gagloeva, D. A., Elfimova, E. M., Станиславовна, К. Е., Laiovich, L. I., Litvin, A. Y., Maykov, E. B., et al. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-3-6-77 · Cited by 8 · see citing works
Eitel, C., İnce, H., Brachmann, J., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01878-z · Cited by 7 · see citing works
Halle, M., Burgstahler, C., Gielen, S., Hambrecht, R., Laszlo, R., & Tiefenbacher, C. (2021) · Der Kardiologe · doi:10.1007/s12181-021-00483-8 · Cited by 7 · see citing works
Brazilian Guideline for Exercise Test in the Adult Population – 2024
de Carvalho, T., de Freitas, O. G. A., Chalela, W. A., Hossri, C. A. C., Milani, M., Buglia, S., Précoma, D. B., Falcão, A. M. G. M., Mastrocola, L. E., Castro, I., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240110 · Cited by 28 · see citing works
Kaiser, D. W., Nasir, J. M., Liem, L. B., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.11.021 · Cited by 7 · see citing works
Leandro, H. I. C., Lebedev, D. S., & Mikhaylov, E. N. (2019) · PubMed Central · doi:10.11909/j.issn.1671-5411.2019.04.008 · Cited by 7 · see citing works
Медведев, М. М. (2020) · Journal of Arrhythmology · doi:10.35336/va-2019-3-48-56 · Cited by 7 · see citing works
Hennecken, J., Arends, B. K. O., Mast, T. P., Dekker, L., van der Harst, P., Blaauw, Y., Dichtl, W., Senoner, T., Hassink, R. J., Loh, P. K. K., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.14385 · Cited by 6 · see citing works
Laursen, S. B., Pareek, M., Polcwiartek, C., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132717 · Cited by 6 · see citing works
Maglia, G., Pentimalli, F., Verlato, R., Solimene, F., Malacrida, M., Aspromonte, V., Bacino, L., Turrini, P., Infusino, T., Greca, C. L., et al. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01519-7 · Cited by 6 · see citing works
“The main findings of our study were as follows: [1] AFL ablation was highly effective in achieving acute CTI Fig.”
BackgroundResultOnuki, T., Shoji, M., Sugiyama, H., Arai, S., Yoshikawa, K., Mase, H., Kurata, M., Kikuchi, M., Wakatsuki, D., Asano, T., et al. (2021) · Clinical Cardiology · doi:10.1002/clc.23594 · Cited by 6 · see citing works
The Challenge of Managing Atrial Fibrillation during Pregnancy
Lucà, F., Oliva, F. G., Abrignani, M. G., Russo, M. G., Parrini, I., Cornara, S., Ceravolo, R., Rao, C. M., Favilli, S., Pozzi, A., et al. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2410279 · Cited by 6 · see citing works
Intermittent Ventricular Pre‐Excitation: Clinical Features and Electrophysiological Properties
Robles, A. G., Palamà, Z., Santoro, F., Rauber, M., Antolič, B., Gianfrancesco, D., Bartolomucci, F., Pellegrino, P. L., Alfieri, S., Borelli, A., et al. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70035 · Cited by 5 · see citing works
Gangaram, P., Pillay, Y., Pillay, B. C., & Alinier, G. (2020) · Qatar medical journal · doi:10.5339/qmj.2020.33 · Cited by 7 · see citing works
Caldarola, P., Iaco, F. D., Pugliese, F. R., Luca, L. D., Fabbri, A., Riccio, C., Scicchitano, P., Vanni, S., Pasquale, G. D., Gulizia, M. M., et al. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad110 · Cited by 5 · see citing works
Yang, J., Zhou, G., Sun, Q., Guo, X., Liu, X., Luo, B., Wei, H., Liang, J. J., Xie, S., Ouyang, F. O., et al. (2017) · EP Europace · doi:10.1093/europace/eux354 · Cited by 5 · see citing works
Vio, R., Zorzi, A., & Corrado, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_19 · Cited by 5 · see citing works
Sex and cardiac electrophysiology
Locati, E. T., Bagliani, G., Ciconte, G., & Pappone, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817728-0.00036-x · Cited by 5 · see citing works
Self-citationHave the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?
Lane, J. D., & Tinker, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00890 · Cited by 4 · see citing works
- Authors
- Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., Lane, D. A., Lip, G. Y. H., Malmborg, H., Oral, H., Pappone, C., Themistoclakis, S., Wood, K. A., Blomström-Lundqvist, C., ESC Scientific Document Group, Gorenek, B., Dagres, N., Dan, G.-A., Vos, M. A., Kudaiberdieva, G., Crijns, H., Roberts-Thomson, K., Lin, Y.-J., Vanegas, D., Caorsi, W. R., Cronin, E., & Rickard, J.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Modena and Reggio Emilia (IT)
- Hospital Universitario De Getafe, Madrid, Spain
- Leipzig University (DE)
- University of Bordeaux, CHU Bordeaux, LIRYC, France
- Berth Israel Deaconess Medical Center, Boston, MA, USA
- Hospital Privado (AR)
- Korea University Medical Center (KR)
- Northwestern Memorial Hospital (US)
- Asklepios Hospital St Georg, Hamburg, Germany
- Birmingham City Hospital (GB)
- Uppsala University (SE)
- University of Michigan (US)
- IRCCS Policlinico San Donato (IT)
- Ospedale dell' Angelo (IT)
- Emory University (US)
- Department of Cardiology and Medical Science, Uppsala University, Uppsala, Sweden
- Cardiology Department, Eskisehir Osmangazi University, Eskisehir, Turkey
- Carol Davila University of Medicine and Pharmacy (RO)
- University Medical Center Utrecht (NL)
- Maastricht University Medical Centre (NL)
- Royal Adelaide Hospital (AU)
- Royal Adelaide Hospital, Adelaide, Australia
- Taipei Veterans General Hospital (TW)
- Hospital Militar Central (CO)
- Hartford Hospital (US)
- Cleveland Clinic (US)
- ORCID
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-17
- Volume
- 19
- Issue
- 3
- Pages
- 465-511
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W3023238132
- Semantic Scholar
- 19df754205fe5f0595ea538026f2df89ae21262c
- Cited by
- 188
- References
- 447
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 20 · 2020: 28 · 2019: 27 · 2018: 23 · 2017: 21 · 2016: 2
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- EP Europace (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- supraventricular arrhythmias, atrial tachycardia, arrhythmia management, antiarrhythmic therapy, catheter ablation, cardioversion, atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia
- MeSH terms
- Action Potentials, Cardiology, Diagnosis, Differential, Heart Rate, Humans, Predictive Value of Tests, Tachycardia, Supraventricular, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review